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Abstract
This thesis presents the visual analysis, clustering, and classification of contrast-enhanced
tumor perfusion magnetic resonance imaging (MRI). Perfusion MRI data plays an important
role for diagnosis of cancer. Cancer is a malignant tumor which can grow uncontrollably and
threaten life when therapy is not effective or started too late. For the evaluation of contrast-
enhanced perfusion MRI, a contrast agent is intravenously injected. It works as tracer of
perfusion and tumorous tissue can be identified due to its increased microvasculature. This
thesis focuses on two major clinical research areas. The first one is the evaluation of dynamic
contrast enhanced MRI (DCE-MRI) data for improved breast cancer diagnosis. The second
one is the evaluation of longitudinal brain tumor studies, covered by dynamic susceptibility
contrast MRI (DCS-MRI) scans. The specialty of this thesis is the underlying set of medical
image data. For both application areas, clinical image data was available and the developed
methods were carefully adapted to the clinical scope. Two frameworks were presented that
allow for visual analysis and exploration of the data sets.
As a special property of the available databases, a report for each breast tumor data set was
available. Thus, an automatic classification could be carried out. Therefore, this thesis presents
clustering techniques for breast DCE-MRI data including an automatic classification approach
based on this clustering results. As a result, the presented methods identified important features
associated with tumor heterogeneity that can be employed in clinical practice and research. In
addition, the brain tumor database contains rare cases of patients where a transformation from
low grade gliomas into high grade gliomas was monitored with DSC-MRI within a longi-
tudinal study. The thesis contributes a carefully adapted framework for this database. The
framework allows for visual analysis of the tumor progression. Furthermore, it contains a pre-
processing pipeline which maintains the analysis of different longitudinal DSC-MRI scans,
acquired at different points in time with different MRI scanners and scanning protocols. In
conclusion, although many properties of cancer are known, a fully automatic tumor classifi-
cation for the specific tumor types based on perfusion MRI does not exist in literature. This
thesis will not close this gap but make it smaller by providing heterogeneity-based features
that were indicative for tumor malignancy as well as sophisticated visual analysis techniques,
and clustering approaches for an improved cancer evaluation and a possible detection of new
discriminative features.

Zusammenfassung
Die vorliegende Dissertation präsentiert Techniken zur visuellen Analyse, sowie Cluster-
ingkonzepte, und automatische Klassifizierungansätze zur verbesserten Auswertung von Tu-
morherden in Kontrastmittel-verstärkten magnetresonanztomographischen (MRT) Perfusions-
daten. Diese Daten sind ein wichtiger Bestandteil für die Diagnose von Krebs. Krebs ist ein
bösartiger Tumor, der unkontrolliert wuchern kann und zum Tode führt, sofern keine effektive
Therapie möglich ist oder eine Therapie zu spät begonnen wurde. Bösartige Tumore zeich-
nen sich durch erhöhte Mikrovaskulatur aus und können daher mit Kontrastmittel detektiert
werden. Die Dissertation behandelt zwei Hauptanwendungsgebiete der klinischen Forschung.
Das erste Anwendungsgebiet ist die Evaluation von dynamic contrast-enhanced (DCE) MRT
Daten für eine verbesserte Brustkrebsdiagnose. Das zweite Anwendungsgebiet ist die Eval-
uation von longitudinalen Kopftumorstudien, akquiriert mit dynamic susceptibility contrast
(DSC) MRT Daten. Für beide Anwendungsgebiete gab es eine besondere Sammlung von
Datensätzen, die eine zielgerichtete Entwicklung von Methoden ermöglichten um klinische
Forschungsfragen zu beantworten. Für die visuelle Analyse und Exploration wurden zwei
verschiedene Software-Prototypen im Rahmen dieser Arbeit entwickelt.
Die Brustkrebstumordatenbank ist für die Computer-gestützte Auswertung besonders wertvoll,
da für jeden Tumor ein Befund zur Verfügung gestellt wurde. Somit konnten zusätzlich
Clusteringtechniken weiterentwickelt und angepasst werden, die die Ausgangslage für die
Adaption von komplexen Klassifizierungansätzen bildeten. Ein Ergebnis dieser Arbeit ist die
Identifikation von wichtigen Tumorattributen (welche eine automatische Abschätzung der Tu-
morheterogenität erlauben), die in der klinischen Forschung und Praxis Anwendung finden
können. Weiterhin enthält die Kopftumordatenbank eine Sammlung von seltenen Fällen, in
denen Patienten mit einem niedriggradigem Gliom regelmäßig mittel MRT-gestützter Perfu-
sionsbildgebung über einige Jahre kontrolliert wurden. Alle niedriggradigen Gliome entwick-
elten sich zu einem höhergradigem Gliom während dieses Zeitraums. In dieser Arbeit wird
ein Framework vorgestellt, welches die visuelle Analyse der Tumorprogression (und somit der
Gliomtransformation) unterstützt. Außerdem wurde eine Vorverarbeitungskette entwickelt,
die es ermöglicht verschiedene Perfusionsdaten einer Longitudinalstudie miteinander zu ver-
gleichen. Dabei müssen verschiedene MRT-Scanner und Scanningprotokollparameter berück-
sichtigt werden. Obwohl viele Eigenschaften von bösartigen Tumoren bekannt sind, existiert
keine exakte automatische Klassifikation für die präsentierten Spezialfälle in der Literatur.
Die vorliegende Dissertation leistet einen wichtigen Beitrag für die verbesserte automatische
Klassifikation, in dem Heterogenitätsbasierte Eigenschaften identifiziert werden, welche mit
der Tumorbösartigkeit korrelieren. Weiterhin ermöglicht die visuelle Analyse in Kombination
mit Clustering eine verbesserte Auswertung der Krebsdaten.
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Introduction
1 Introduction
In these early years of the 21st century, the broad group of cancer-related diseases often lead-
ing to cancer-related deaths is a major challenge for clinicians and biomedical researchers.
Cancer is a malignant tumor which can grow uncontrollably and threaten life when therapy is
not effective or started too late. With the development in the area of medical imaging, detec-
tion of cancer has been improved and diagnoses as well as therapies benefit from the newly
available information. However, a manifold of challenges still remains when interpreting the
medical image data. An important clinical research area is the evaluation of perfusion mag-
netic resonance imaging (MRI). A contrast agent is injected that works as tracer of perfusion.
Even early stages of cancer develop an increased demand for oxygen and nutrients causing
angiogenesis, the growing and sprouting of new or existing vessels. Angiogenesis is the key
for perfusion imaging, as it causes increased perfusion in tumorous tissue. Two variants are
exploited for perfusion MRI acquisition: the T2 effect, covered with a dynamic susceptibility
contrast MRI (DCS-MRI) scan, and the T1 effect, covered with a dynamic contrast enhanced
MRI (DCE-MRI) scan. This thesis focuses on the improved evaluation of breast cancer based
on DCE-MRI data, and longitudinal brain tumors monitored with DSC-MRI. The diagnosis
based on time-varying 4D MRI perfusion data benefits from dedicated support by computer-
aided systems. Although many cancer properties are known, a fully automatic tumor classifi-
cation for the mentioned specific tumor types does not exist in literature. This is why the thesis
will not close the gap but make it smaller. A great variety still exists among these diseases,
and the application scenario is narrowed down to two important clinical research areas:
• Small breast lesions, only detectable in perfusion MRI and not conventional X-ray mam-
mography.
• Low grade gliomas of the brain which in special cases are subject to lifelong monitoring
to detect a transformation into a high grade glioma.
Regarding breast cancer, two major aspects are analyzed in more detail. First, the manual and
error-prone placement of regions of interest by an expert could mislead the tumor classification
as well as further diagnosis like core needle biopsy. Second, the high sensitivity of DCE-MRI
is the main reason for employing it in breast cancer detection, but its low specificity (when
compared to conventional X-ray mammography) demands for computer-aided improvement.
For gliomas of the brain, many studies in the literature reported a correlation between tumor
progression, surveillance rate, and tumor grade with a specific perfusion parameter - cerebral
blood volume - that can only be extracted from perfusion DSC-MRI scans. However, the anal-
ysis of longitudinal scans involves many preprocessing steps and challenges when comparing
different scans, acquired at different points in time, different MRI scanners, and even different
scanning protocols.
The contribution of this thesis is the improvement of these aspects via visual analysis-based
exploration and visualization, clustering methods to extract a tumor’s most malignant part,
and classification analyses to extract a feature set that is most indicative for tumor malignancy
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regarding the heterogeneity of contrast enhancement kinetics. In particular, the combination of
these techniques tailored to tumor perfusion data sets is based on two very specific databases.
This is in contrast with many computer science-motivated approaches where only a small
number of cases is available for initial tests or exploration. The breast tumor database is a
clinical study comprising small suspicious breast tumors detected in perfusion MRI where
a ground truth was discovered via histopathologic reports or follow-up studies. The tumors
could not be detected in X-ray mammography and thus represent a very special and important
collection of tumors. Likewise, the longitudinal brain tumor perfusion database is important
for clinical research. In clinical practice, these data sets are not evaluated with visual analytic
methods. However, they bear great potential for such an evaluation, which will be presented
later on. In summary, the amount of data and the clinical background information allow for
a target-oriented combination of computer science algorithms for the clinical research and
practice.
This thesis was created within the priority program “Scalable Visual Analytics” (DFG SPP
1335) of the German research council. The goal of the project “Efficient Visual Analysis of
Dynamic Medical Image Data” was not only the visual exploration of the time-dependent med-
ical perfusion data but the integration from sophisticated data mining methods as well, yield-
ing the visual analytics approaches. Based on a thorough cooperation with Dr. Uta Preim,
a professional radiologist with many years of experience, this thesis’ contribution is the vi-
sual analysis of brain and breast tumor perfusion data, including carefully application-adapted
sophisticated clustering and classifier algorithms for the radiologists in clinical practice and
clinical research. The thesis at hand is organized as follows:
• Chapter 2 covers the medical imaging of tumor perfusion data restricted to breast and
brain tumors. In addition to the medical background and MR imaging modalities, the
calibration of signal intensities and the extraction of perfusion parameters are described.
Goals for this thesis are listed at the end of this chapter.
• Chapter 3 is dedicated to the clustering of medical perfusion data due to the importance
of this subject for the subsequent analyses. Hence, a general categorization of clus-
ter analysis is presented with focus on density-based clustering, detection of attribute
dependency dimensional reduction, and region merging.
• Chapter 4 covers the related work that has been presented in literature, starting from a
more general aspect - the visualization of high-dimensional data - and proceeding to the
evaluation of breast tumors in DCE-MRI data as well as the evaluation of low and high
grade gliomas in DSC-MRI data.
• Chapter 5 introduces the PerfusionAnalyzer framework. This framework was developed
in this thesis to allow for a 2D visual exploration of breast tumor perfusion data including
a lesion detection method, a glyph visualization, a region merging approach and the new
File-Card-Browser View. Furthermore, a combination of the DCE-MRI perfusion data
set with T2-weighted MRI data is suggested.
• Chapter 6 comprises 3D exploration techniques for breast perfusion data, including a
new scatterplot technique to explore a tumor clustering result. This technique is not
restricted to breast perfusion data and can be adapted to other medical tomographic data
as well.
• Chapter 7 covers four classification approaches that allow for an automatic classification
of small breast tumors, only detectable in perfusion DCE-MRI. Hence, the focus is set
3
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to the analysis of heterogeneity regarding the contrast enhancement kinetics. The clas-
sification approaches can be integrated in current breast evaluation systems in clinical
practice.
• Chapter 8 focuses on the visual analysis of longitudinal brain perfusion tumor scans for
characterization of low grade gliomas and their transformation into high grade gliomas.
The presented framework visualizes the longitudinal studies and highlights perfusion
parameter changes.
• Chapter 9 holds the conclusion of this thesis including a discussion of the presented
methods and future application areas for the designated techniques.
4
2.
2.
Medical Imaging of Tumor
Perfusion
Medical Imaging of Tumor
Perfusion
2 Medical Imaging of Tumor Perfusion
Medical imaging of tumor perfusion plays a more and more important role for tumor diagno-
sis. This thesis covers two important medical research areas: the evaluation of breast tumor
perfusion and brain tumor perfusion with magnetic resonance imaging (MRI). For perfusion
MRI, basically two variants are exploited: the T ∗2 effect, covered with a dynamic susceptibility
contrast (DSC) MRI scan, and the T1 effect, covered with a dynamic contrast enhanced (DCE)
MRI scan.
In this chapter, the reader is introduced to breast and brain tumor diagnosis as well as the
MRI sequences, dedicated to these application scenarios. Section 2.1 refers to breast tumors.
Medical background information is provided to understand tumors and their neoangiogenetic
activity that is fundamental for perfusion imaging.
Afterwards, Perfusion MRI is explained and the different weighted DSC-MRI and DCE-MRI
scans are described in more detail. For breast tumor perfusion imaging, T1-weighted DCE-
MRI data sets are acquired and the image acquisition as well as the calibration of the acquired
MRI signal intensities are explained.
Likewise, the Section 2.2 covers the medical background of brain tumors. Due to the specific
cerebral vasculature system encompassed by the blood brain barrier, the human brain provides
a unique environment, favoring a T ∗2 -weighted MRI sequence and dedicated methods for the
conversion from time-intensity curves to concentration-time curves. This chapter is concluded
with a summary and the identification of the important goals for this thesis.
2.1 Perfusion Imaging for Breast Cancer Diagnosis
This section comprises the anatomy of the breast and the medical background for breast tumors
including diagnosis and treatment planning. In the second part of this section, DCE-MRI
and DSC-MRI are described in more detail, revealing the advantages of each method for the
specific medical application area. Afterwards, a more detailed analysis of DCE-MRI of breast
tumors, including the image acquisition, calibration of signal intensities, and MR-based tumor
classification, is provided.
2.1.1 Medical Background
This section deals with the anatomy of the breast. Furthermore, breast cancer and the ac-
companying neoangiogenesis is described, followed by a short description of diagnosis and
treatment planning.
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Anatomy of the Breast
The human breasts (mammae) overlay the pectoralis muscles and cover the chest area and
chest wall. The male breasts are in a rudimentary state, whereas the female breasts equal two
hemispherical eminences. In adult women, breasts are milk-producing, tear-shaped glands and
their primary function is the nourishing of an infant child. In Figure 2.1, the anatomy of the
breast is illustrated. The breast consists of gland, fibrous, and fatty tissue. These tissue types
hold and sustain the inner parts of the breast, like the lobes and the ducts. In general, each
breast has 12 to 20 lobes that are arranged in a circular manner. Each lobe comprises many
lobules which end with tiny bulb like glands, where milk is produced in response to hormonal
signals. The lobes are covered by fatty tissue, that gives the breast its size and shape. The ducts
connect the glands and lobes. After child birth, milk is produced in the lobules and transported
to the nipple (papilla mamilla), the tip of the breasts, via the ducts. As a mammary gland, the
breast is an inhomogeneous anatomic structure.
Figure 2.1: Anatomy of the human female breast. The ducts connecting the lobules to the tip
of the nipple. The areola is the darker-pigmented area around the nipple. (Adapted from an
illustration by Patrick J. Lynch, medical illustrator.)
The breasts’ blood supply is maintained by arteries from the thoracic branches of the axillary
artery, the intercostal artery and the internal thoracic artery. The veins are ordered in an anas-
tomotic circle around the nipple. Deriving from this circle, large branches transmit blood to
the circumference of the gland before they end in the axillary and internal mammary veins.
Breast Cancer
Like all cancers, breast cancer is caused by a cell mutation and it originates from breast tissue.
Ductal carcinomas refer to cancers originating from the ducts. Lobular carcinomas denote
cancer originating from the lobules.
After invasive breast cancers grow beyond a size of a few mm, they have a higher oxygen and
nutrients demand that exceeds the supply through normal vessels of the glandular tissue. With
increasing tumor growth, the gap between demand and supply is increasing as well. Therefore
peptide hormones, like the vascular endothelial growth factor (VEGF), are released, causing
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the formation of new vessels and or sprouting of existing vessels [Folkman, 1990, 1995]. This
process is called angiogenesis or neoangiogenesis and is depicted in Figure 2.2. These newly
formed vessels are very permeable. Thus, they allow for a leakage of proteins or contrast
agent, a very important effect for breast cancer imaging. During neoangiogenesis and tumor
growth, breast cancer may reach an advanced stage and may spread metastasis to lymph nodes
or more distant parts of the body, mostly the bones, the lung, the liver or the brain.
Tumor GrowthBlood Vessel GrowthVEGF (  ) Release
Figure 2.2: Illustration of angiogenesis. The tumor’s increased demand for oxygen and nutri-
ents causes the release of proteins, mainly the VEGF, which in turn causes formation of new
vessels and sprouting of existing ones. These vessels allow for tumor growth.
Breast cancer is the most common incident cancer and cause of cancer-related death in women.
In Germany, incidence and mortality rates (for women in 2008) were 171.1 per 100,000
and 41.1 per 100,000 [The Robert Koch-Institute, 2012]. For international comparison, age-
standardization is carried out to account for the national age distribution. Age-standardized
incidence and age-standardized mortality was 123.1 per 100,000 and 24.6 per 100,000 for the
year 2008 [The Robert Koch-Institute, 2012]. Similar age-standardized rates were reported for
developed countries. The age-standardized survival rates from breast cancer slowly increased
in developed countries to 85% due to improved screening practices and treatments, whereas
the survival rates remains 50-60% in developing countries [International Agency for Re-
search on Cancer, 2008]. Furthermore, the incidence rate is increasing in developed countries.
This rise (in contrast to the mortality rate) is interpreted as direct consequence of the improved
screening practices. This disease mostly occurs in women, i.e., less than 1% of all breast
cancer patients are male [Sasco et al., 1993].
The risk factors for breast cancer are female sex, age, the lack of childbearing (or late child
birth), the lack of breastfeeding, and the age at menarche and menopause (i.e., the risk of breast
cancer increases with cumulative number of ovarian cycles) [Collaborative Group on Hor-
monal Factors in Breast Cancer, 2002, International Agency for Research on Cancer, 2008].
The family history, i.e., a family relative that developed breast cancer, does also lead to an
increased breast cancer risk. This relationship may be caused by low-penetrance genes, par-
ticularly the CYP19 gene, or high-penetrance genes, e.g., BRCA1, BRCA2, and p53, but
these genes are rare in most populations and only cause a small fraction of total cases [In-
ternational Agency for Research on Cancer, 2008]. Although the incidence and mortality for
breast cancer varies between countries, it is assumed that environmental factors are of greater
importance than the genetic factors [McPherson et al., 2000].
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For the exact description of breast cancer and its properties, like size or shape, a classification
is carried out. There are different ways based on several underlying classification systems.
The three most common approaches are:
• The histopathological analysis.
• The tumor grading.
• The staging of the tumor’s spread.
For histopathological analysis, breast tissue is removed and histopathological characteristics
are evaluated with light microscopy. The three major histopathological types are the invasive
ductal carcinoma, the ductal carcinoma in situ, and the invasive lobular carcinoma. The World
Health Organization recommends detailed pathological types for histopathological classifica-
tion in [Tavassoli and Devilee, 2003].
For tumor grading, the microscopic similarity of a breast cancer cell to normal breast tissue
cells is evaluated. Three categories are possible:
(1) Low grade, for well differentiated cancer cells.
(2) Intermediate grade, for moderately differentiated cancer cells.
(3) High grade, for poorly differentiated / undifferentiated cancer cells.
Lower graded tumors have a better prognosis and can be treated more aggressively, whereas
higher grades indicate a worse prognosis, since the associated tumor cells will divide more
rapidly and tend to spread. Elston and Ellis [1991] refine this system by defining an overall
score based on tubule formation, nuclear pleomorphism, and mitotic count.
Beyond grading, the TNM classification system allows for assigning a tumor stage to describe
the extent of a person’s cancer and cancer spread. Hence, the extent of a primary tumor (T),
the existence of regional lymph node metastasis (N), and the presence of distant metastasis
(M) are taken into account [Sobin and Wittekind, 2002]. The TNM classification system is
developed and maintained by the Union for International Cancer Control.1 Since this system
includes therapy guidelines for the different TNM stages, it is important in clinical practice for
further therapy of breast cancer.
Diagnosis and Treatment Planning of Breast Cancers
Investigation of the breast comprises a clinical study, i.e., inspection and palpation of breasts
and axillary lymph nodes. If there is a unclear finding and suspicion of cancer, an imaging-
based technique is taken into account. During the last decades, several image acquisition
techniques have been employed for breast cancer diagnosis.
X-ray mammography is the most conventional and wide-spread image modality. In contrast
to other imaging techniques, it allows for detection of micro-calcification. However, the den-
sity of the breast tissue strongly influences accuracy of X-ray mammography, which is why
supplemental modalities are taken into account. Beyond X-ray mammography, breast ultra-
sound is carried out. This modality is especially well suited for dense fibrous breast tissue
that occurs in younger women. However, breast ultrasound is limited due to its resolution.
1Non-governmental organization Union for International Cancer Control; www.uicc.org (12/01/2013)
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Breast MRI is currently the most sensitive imaging modality for invasive breast cancer [Kuhl,
2007]. It allows for differential diagnosis after ambiguous X-ray mammography findings. The
images provide tissue information and cross-sectional morphology. DCE-MRI is acquired for
the analysis of local perfusion and described in more detail in the following.
Once, the exact localization of the breast cancer was determined and classification took place,
further treatment can be planned. In clinical practice, the treatment is dependent of specific
cancer attributes. In general it consists of surgery, radiation therapy, medication, or any com-
bination thereof.
Due to its prevalence as most common incident cancer in women and the importance of an
early detection for the further treatment planning, breast cancer awareness campaigns aim
at getting attention for the disease. The pink ribbon, see Figure 2.3, is the symbol of these
campaigns. With the increased knowledge and attention, more women participate in screening
studies, which in turn leads to an earlier breast cancer detection. Due to these detections
of very small lesions in early tumor stages, the demand for computer-aided diagnosis for an
automatic classification increases.
Figure 2.3: A pink ribbon is the worldwide symbol for the breast cancer awareness campaign.
2.1.2 Breast Tumor Perfusion Imaging with DCE-MRI
Over the past 20 years, perfusion DCE-MRI of the breast has gained increasing importance due
to its unsurpassed sensitivity for the detection of invasive breast cancer [Heywang-Köbrunner,
1994, Kuhl, 2007]. Thus, the number of malignant cancers which are not detected (false nega-
tives) with MRI and DCE-MRI is lower compared to other imaging modalities. However, com-
pared to conventional X-ray mammography, DCE-MRI only exhibits a moderate specificity,
i.e., a relative high rate of tumors are incorrectly classified as being malignant (false posi-
tives). Therefore, many benign tumors could not be correctly classified as benign tumors and
there is a great demand for further improvements to predict malignancy in DCE-MRI [Kuhl,
2007]. DCE-MRI has the ability to reveal small tumors that could not be detected with X-ray
mammography. This might be necessary in case of an existing primary tumor, detected with
X-ray. Hence, additional small tumors in the primary tumor’s environment as well as in the
bilateral breast have to be found and identified with DCE-MRI for further treatment planning.
Moreover, suspicious tumors that could not be classified with X-ray or sonography, will be
evaluated with DCE-MRI, since additional information about the tumor’s enhancement kinet-
ics could be provided. In conclusion, the advantage of DCE-MRI of providing morphologic
and functional information makes it important for differential diagnosis.
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Role of Perfusion Imaging in the Clinical Workflow
As it was stated in Section 2.1.1, DCE-MRI data is acquired after suspicious findings during
palpation or X-ray mammography. If the evaluation of the data set reveals contrast agent
enhancement, the further treatment depends on the properties / attributes, see Figure 2.4.
Lesion enhance-
ment (LE)
No en-
hancement
Suspicious microcalcifi-
cations or architectural
distortion on Mx1
Yes
Biopsy
No
Routine
follow-up
Suspicious focal
enhancement
Hormone
induced
Repeat MRI after
altering hormonal
stiumlation
Not hormone
induced
Biopsy
Focal indeterminate / atypical enhance-
ment (well-circumscribed, delayed)
Mx1/US2
suspicious
Biopsy
Mx1/US2 in-
determinate
Biopsy
Visible by
MRI alone
Follow-up
(MR-guided
biopsy)
Diffuse en-
hancement
Clinical information,
conventional imaging
Suspicious
Biopsy
Negative
Follow-up
(not by MRI)
Figure 2.4: A guideline for the interpretation of lesion enhancement in breast MRI of the
breast in the clinical routine (adapted from [Heywang-Köbrunner and Schreer, 2001]).
1 Mx denotes X-ray mammography,
2 US denotes ultrasound.
Image Acquisition
Perfusion MRI allows for the acquisition of sequential sets of morphological data, which are
widely used for oncology and thus breast cancer diagnosis [Kuhl et al., 1999, Knopp et al.,
2001]. It is based on the MRI technique that exploits the nuclear magnetic resonance, i.e., the
electromagnetic interaction of nuclei in a magnetic field. The relaxation times differ due to the
hydrogen proton density and cause different signal intensities for the different tissue types. For
the specific aim of perfusion analysis, a contrast agent is administered as a single intravenous
bolus injection and its enhancement is tracked. Hence, it is also referred to as a tracer.
As it was stated earlier, tumor growth is strongly related to angiogenesis and thus an increased
perfusion. This effect is exploited by perfusion imaging and illustrated in Figure 2.5. Hence,
the contrast agent accumulates in the extravascular-extracellular space before it diffuses back
into the vasculature. From there, it is excreted via the kidneys. In Figure 2.5(a), tumor growth
in combination with angiogenesis and the resulting new blood capillaries are depicted. A
single voxel of the MR image is shown in Figure 2.5(b). The voxel’s extent and thus the
resolution of the resulting 4D image is characterized by the image matrix, i.e., how many
pixels are acquired in one slice, and the slice thickness. In the inlet of Figure 2.5(c), the
contrast agent administration is depicted. The MRI signal intensity changes due to contrast
agent administration yield a contrast agent enhancement curve, see Figure 2.5(d). This curve
covers the enhancement kinetics during the passage of the contrast agent. The curve shape
for the scheme from line 1 to 2 refers to the time before contrast agent injection, which took
place right after at line 2. The scheme from line 2 to 4 illustrates contrast agent leakage in
extravascular-extracellular space and its diffusion back into the vasculature. The patterns of
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increased signal intensities in perfusion MRI depend from physiological factors like vessel
density, blood flow, endothelial permeability, and the size of the extravascular-extracellular
space in which the contrast agent is distributed [Hayes et al., 2002].
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Figure 2.5: Illustration of diffusible contrast agent administration. In (a), a tumor and its
permeable vasculature are depicted. The box inlet visualizes a single voxel in (b), whose size
depends on the image matrix and the slice thickness of the MRI protocol. In (c), the contrast
agent administration is depicted, where the contrast agent bolus injection is carried out at line
2. The agent leaks into the extravascular-extracellular space (line 2 to 3) and diffuses back
into vasculature (line 3 to 4), resulting in a MR signal intensity change that is represented in
(d). (Adapted from [Gribbestad et al., 2005].)
At this point, the difference between types of contrast agent are explained. Two main types of
contrast agent exist:
• Diffusible contrast agents pass the border between the intravascular and the extravascular-
extracellular space, as depicted in Figure 2.5.
• Intravascular contrast agents do not leak into the extravascular-extracellular space but
stay inside the vessel lumen.
The first property is necessary for DCE-MRI. In contrast, DSC-MRI requires an intravascular
contrast agent. Since no intravascular contrast agents have been approved for assessing cere-
bral perfusion in the clinical routine, intravascular agents are employed for DSC-MRI as well.
However, in case of an intact blood-brain barrier, the diffusible contrast agents behave equally.
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The most commonly used group of diffusible contrast agents are the paramagnetic gadolin-
ium chelates, e.g., gadolinium diethylene triamine pentacetic acid (Gd-DTPA) [Caravan et al.,
1999].
For different MRI sequences, different effects of the contrast agent are exploited. The tracer’s
paramagnetic properties cause a decrease in the T1 and the T2 / T ∗2 properties of the water
yielding a signal enhancement in T1-weighted sequences, and a signal loss in T2 / T ∗2 -weighted
sequences. In contrast to T2 sequences, the T ∗2 sequences also depend on the magnetic field
gradient irregularities, but have a shorter relaxation time. The signal enhancement increase
in T1-weighted sequences is caused by dipole-dipole interaction, which only occurs in short
distances to the contrast agent. Thus, the T1 enhancement is only present in areas with direct
access to the contrast agent and a tracer that diffuses in the extravascular-extracellular space is
well suited for this purpose. In contrast, the T2 effect is caused by strong susceptibility-induced
gradients surrounding the contrast agent. Therefore, it is more prominent if the contrast agent
is compartmentalized [Villringer et al., 1988]. As a conclusion, these effects arise in a com-
plementary manner. As a first example, an area with a uniform and homogeneously distributed
contrast agent will cause a very large T1 effect due to the direct access, but only a very small T2
effect due to the missing gradients. On the contrary, an area with contrast agent in small com-
partments will cause a strong T2 effect, whereas the T1 effect is negligible. Thus, intermediate
contrast agent distributions causes both effects and they both compete against each other.
In conclusion, breast T1-weighted DCE-MRI sequences are acquired with a diffusible tracer
due to the direct access of breast tissue to the tracer. The signal intensity increase in T1-
weighted sequences is based on various physiological and physical factors, like tissue perfu-
sion, vessel density, angiogenesis-induced pathological capillary permeability, and volume of
the extracellular leakage space. Signal intensities arising from T2-weighted first-pass perfusion
images are more directly related to vessel density and angiogenesis-induced pathological ves-
sel permeability. T2-weighted MRI scans are applied to improve differential diagnosis for the
T1 sequence [Kuhl et al., 1997], e.g., the differentiation of small tumor lesions and cysts. The
T1-weighted sequence is adjusted such that a high spatial resolution is maintained to allow for
evaluation of the lesion’s morphology. However, any increase in spatial resolution causes an
increased acquisition time. Typically, dynamic MRI protocols comprise a dynamic acquisition
time from 60 - 120 s, with 5 - 6 acquistions, an image matrix of 512 × 512 resulting in 0.5 ×
0.5 mm2 to 0.8 × 0.8 mm2, a through-plane pixel size (section thickness) of 1-3 mm and use
fast gradient echo sequences [Kuhl, 2007]. Even with the largest image matrix, a voxel always
contains a set of different cells. Thus, the voxel’s signal intensity accumulates the different
tissue cells covered by this voxel, which is defined as partial volume effect.
Motion Correction
Perfusion DCE-MRI data sets exhibit severe motion artifacts mainly due to thorax expansion
through breathing and patient’s movement. To establish a better inter-pixel correspondence
and to reduce the interference, motion correction via image registration is carried out.
The scope of image registration of different medical image data sets is the geometrically align-
ment of these data sets. For example, the images may arise from:
• different imaging modalities (e.g., T1-weighted and T2-weighted sequences),
• different patients (e.g., from a cohort study), or
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• from the same patient but acquired at different time steps (e.g. perfusion image data or
follow-up studies).
In general, for perfusion data sets, the registration is the process of transforming the different
images arising from different points in time such that they optimally fit to the first acquired
image at the first point in time. This first image is referred to as reference image and the others
are referred to as target or template images. The optimal fit is usually quantified by a similarity
criterion based on the comparison of the reference image and the target image. The similarity
criterion can be subdivided into intensity-based criteria and geometry-based criteria. Intensity-
based criteria are based on the MR intensity of the perfusion data sets, whereas the geometry-
based criteria are based on the geometrical position of landmarks. The transformation model
of the registration can be divided into global transformations and local transformations. Global
transformations are carried out over the whole target image, whereas local transformations are
only carried out on a part of the target image. Hence, the global models are further divided
into:
• Rigid transformation, where only translation, rotation, and a combination thereof are
applied to the target image.
• Affine transformation, where translation, rotation, scaling, shearing, and a combination
thereof are applied to the target image.
• Polynomial transformations, where thin plate splines are applied to the target image.
Local transformations models include a variety of different techniques and parameters to lo-
cally fit parts of the template image to the reference image, e.g., via cubic B-spline transfor-
mations [Rueckert et al., 1999]. The motion correction of breast perfusion data is a special ap-
plication of medical image registration. A survey about breast image registration is presented
by Guo et al. [2006]. Motion correction and registration of perfusion data is also discussed in
Preim and Botha [2013].
For the optimal registration of breast DCE-MRI data, the deformation cannot be described by
affine transformations adequately due to the soft tissue of the breast. A similarity criterion to
characterize the similarity between the time step images is defined and optimized. Sophisti-
cated approaches apply a combination of rigid and non-rigid transformations [Rueckert et al.,
1999, Fischer and Modersitzki, 2002, Rohlfing et al., 2003].
A challenge in breast DCE-MRI registration is the contrast enhanced-induced increase of sig-
nal intensities. Further approaches do not only take the MR signal intensity but also pharma-
cokinetic modeling into account, as presented by Hayton [1998]. Their framework employs
the pharmacokinetic model by Tofts et al. [1995]. Schäfer et al. [2011] apply a combination of
rigid and non-rigid transformations and a pharmacokinetic modeling of breast DCE-MRI en-
hancement as presented by Radjenovic et al. [2008]. However, the pharmacokinetic modeling
may be hampered due to the very low temporal resolution of breast DCE-MRI data comprising
only five to six acquisitions.
Calibration of Signal Intensities and Perfusion Parameter Extraction
For the interpretation of the dynamic contrast enhancement of breast DCE-MRI, the following
questions arise [Kuhl and Schild, 2000]:
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• How fast does the lesion enhance?
• When does the lesion start to enhance?
• Where (within the lesion) does the lesion start to enhance?
• What happens after the initial signal increase?
For the evaluation of these criteria, different approaches exist, including a prior calibration
of signal intensities, the extraction of perfusion related parameters, and the evaluation of the
enhancement curves.
The signal intensities of breast DCE-MRI perfusion data depend on different parameters and
the MR scanning protocol. For the quantification of contrast enhancement, different normal-
ization schemes were suggested, e.g., a normalization based on the signal of fatty tissue [Hey-
wang et al., 1989] or a normalization based on the initial signal intensity at the first acquired
time step [Kaiser and Zeitler, 1989]. The latter approach is widely used in clinical prac-
tice [Kuhl et al., 1999]. Hence, the relative enhancement (RE), i.e., the percentaged signal
intensity increase is calculated:
RE =
(SIc−SI)
SI
×100, (2.1)
where SI is the pre-contrast and SIc is the post-contrast signal intensity. Pre-contrast refers to
the early phase of enhancement. In general, a strong uptake due to the bolus injection can be
observed in the beginning of contrast enhancement. Post-contrast refers to the phase following.
The RE of a voxel can be plotted over time, which is illustrated in Figure 2.6. Hence, the pre-
and post-contrast phase are also illustrated.
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Figure 2.6: Example of a T1-weighted DCE-MRI breast data set. In (a), the T1 source view at
the first time step is presented. The blue shape masks a tumor, whose average signal-intensity
(SI) curve is depicted in (b). In (c), the corresponding RE curve is visualized. (Data is courtesy
of U. Preim, Municipal Hospital Magdeburg, Germany.)
In clinical practice, the RE curves are classified into three different types [Kuhl et al., 1999]:
• steady or continuously increasing curves (also referred to as washin curves),
• plateau curves, and
• washout curves.
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See the examples in Figure 2.7(a). A steady curve is characterized by continuously increas-
ing RE values. The plateau curve exhibits a plateau shape during the intermediate and late
post-contrast phase. The washout curve is a descending curve after the initial contrast agent
washin. The washout curve, with a rapid and intense enhancement, is indicative for permeable
capillaries and neoangiogenesis and thus malignancy [Kuhl et al., 1999].
A further classification of RE curves was presented by Degani et al. [1997] and Furman-Haran
et al. [1998], who evaluated the contrast enhancement behavior at three points in time yielding
the three-time-point (3TP) method. The three time steps t ′1, t
′
2, and t
′
3 are extracted with model-
based calculations and depend on the MRI protocol that they used. Hence, t ′1 refers to the first
point in time before the contrast agent injection, t ′2 to the point in time 2min after t
′
1, and t
′
3 to
the point in time 4min after t ′2 and thus 6min after t
′
1. With the 3TP method, the initial contrast
agent accumulation (CAearly) in the early post-contrast phase is classified into
CAearly =

slow i f 0%≤ RE(t ′2)< 50%
normal i f 50%≤ RE(t ′2)< 100%
f ast i f RE(t ′2)≥ 100%.
(2.2)
Furthermore, the contrast accumulation (CAlate) in the intermediate and late post-contrast
phase is classified based on the curve’s behavior between t ′2 and t
′
3:
CAlate =

steady i f RE(t ′3)−RE(t ′2)> 10%
plateau i f |RE(t ′3)−RE(t ′2)| ≤ 10%
washout i f RE(t ′3)−RE(t ′2)<−10%.
(2.3)
By applying Eq. 2.2 and Eq. 2.3 to the RE values at the three time steps t ′1, t
′
2, and t
′
3, nine
different classes of RE curves are obtained, see Figure 2.7(b).
Beyond the classification of the RE curve shape, the RE curves are further characterized by
descriptive perfusion parameters. For breast perfusion imaging, the following parameters are
derived from the RE curve (see Fig. 2.7(c)):
• Peak enhancement (PE): the RE curve’s maximum value.
• Time to peak (TTP): the point in time where PE occurs. Washin takes place between the
first time step and TTP, whereas the washout occurs between TTP and the last point in
time. Thus, steady curves will exhibit TTP values that equal the last point in time.
• Integral: the approximated area under the curve for the whole time period.
• UpSlope: the curve’s steepness during the early postcontrast phase. Synonyms of Up-
Slope are washin, curve slope, early phase enhancement rate, and enhancement velocity.
• DownSlope: the steepness of the descending curve during the intermediate and late post-
contrast phase. A synonym for this parameter is washout.
Integral and PE yield important information about how much the lesion enhances, whereas
TTP indicates an early or late enhancement. Naturally, these parameters are well suited for
breast perfusion data because of the low temporal resolution. However, other image modalities
like brain perfusion data exhibit a higher temporal resolution and thus a more complex time-
intensity curve. Then, additional descriptive perfusion parameters may be derived, see [Preim
et al., 2009] for more information.
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Figure 2.7: In (a), the schematic drawings of the RE curve shapes steady, plateau, and washout
are presented. In (b), the 3TP classification is shown. Each curve is classified based on the
contrast enhancement between t ′1 and t
′
2 (slow, normal, and fast) and between t
′
2 and t
′
3 (steady,
plateau, and washout) yielding nine different classes. In (c), an RE curve with a washout
shape and the annotated perfusion parameters PE, TTP, Integral, UpSlope, and DownSlope is
depicted.
The extraction of physiological parameters is based on the pharmacokinetic analysis which
in turn is in general applied to the T2 sequence. Hence, the enhancement curve is fitted to
a pharmacokinetic modeled curve, e.g., based on the model described by Radjenovic et al.
[2008]. The benefit of a pharmacokinetic model fit is the possibility to extract values that are
proportional to physiological parameters like the volume of the leakage space and capillary
permeability [Tofts et al., 1999]. However, appropriate model fitting requires a high temporal
resolution, which is not available for breast perfusion data yet.
In clinical practice, the radiologist places a region of interest (ROI) in the most suspect part of
the lesion. Next, the averaged RE curve of the ROI is extracted and the shape of the RE curve
is evaluated qualitatively, i.e., the referring radiologist visually interprets the whole RE curve.
More advanced workstations do also offer automatically extracted parameter maps. However,
different recommendations for the optimal ROI size and placement exist, ranging from 3-4
pixels to the whole enhancing lesion [Mussurakis et al., 1997, Kuhl et al., 1999, Kuhl, 2007]
resulting in a substantial inter-observer variability.
Classification of Breast MRI Lesions
For the categorization of a breast lesion in MRI, the Breast Imaging Reporting and Data System
(BI-RADS) for MR imaging is applied [American College of Radiology, 2003].
The MR BI-RADS lexicon classifies a lesion as:
• mass,
• area of non-masslike enhancement, or
• a focus.
Mass refers to a space-occupying tumor. The non-masslike enhancement does not occupy any
space, but describes an enhancing area that appears normal on the pre-contrast images. The
focus is a small enhancing area of less than 5 mm size. Based on this classification and the
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Table 2.1: Categories of the MR BI-RADS by American College of Radiology [2003].
Category Assessment Follow-Up
0 Need additional imaging
evaluation
Additional imaging needed before a category
can be assigned
1 Negative Continue annual screening X-ray mammog-
raphy (for women over age 40)
2 Benign (non-cancerous)
finding
Continue annual screening X-ray mammog-
raphy (for women over age 40)
3 Probably benign Receive a 6-month follow-up X-ray mam-
mography
4 Suspicious abnormality May require biopsy
5 Highly suggestive of ma-
lignancy (cancer)
Requires biopsy
6 Known biopsy - proven
malignancy (cancer)
Biopsy confirms presence of cancer before
treatment begins
evaluation of shape, margin, and enhancement kinetics, the lesion is categorized into one of
the seven categories in Table 2.1. For masses, the shape and margin of the mass are analyzed.
Furthermore, enhancement kinetics of masses and non-masslike enhancement are evaluated,
where special care must be taken since non-masslike enhancement may also include ductal
carcinoma in situ and lobular cancers that exhibit inconsistent angiogenetic activity.
Benign tumors are predominantly more homogeneous [Okafuji et al., 2008] than malignant
ones. They also exhibit a lower vessel density than recurrent invasive breast cancer [Obermair
et al., 1994]. However, fibroadenomas as well may display a heterogeneous internal enhance-
ment in contrast enhanced perfusion imaging due to mucinous or myxoid degeneration [Kuhl,
2007]. Malignant lesions often exhibit necrosis and fibrosis in the tumor center in an advanced
tumor stage. Thus, they show rim enhancement or heterogeneous enhancement in their centers
and angiogenetic activity predominantly at their peripheries [Buadu et al., 1996]. The study
of Mavroforakis et al. [2005] identifies the tumor shape type and the boundary sharpness as
important features for classification of benign and malignant tumors in X-ray mammography,
see Figure 2.8. The same holds for DCE-MRI, and smooth borders and well-defined margins
are associated with benign diseases, whereas irregular and spiculated borders are indicative for
malignancy. Recent studies divide the tumor’s margin into [Fischer et al., 1999]:
• well defined and
• ill defined
and the tumor’s shape into [Szabo et al., 2003]:
• smooth,
• lobulated,
• irregular, and
• spiculated.
As a prerequisite, a contrast-enhancing lesion must be present in the DCE-MRI data set. Fur-
thermore, ring enhancement of contrast agent and a more heterogeneous enhancement over
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Tumor Margin
Figure 2.8: Illustration of morphological shape types of breast tumors. (Adapted from [Mavro-
forakis et al., 2005].)
time in general is considered to be indicative for malignancy [Behrens et al., 2007]. The mor-
phology of lesions without contrast enhancement cannot be adequately evaluated.
2.2 Perfusion Imaging for Brain Tumor Diagnosis
This section provides medical background information about the human brain and the most
common brain tumors: gliomas. In the second part, T ∗2 -weighted MRI acquisition is explained
in more detail, including the calibration of signal intensities and the extraction of perfusion
parameters.
2.2.1 Medical Background
In this section, the reader gets familiar with the basic terms for anatomical structures of the
brain. Afterwards, important aspects of the brain tumor epidemiology and the brain tumor
classification are described. Finally, the brain tumor diagnosis and the treatment planning with
focus on gliomas is presented.
Anatomy of the Brain
The human brain is the center of the nervous system, placed into cerebrospinal fluid and pro-
tected by the skull. Its structure is depicted in Figure 2.9. The brain is divided into the cere-
brum, cerebellum, and brain stem. Cerebrum and cerebellum are covered with the cerebral
cortex, the outermost thick layer of neural tissues. The cerebral cortex is folded to increase the
surface of this layer in the available volume in the skull. A cortical fold is referred to as sulcus
and the smooth areas between the folds are named gyri. The cortex is divided in the four lobes:
the frontal lobe, parietal lobe, temporal lobe, and occipital lobe, see Figure 2.9(b). Each lobe
comprises several cortical areas that process different information and are associated with a
particular function like language or vision.
The cortex is nearly symmetrical and it is divided into a left and a right hemisphere, see
Figure 2.10. The central nervous system has two major components: gray matter and white
matter. The gray matter can be found at the surface of the cerebral cortex and surrounds the
white matter. It consists of neuronal cell bodies for muscle control, sensory perception such
as seeing and hearing, memory, emotions, and speech. The white matter transmits signals
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Figure 2.9: Anatomy of the human brain. In (a), the brain comprising the cerebrum, cerebel-
lum, and the brain stem as well as the anatomical directions are depicted. In (b), the four lobes
of the cortex and the central and lateral sulcus are illustrated. (Adapted from an illustration
by Patrick J. Lynch, medical illustrator.)
from one region of the cerebrum to another. The cerebral cortex is covered by the meninges, a
membrane system consisting of the dura mater, the arachnoid mater, and the pia mater.
Left hemisphereRight hemisphere
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Menigeal vein
Cerebral vein
Meninges
Arachnoid
Dura mater
Pia mater
(a) (b)
Figure 2.10: In (a), a cross section of the brain illustrates its division into the right and the left
hemisphere as well as the white and the gray matter. The inlet is shown in (b) and visualizes
the meninges, consisting of the arachnoid, dura mater, and pia mater.
The human brain is the organ with highest demand for blood and oxygen supply. The arterial
system of the brain is illustrated in Figure 2.11. The arterial cerebral circulation comprises
the anterior and the posterior cerebral circulation. The anterior cerebral circulation is built
up by the right and left internal carotid artery that branch from the left and right common
artery. From each internal carotid artery, the ophthalmic artery is branching, supplying the
eye and parts of the nose, face and the meninges. Next, the internal carotids split into the
middle cerebral arteries and the anterior cerebral arteries. They are connected via the anterior
communicating artery and supply the lateral and medial portions of the brain. In contrast, parts
of the temporal lobe and the occipital lobe are supplied by the posterior cerebral circulation.
Inner parts of the brain, like basal ganglia and thalamus are supplied by both, the anterior
and the posterior cerebral circulation. The posterior cerebral circulation is created by the
left and the right vertebral artery. They unite to the basilar artery. Branches of the vertebral
arteries and the basilar artery supply the brain stem and the cerebellum. The basilar artery
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splits into two posterior cerebral arteries, which supply the occipital lobe. The basilar artery
is connected via the bilateral posterior communicating arteries to the internal carotid arteries
on each side: forming the Circle of Willis, see Figure 2.11(b). The Circle of Willis serves
as backup circulation of the brain if the blood supply is hampered, i.e., if one of the supply
arteries is occluded. The anatomical manifestation of the described arteries may vary among
different patients, e.g., underdeveloped communicating arteries.
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Figure 2.11: The blood supply of the brain is maintained by the anterior and the posterior
cerebral circulation, see (a), and the Circle of Willis, see (b), as backup circulation. (Adapted
from illustrations in [Gray, 2000].)
Brain Tumors and Their Epidemiology and Classification
Brain tumors are masses of abnormally growing cells in the brain or the skull. Like breast
tumors, they can be benign (i.e., non-cancerous) or malignant (i.e., cancerous). However, on
clinical grounds, also benign tumors are very dangerous, since a growing tumor will damage
or compress other brain structures, see Figure 2.12.
Tumor Tumor
(a) (b)
Figure 2.12: Illustration of negative tumor impact. In (a), the brain tumor invades and destroys
normal brain tissue. In (b), the brain tumor does not infiltrate brain tissue but causes increased
pressure within the brain as well as pressure on the surrounding tissue.
Brain tumors that are arising from brain tissue are referred to as primary brain tumors. Unlike
other cancers, they do rarely spread. However, they could be caused by the spreading of other
tumors in the body, like breast or colon cancer, which is referred to as secondary or metastatic
brain tumors.
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Primary brain tumors are much less common than secondary ones. They are named based
on the cell types they are arising from. Brain tumors that arise from the meninges are called
meningiomas, while schwannomas (also called neurilemomas) arise from the Schwann cells
of the nerve sheath. Both tumor types are mainly benign.
Gliomas - tumors with a glial cell origin - are the most common primary brain tumors [Inter-
national Agency for Research on Cancer, 2008]. Even worse, they are the most lethal forms of
this tumor kind [Ohgaki and Kleihues, 2005]. Glioma cells are highly invasive and infiltrate
the brain parenchyma. Furthermore, the tumor growth can be rather fast.
Pathological classification divides gliomas into astrocytomas, also prescribed with low grade
gliomas (LGG) and glioblastomas, i.e., high grade gliomas (HGG). LGGs may transform into
HGGs at some point in time and an early detection of such a transformation is of signifi-
cant clinical importance. The incidence of gliomas is slightly higher in men than in women
with a male to female ratio of approximately 1.3. The age distribution of brain tumors has a
maximum peak incidence in adults between 45 and 70 years and a smaller peak in children [In-
ternational Agency for Research on Cancer, 2008]. The prognosis for patients with gliomas is
very bad and, only 3% of patients with a glioblastoma survive longer than 3 years, the majority
dies within 9-12 months [Ohgaki and Kleihues, 2005].
The classification of tumors of the nervous system by the world health organization (WHO)
covers more than 50 clinicopathological entities. LGGs are classified as WHO grade I and
II, HGGs are assigned with WHO grade III to IV, depending on the tumor type. The most
frequent tumor types, their grade, and their typical location are listed in Table 2.2.
Table 2.2: The most frequent tumors of the nervous system, from [International Agency for Re-
search on Cancer, 2008].
Tumor WHO Grade Typical location
Pilocytic astrocytoma Grade I Cerebellum, optic nerve
Low grade diffuse as-
trocytoma
Grade II Cerebral hemispheres
Glioblastoma Grade IV Cerebral hemispheres
Oligodendroglioma Grade II / Grade III Cerebral hemispheres
Ependymoma Grade II Ventricles, spinal cord
Medulloblastoma Grade IV Cerebellum
Neuroblastoma Grade IV Abdomen
The incidence of primary brain tumors has been increased in the developed countries during
the last few decades. However, this increase correlates with improved diagnostic methods and
imaging technologies [International Agency for Research on Cancer, 2008].
Brain Tumor Diagnosis and Treatment Planning
There is no specific clinical singular symptom for brain tumors. Symptoms depend on the
tumor’s size, location, and rate of growth. Commonly, the first symptom may be an epileptic
seizure. The list of symptoms may further include unusual or more frequent and more severe
headaches, difficulties with vision, balance, speech, or hearing, as well as unexplained nausea
or vomiting. If the patient suffers from such symptoms or a combination thereof, diagnostic
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investigation starts with an anamnesis. Next, clinical and laboratory investigations can exclude
infections. Non-invasive, high-resolution imaging techniques like MRI and computer tomog-
raphy scans may identify brain tumors since they often exhibit different colored masses in the
image data. However, brain tumor detection is hardened by the blood-brain barrier (BBB).
Since the BBB separates blood from the brain, many contrast agents could not reach the tumor
at its very early stage. Once the tumor causes a BBB disruption, a stronger contrast agent
enhancement will occur. This will also influence the signal intensity calibration, a problem
that is discussed later on. Finally, only the histopathological examination of tumor tissue, ex-
tracted by brain biopsy or open surgery, can confirm or reject a brain tumor diagnosis. After
this diagnosis, the standard treatment is similar to many malignancies and includes surgery
(when feasible), radiation therapy, and adjuvant chemotherapy during and after radiation.
Surgery aims at the removal of the brain tumor and thus the diminishing of the mass effect
and the compression of brain structures. Furthermore, normal cerebrospinal fluid pathways
should be restored. Brain tissue is removed for pathological diagnosis and the tumor burden is
reduced for other therapies. Glioma cells are highly invasive and infiltrate normal functioning
brain parenchyma. First, the resection of this tissue could cause unacceptable neurological
deficits. Second, the exact spatial extent of the tumor cannot be precisely determined. Thus, a
total excision of a glioma is rarely possible [Mamelak and Jacoby, 2007].
Gliomas are not radiosensitive, but radiation is effective in retarding the glioma progression. A
general cure of long-term control of the disease cannot be achieved. Radiation is further limited
since normal brain parenchyma is also sensitive to radiation effects and a radiation injury and
radiation-induced cell death is often as damaging as the primary tumor itself [Mamelak and
Jacoby, 2007].
Also, systematic chemotherapy does not perform very well, since the blood-brain barrier ham-
pers the distribution of the drug into the brain. Combination of radiation and chemotherapy
has been found to increase the median survival by two months when compared to radiation
alone for patients with newly diagnosed glioblastoma multiforme [Stupp et al., 2005].
The very bad prognosis for patients with an HGG and the lack of meaningful therapies has led
to a continued research for better treatment. In addition, the differentiation between LGGs and
HGGs plays an important role for treatment planning and patient outcome [Covarrubias et al.,
2004]. Further, LGGs may transform to HGGs at some point in time and patients with LGGs
are commonly subject to a life long monitoring.
2.2.2 Brain Perfusion Imaging with DSC-MRI
Conventional MRI is widely used for the diagnosis and follow-op of brain tumor patients.
The MRI protocol used for brain tumor diagnosis comprises several acquisitions, structural T1
and T2-weighted sequences with high spatial resolution for morphologic analysis and the T ∗2 -
weighted perfusion series, with high temporal resolution. In this section, the image acquisition,
the motion correction, the calibration of signal intensities, and the extraction of perfusion
parameters are described.
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Image Acquisition
The developments in perfusion-sensitive MRI in the last decades made it possible to assess the
cerebral microvasculature including brain tumor perfusion. The neoangiogenetic tumor activ-
ity is exploited, which causes increased microvasculature and perfusion of tumorous tissue. In
contrast to breast perfusion imaging with DCE-MRI (recall Section 2.1.2), the perfusion imag-
ing of the brain is carried out with DSC-MRI. Due to the existence of the BBB, the human brain
provides a unique environment for tracers, where the contrast agent remains compartmental-
ized, i.e., the agent remains intravascular. Thus, it causes a significant T2 and T ∗2 effect. The
diffusible Gd-DTPA-based contrast agents (which are also employed for breast DCE-MRI, re-
call Sect. 2.1.2) behave like intravascular tracers, and are used for brain perfusion imaging as
well.
When comparing T2 and T ∗2 sequences, it can be stated that the latter is sensitive to microvas-
culature whereas the T2 sequence is more sensitive to the total vasculature [Weisskoff et al.,
1994, Boxerman et al., 1995]. Recent studies [Donahue et al., 2000, Sugahara et al., 2001]
favor the gradient-echo T ∗2 sequence for brain tumor perfusion imaging since large, tortuous
vessels are often present in tumors. Furthermore, T ∗2 sequences are accompanied with shorter
relaxation times than T2 sequences (recall also Sect. 2.1.2). Thus, T ∗2 DSC-MRI is the most
established method for brain perfusion imaging [Provenzale et al., 2002].
The contrast agent is injected with an intravenous catheter such that a tight bolus of contrast
material will pass through the brain. Successive images are acquired to analyse the first pass of
contrast agent through the capillary bed of the brain, see Figure 2.13. The susceptibility effect
causes a drop of the T ∗2 signal intensities and its magnitude depends on the local blood volume
and flow. Furthermore, the signal intensity decrease does not only occur inside the vessel
lumen but extends in to the surrounding tissue as well [Villringer et al., 1988]. The signal
intensity decrease is acquired on a voxel-by-voxel basis to extract a time-intensity curve, see
Figure 2.14.
The most common sequences are adapted to the short transit times (only a few seconds) of the
contrast agent’s travel through the tissue. Hence a rapid MRI technique is required, like echo-
planar imaging (EPI) and fast low-angle single-shot (FLASH) sequences. Thus, the repetition
time ranges from one to two seconds, which in turn limits the number of slices that can be
covered within this period. Typical spatial parameters of EPI sequences with this repetition
time are: 128 × 128 image matrix, 2 mm spatial resolution and 7 mm slice distance for 10-15
acquired slices per point in time. Image acquisition covers about 40 - 80 time steps. FLASH
sequences are used to overcome EPI image distortions (which may occur in areas with different
susceptibility properties like tissue-air boundaries). However, a repetition time of 1-2 s only
allows for a few slices of spatial coverage. One of these slice is positioned such that a major
artery for extraction of the arterial input function is covered (this function will be described
later on) with only a few slices left for the tissue of interest [Rempp et al., 1994]. In conclusion,
the selection of temporal and spatial resolution is in general a compromise accounting for the
particular application and the tissue that has to be studied. In contrast to the MR BI-RADS
protocol, there is no equivalent MRI rating protocol for brain tumors available.
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Figure 2.13: Views of a T ∗2 -weighted sequence of an HGG (see arrow). The MRI views il-
lustrate the decrease of signal intensity at selected time steps with a repetition time of 1.45 s.
Two ROIs have been defined for further analysis, see Figure 2.14. (Data is courtesy of Atle
Bjørnerud, Department of Medical Physics, Rikshospitalet-Radiumhospitalet Medical Centre
and Department of Physics, University of Oslo, Norway.)
Motion Correction
The motion correction of DSC-MRI perfusion data of brain tumors is less complicated than
breast perfusion registration (recall Sect. 2.1.2) due to the shorter acquisition time, i.e., less
patient movement, and the skull as static reference object. Motion artifacts may arise due to
head movement. However, this movement does not change the shape of the brain. Thus, a rigid
body registration is sufficient to generate satisfying results. Hence, summarized information
about perfusion data registration is also provided in [Preim and Botha, 2013].
Calibration of Signal Intensities
The T ∗2 effect, i.e., the signal intensity decrease per voxel, yields a time-intensity curve, re-
call Figure 2.14. The transverse relaxation rate R∗2, with R
∗
2 = 1/T
∗
2 , is proportional to the
time-dependent concentration of contrast agent C(t), a relation that has been determined the-
oretically and experimentally in the studies by Villringer et al. [1988], Rosen et al. [1990],
and Weisskoff et al. [1994]. For the quantification of C(t), a conversion from time-intensity to
concentration-time curve is carried out:
C(t) = κt∆R∗2(t) =
κt
TE
· ln
(
S(t)
S0
)
, (2.4)
where S(t) denotes the MRI signal intensity at time t and S0 is the signal intensity of the
baseline of the time-intensity curve. An illustration is provided in Figure 2.15. T E denotes
the echo-time of the MRI scan. The proportionality constant κt depends on [Weisskoff et al.,
1994, Boxerman et al., 1995]:
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Figure 2.14: Two ROIs and their corresponding time-intensity curves are presented, extracted
from the data set shown in Figure 2.13. The first region covers a vessel (blue), whereas the
second one covers white matter in the contralateral brain side to the tumor (orange). The
average time-intensity curves (a.u., arbitrary units) are depicted in (b). The arterial region
exhibits a larger signal intensity decrease than the white matter region. (Data is courtesy
of Atle Bjørnerud, Department of Medical Physics, Rikshospitalet-Radiumhospitalet Medical
Centre and Department of Physics, University of Oslo, Norway.)
• the contrast agent,
• the pulse sequence parameters, and
• the MR field strength.
For the relationship of C(t) and R∗2, expressed by Eq. (2.4), negligible T1 effects are assumed.
This assumption is in general fulfilled with intravascular contrast agents and thus, with dif-
fusible contrast agents and an intact BBB.
The calibration of signal intensities is only applicable for the first pass of the tracer. In Fig-
ures 2.14 and 2.15, also the recirculation phase, i.e., the second pass of the contrast agent,
is illustrated. The relationship between C(t) and R∗2(t) expressed by Eq. (2.4) is not main-
tained in this phase. In practice, two approaches exist. First, the calibration is only carried
out until the last time step before recirculation begins. Second, the contrast agent’s first pass
concentration-time curve is fitted to a gamma variate function to model an ideal bolus shape
function, see again Figure 2.15. The gamma variate fitting is conducted via [Thompson et al.,
1964]:
C(t) = s · (t− tBA)r · e−b·(t−tBA), (2.5)
where tBA is the arrival time of the contrast agent, s a constant scaling factor, and r and b the
coefficients determining the gamma variate function’s shape.
Extraction of Brain Tumor Perfusion Parameters
To characterize perfusion of cerebral microvasculature, the quantitative hemodynamic param-
eters cerebral blood volume (CBV), cerebral blood flow (CBF), and the mean transit time
(MTT) are extracted based on the concentration-time curve, i.e., the C(t) curve. CBV is ap-
proximated as the area under a voxel’s concentration-time-curve due to the compartmental-
ization of the tracer within the intravascular space. It is defined as the total volume of blood
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Figure 2.15: Illustration of the conversion from the time-intensity curve (TIC) in (a) to the
concentration-time curve (CTC) in (b) and a gamma variate fitting in (c). The time-intensity
curve equals the curve extracted for the vessel in Figure 2.14. The time-intensity curve shape
illustrates the different periods of contrast agent washin: the baseline period (before the ar-
rival of the contrast agent bolus), the first passage of the contrast agent, and the period of
recirculation. Hence, the second pass of the contrast agent is indicated with the smaller
peak. The conversion from signal intensity (a.u., arbitrary units) to concentration yields the
concentration-time curve depicted in (b). To eliminate the influence of recirculation, gamma
variate fitting is carried out according to Eq. (2.5).
traversing a given region of brain, measured in ml of blood per 100 g of brain tissue. CBV is
proportional to the integral of C(t), normalized to the total amount of tracer:
CBV =
1
α
∫
C(t)∫
CAIF(t)
, (2.6)
where α is a proportionality constant. It depends on:
• the density of brain tissue and
• the difference in haematocrit levels between capillaries and large vessels.
The second issue arose since only the plasma volume is accessible to the contrast agent [Cala-
mante et al., 1999]. CAIF(t) denotes the concentration-time curve of the arterial input func-
tion (AIF), i.e., the contrast agent concentration that reaches the cerebral tissue at the time t.
CAIF(t) is in general extracted from a major cerebral artery, like the middle cerebral artery
[Østergaard et al., 1996a] or the internal carotid artery [van Osch et al., 2001] (recall Fig. 2.11).
The extraction of CAIF(t) is conducted with Eq. (2.4) with a corresponding proportionality
constant κa. Hence, the same dependancies hold for κa as for κt , recall Eq. (2.4). The more
contrast agent is injected, the greater contrast concentration will reach the cerebral tissue, in-
dependently of the actual CBV. This is the reason why, the normalization to the CAIF(t) is
carried out for CBV approximation.
The parameter CBF denotes the cerebral blood flow and describes the volume of blood travers-
ing a given region of brain per unit time, measured in ml of blood per 100 g of brain tissue per
minute. For the CBF analysis, the indicator dilution theory for intravascular contrast agents is
applied. Thereby, the contrast agent concentration C(t) can be described as [Østergaard et al.,
1996b, Calamante et al., 1999]:
C(t) = α ·CBF · (CAIF(t)⊗R(t)) = α ·CBF ·
∫ t
0
(CAIF(τ)R(t− τ))dτ, (2.7)
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where CAIF(t) is the concentration of the AIF and R(t− τ) denotes the residue function, i.e.,
the fraction of contrast agent that remains in the tissue at time t after the contrast agent bolus
injection at time τ . Thus, R(0) = 1 since no contrast agent particles have left the tissue at time
t = τ , and R(∞) = 0 since no contrast agent particles remain in the tissue due to the intact
BBB and the washout of the contrast agent through normal perfusion. Hence, the convolution
of two functions is denoted with the ⊗ operator. Its expression as integral is provided by the
last term in Eq. (2.7). As introduced in Eq. (2.6), α is a proportionality constant.
To extract the CBF, the term CBF ·R(t) is isolated via deconvolution of Eq. (2.7). Next, CBF is
obtained with CBF ·R(t) and R(0) = 1 at time t = 0. For the deconvolution operation, different
mathematical approaches exist and a more detailed description can be found in [Østergaard
et al., 1996b]. The most wide-spread method is the singular value decomposition [Rosen
et al., 1990, Østergaard et al., 1996b].
The parameter MTT describes the average time for a molecule of contrast agent to pass through
the cerebral vasculature. Since the three physiological parameters CBV, CBF, and MTT are
related through the central volume theorem [Stewart, 1894], MTT can be extracted via:
MT T =
CBV
CBF
. (2.8)
In theory, the equations (2.4), (2.6), and (2.7) can provide absolute units of CBV, CBF and
MTT. However, the proportionality constants α , κt , and κa would have to be acquired. Yet,
an absolute and correct measurement of CBV, CBF, and MTT is not available. This issue is
addressed by Calamante [2005] in more detail. The following problems were identified:
• potential errors due to the presence of delay and dispersion on the estimated AIF,
• partial volume effects in the quantification of the AIF,
• a change in the proportionality constants or scaling factors, and
• changes in haematocrit levels.
Although absolute measurements of CBV, CBF, and MTT are not possible yet, the extracted
parameters approximated with the described methods are closely related, i.e., proportional, to
the underlying absolute parameter values.
When it comes to brain tumor perfusion analysis, a disruption of the BBB has to be taken
into account due to infiltrating tumor growth. Because of a disrupted BBB, the contrast agent
could leak into the extravascular space and the assumption of the intravascular tracer is incor-
rect. Furthermore, the second assumption of a negligible T1 effect is not valid. To solve this
problem, it has been suggested to apply a small pre-loading dose of contrast agent to tissue
with moderate contrast extravasation such that the T1 effect of the main bolus, i.e., the second
bolus, is negligible [Kassner et al., 2000]. Another approach is the modeling of the combined
T1 and T2 effects, to extract ∆R∗2 values that are not contaminated by T1 enhancement [Weis-
skoff et al., 1994]. Furthermore, studies suggest to employ a dual-echo T ∗2 -weighted sequence
to extract ∆R∗2 without T1 enhancement [Barbier et al., 1999]. These methods are explained in
more detail in [Calamante, 2005].
In general, the evaluation of brain tumor perfusion MRI is based on the parameter CBV,
whereas CBF and MTT are more important for the assessment of cerebral ischemic stroke
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[Covarrubias et al., 2004]. The term relative refers to a normalization of CBV values. Dif-
ferent approaches exist and the most general consists of the normalization with the averaged
white matter’s CBV values of the contralateral side [Wetzel et al., 2002], yielding relative CBV
(rCBV) values. The parameter rCBV is an important indicator for a patient’s survival since
tumor growth induces angiogenesis and thus elevated rCBV values. It can further be employed
for brain tumor grading into LGG and HGG, since rCBV correlates with the tumor grade [Law
et al., 2004]. Like the ROI-based evaluation of contrast enhancement, rCBV is extracted as
average value of a ROI as well. Since the ROI is placed such that it includes highest rCBV
values but no brain vessels, the ROI is also referred to as hot spot.
Beyond the extraction of quantitative parameters, descriptive perfusion parameters (also called
summary parameters) are calculated for characterization of brain perfusion data. They are il-
lustrated in Figure 2.16, including the parameters TTP, PE, Integral, UpSlope, and DownSlope
that have been introduced for breast perfusion, recall Section 2.1.2. Additionally, the follow-
ing parameters are extracted: full width at half maximum (FWHM), the first moment of the
concentration-time curve (FMC), and the time points tBA and tend , representing the arrival of
the contrast agent and the end of the first pass of the bolus, respectively. In the survey by
Preim et al. [2009], the reader becomes acquainted with a more detailed description of sum-
mary parameters in perfusion imaging. The main advantage of these parameters is the fast and
straightforward approximation without extracting the AIF. Summary perfusion parameters in
general are widely employed in clinical applications like stroke diagnosis. The parameters
may provide important clinical information. However, none of these parameters can provide
a direct measurement of the underlying perfusion. Furthermore, they may be prone to errors
due to the lack of the integration of the AIF and the residue function. As a result, the parame-
ters may be hampered by the injection conditions of the contrast agent, the patient’s vascular
structures and the patient’s cardiac output [Perthen et al., 2002].
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Figure 2.16: Illustration of the summary parameters PE, Integral, UpSlope, DownSlope,
FWHM, and the time related parameters TTP, FMC, tBA and tend . Summary parameters are
only extracted for the first pass of the contrast agent from the concentration-time curve (as
illustrated) or even from the time-intensity curve.
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2.3 Summary and Implications for this Thesis
Evaluation of perfusion MRI plays an important role to narrow down the differential diagnosis
of tumors in medical imaging. This thesis focuses on two application scenarios: the evaluation
of breast tumor perfusion data and brain perfusion data. These pathologies fundamentally
differ concerning the underlying vasculature: the breast tissue and thus a breast tumor have
direct access to the contrast agent, whereas the blood in the brain remains compartmentalized
due to the BBB. Therefore, T1-weighted as well as T ∗2 -weighted MR sequences are acquired,
each accompanied by its own advantages and disadvantages.
The breast MR perfusion analysis is strongly intertwined with the evaluation of the shape of the
corresponding RE curve courses. Thus, the main focus of this thesis is the optimal evaluation
of the contrast enhancement of a tumor, under consideration of finding the best ROI for RE
curve extraction. The forming of these ROIs is adapted to the detection of similarly perfused
regions. Hence a tumor subdivision has to be carried out via clustering. Due to the limited
number of time steps, the approximation of the similarity of perfusion characteristics rather
based on the summary perfusion parameters instead of pharmacokinetic modeling parameters.
Furthermore, the tumor subdivision via clustering allows for automatic detection of a most
suspect ROI as well as the extraction of specific features. Since heterogeneity is indicative for
tumor malignancy, the clustering result will be employed to extract features that describe the
tumor’s heterogeneity.
For glioma diagnosis, promoted by brain tumor perfusion MRI, it is important to differentiate
between LGG and HGG since important attributes, e.g., progression time and survival rate,
are associated to the tumor types. Hence, quantitative parameters, predominantly CBV, should
be evaluated in more detail, especially when MR perfusion scans of the brain are compared
to characterize a longitudinal progression. To examine the transformation from an LGG into
an HGG, this thesis focuses on the visual analysis of longitudinal brain tumor MR perfusion
studies that comprise such transformations. Due to the need of comparison from perfusion
studies arising from different time steps of the same patients, the usage of summary parameters
is avoided, and the analysis is mainly based on the evaluation of the parameter CBV due to its
high importance for LGG and HGG characterization.
In summary, this thesis has the following goals:
1. The improved (visual) evaluation of breast tumor DCE-MRI data, including a subdivi-
sion via clustering in similarly perfused regions.
2. The 3D visualization of breast tumor DCE-MRI data, including the 3D view of the
clustered tumor.
3. A thorough cluster analysis of breast tumor DCE-MRI data as well as the discriminative
power of clustering results for an automatic classification with focus on heterogeneity
and kinetic features.
4. The visual analysis of transformation from LGGs into HGGs within a longitudinal brain
tumor MRI study.
These goals will be tackled (in this order) in Chapters 5, 6, 7, and 8.
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3 Clustering of Medical Perfusion Data
For biomedical research, increasing sets of data have to be evaluated. Clustering is carried out
to provide insight in the natural grouping or structure of these data sets. In general, it is applied
to create groups of meaningful subclasses of a set of objects. Alternatively, it can be employed
as a preprocessing tool such that further algorithms evaluate the attributes of detected clusters,
e.g., for biomedical purposes.
In this chapter, the importance of clustering for perfusion data is explained in Section 3.1.
Afterwards, a general clustering categorization is provided in Section 3.2, including advan-
tages and disadvantages of the clustering algorithms with respect to medical perfusion data.
Particular important concepts for this thesis are identified. These concepts are:
• density-based clustering approaches, described in Section 3.3,
• the reduction of feature space dimensionality via a principal component analysis as well
as clustering in the spectral domain, explained in Section 3.4, and
• the region merging approach, presented in Section 3.5.
Finally, a conclusion of this chapter in given in Section 3.6.
3.1 The Importance of Clustering for Evaluation of
Perfusion Data
As it was explained in Chapter 2, the evaluation of perfusion MRI data is based on the evalua-
tion of the contrast enhancement. Hence, a region of interest (ROI) is manually placed for the
clinical evaluation of breast tumor perfusion as well as brain tumor perfusion. The ROI covers
voxels with similar relative enhancement (RE) kinetics. Next, the contrast agent kinetics are
evaluated via averaging the voxels’ RE values. Such ROIs need to contain at least a few voxels
and yet they must not contain too many voxels. This is reasoned by:
1. A single voxel could be an outlier and the ROI is assumed to be more robust against
artifacts.
2. Large ROIs could cover different tumor parts, e.g., benign and malignant ones.
These problems are illustrated in Figure 3.1. Hence, single voxels show arbitrary enhance-
ment kinetics and it is difficult to rate the tumor’s malignancy, see Figure 3.1(c). Furthermore,
the large ROI does not reflect the washout characteristics, see Figure 3.1(i). Since the intra-
and inter-observer variability of the manual ROI placement is identified as drawback in many
classification approaches (e.g., [Stoutjesdijk et al., 2005]), this thesis will come up with an au-
tomatic ROI identification. The automatic ROI identification is based on an automatic subdivi-
sion of the tumor into similarly perfused tumor parts and the detection of the most suspicious
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or malignant tumor part of this subdivision. For the subdivision of the tumor, clustering is
essential. Furthermore, each of the clusters of an appropriate clustering algorithm fulfills both
reasons above.
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Figure 3.1: The challenges of tumor perfusion enhancement evaluation. In (a), the subtract
view reveals two tumors, focus is set on the round one (marked with an arrow). In (b), three
single voxels have been marked and their corresponding RE curves are depicted in (c). Note
that exactly three different curves are presented: a washout curve, a plateau curve, and a
continuously increasing one. In (d) - (f), the pitfalls of ROI placement are illustrated. The ROI
in (d) covers benign tumor parts with an average increasing curve, see (g). The ROI in (e)
covers malignant tumor parts with an average washout curve, see (h). The ROI in (f) covers
both tissue types and the averaged curve is distorted, yielding an average plateau curve. This
lesion was histopathological proven to be malignant. (Data is courtesy of U. Preim, Municipal
Hospital Magdeburg, Germany.)
Beyond the automatic ROI determination for clinical practice, the clustering of tumor perfu-
sion data is important for clinical research. Many automatic classification systems, which auto-
matically divide into benign and malignant tumors, employ features extracted from a clustering
result. For example, the study by Chen et al. [2006a] automatically classifies breast DCE-MRI
tumors into benign and malignant based on features from a fuzzy c-means clustering. There
is no gold standard for clustering of perfusion data available yet and each clustering-based
classification approach is heavily dependent on the clustering result.
One further property of the underlying data is the small size of tumors (30− 1000 voxels).
Therefore, the runtimes of the different clustering algorithms were almost irrelevant for all
developed methods. Thus, no further discussion about the runtimes are provided in this chap-
ter and the reader is encouraged to have a look at the referenced algorithms for a detailed
algorithm’s runtime specification.
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3.2 Categorization of Cluster Analysis
In this section, the concept of clustering is explained in detail. Therefore, a categorization
of clustering approaches is presented, including the adaption of the clustering concepts to the
perfusion data, on which this thesis is based upon.
Clustering is the partitioning of a set of objects into distinct groups, i.e., clusters, such that two
objects from the same cluster are similar to each other and two objects from distinct clusters
are not. The objects exhibit certain features in their feature space. The similarity between
objects is calculated with a distance function over their features, e.g., the Euclidean distance
or a correlation coefficient that approximates the dependency between two variables. For
perfusion data, each voxel is interpreted as an object and its perfusion parameter values (e.g.,
DownSlope) are interpreted as features. All tumor voxels form the database for the actual
clustering run. The number of features that are employed for the clustering process defines the
dimensionality of the feature space.
Various cluster analysis techniques have been presented: each one with advantages and disad-
vantages when applied to solve a specific problem. The categorization of cluster algorithms
is not standardized since different researchers need to extract different clusters on different
databases. Clustering algorithms rely on different concepts. The two most fundamental con-
cepts are the partitioning and hierarchical approach [Kaufman and Rousseeuw, 1990]. In [Han
et al., 2011], two more concepts are added: the grid-based and the density-based concept.
Therefore, they yield four basic clustering concepts:
• Partitioning clustering algorithms,
• Hierarchical clustering algorithms,
• Grid-based clustering algorithms, and
• Density-based clustering algorithms.
Beyond these basic concepts, Han et al. [2011] introduce advanced clustering concepts, see
Figure 3.2:
• Fuzzy and probabilistic model-based approaches,
• Clustering of high-dimensional data, including the subspace clustering and the dimen-
sionality reduction,
• Clustering of graph and network data, and
• Clustering with constraints, including hard and soft constraints.
This categorization is only one of many possible categorizations due to the complexity of data
clustering in general. For a more comprehensive overview the reader is referred to the survey
by Jain et al. [1999].
3.2.1 Basic Clustering Concepts
The first part of this section provides an overview of the four basic clustering concepts. Fur-
thermore, for each concept, a clustering algorithm is introduced and applied to an artificially
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Figure 3.2: Overview of basic and advanced clustering concepts based on [Han et al., 2011].
generated data set, see Figure 3.3. Next, the adaption to perfusion data is described. The cate-
gorization of clustering concepts is not exclusive, and as it will be described in the following,
many clustering algorithms combine different concepts.
Partitioning Clustering Algorithms
Partitioning clustering algorithms create k clusters from a set of n objects, k≤ n. Furthermore,
k is an input parameter and domain knowledge is needed to define the appropriate number of
clusters k in advance. The algorithm starts in general with an initial partition of the database’s
feature space by creating k representatives in this feature space. Next, each object is assigned
to its closest representative in terms of the similarity function. The cluster result is optimized
by iteratively adjusting the representatives (e.g., as a centroid or mediod calculation) and as-
signing the objects to clusters. Hence, the clusters are convex w.r.t. the distance function,
which is very restrictive for some applications. Note that the term convex clusters describes
a clustering result where the intersection of the convex hulls for each pair of two clusters is
always empty.
The most wide-spread example for the group of partitioning clustering algorithms is the k-
means algorithm [MacQueen, 1967]. Each cluster is defined by its mean, i.e., its centroid.
Initially, the k centroids are randomly distributed. Next, an optimization is carried out by iter-
atively assigning objects to their closest centroid and updating the centroids’ positions based
on the actual assigned objects. Thus, the assignment of objects may change due to the updated
centroids’ positions. The clustering is finished if the algorithm converges or the change is suf-
ficiently small. In Figure 3.3 (b), the clustering result of k-means with k = 2 is presented. Due
to the convex clusters, the two groups of objects could not adequately be identified. Further-
more, an unfavorable initialization of initial cluster centers may hamper the clustering result.
For example, one cluster contains the object near the origin and the second cluster contains all
remaining objects in the example of Figure 3.3 (b).
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Figure 3.3: Illustration of the four basic clustering concepts [Han et al., 2011]. In (a), the 2D
feature space of the data is presented in the scatterplot. The data was artificially generated
for illustration purpose. In (b), the partitioning k-means cluster result is depicted. In (c), the
grid-based STING algorithm is presented. In (d), the hierarchical clustering result, based on
Ward’s method, and the corresponding dendrogram are depicted. In (e), the density-based
DBSCAN algorithm is illustrated. For all basic clustering concepts an Euclidean distance
function was employed.
Hierarchical Clustering Algorithms
Hierarchical clustering algorithms yield a hierarchical decomposition of the database, rep-
resented by a dendrogram. They are subdivided in agglomerative and divisive approaches.
Agglomerative approaches initially group each object into one cluster. Then, similar clusters
are iteratively combined into a new cluster until all objects are contained in one remaining
cluster. Alternatively, divisive approaches start with a cluster comprising all objects and iter-
atively split them up until each object forms a single cluster. Hierarchical algorithms need a
termination condition that indicates when the merging or splitting approach has to be stopped.
In contrast to partitioning algorithms, the number of clusters is not needed as input, but the
finding of an appropriate termination condition can be challenging. However, based on the
application scenario, the termination condition can be defined such that the user aims at a par-
tition with k clusters. Hierarchical clustering approaches are also referred to as connectivity
clustering approaches since the dendrogram connects the clusters.
Ward’s method [Ward, 1963] is an agglomerative hierarchical clustering where the similarity
function is based on the within-cluster variance. The within-cluster variance for each pair of
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clusters is extracted based on their sum of squared errors. Iteratively, the pair with minimum
within-cluster variance is merged. In Figure 3.3 (d), the clustering result of Ward’s method is
depicted as well as the dendrogram representing the hierarchical decomposition of the data.
The termination condition was set to a certain threshold for within-cluster variance to obtain
two clusters.
Grid-Based Clustering Algorithms
Grid-based clustering algorithms divide the database’s feature space in a limited number of
cells - the grid. Grid-based methods are feature space-driven. This is in contrast to the other
basic concepts, which are in general data-driven and adapted to the distribution of objects in the
feature space. The partitioning of the feature space into cells is independent of the distribution
of the objects and yields a multi-resolution grid data structure. Since all operations are carried
out along the grid, a fast execution time is achieved that depends on the grid resolution instead
of the number of objects. However, for the application of perfusion data, the fast execution
time is not mandatory.
The statistical information grid (STING) approach [Wang et al., 1997] stores statistical infor-
mation for each cell like the minimum and maximum of the cell’s objects. These statistical
information are employed for query processing and other data analysis tasks. To obtain the
hierarchical structure of grid cells, the first cell contains the whole feature space. Next, this
cell is iteratively split into a given number n of children by dividing the parent cell in n equally
sized regions until a user-defined resolution is achieved. To group similar objects as answer
for a query process, only relevant cells (i.e., whom statistical information met the query) are
analyzed in the hierarchy. Irrelevant cells as well as their children are not examined. Natu-
rally, the quality of STING depends on the granularity of the bottom layer. The cluster shapes
are isothetic, i.e., they depend on the grid cell. Figure 3.3(c) illustrates the STING clustering
result, including the bottom layer of the hierarchy.
Density-Based Clustering Algorithms
Density-based algorithms identify clusters as regions with increased density separated by areas
with lower density in the feature space. Objects of these sparse areas are usually considered
to be noise (outliers) or part of the cluster border. The extraction of the density is based on
the neighborhood of an object in the feature space. The size of this neighborhood has to be
provided as input parameter. However, the identification of the number of clusters as well as
outlier identification is automatically carried out.
The most prominent algorithm is the density-based spatial clustering of application with noise
(DBSCAN), presented by Ester et al. [1996]. Each object’s neighborhood is analyzed in the
feature space. Depending on the number of objects in the neighborhood, the object is defined
as core object, border object, or outlier. If core objects and border objects are connected, they
form a cluster, a process that will be described in more detail in Section 3.3. In Figure 3.3(e),
the clustering result of the DBSCAN algorithm is illustrated. The algorithm has no problems
to detect arbitrarily shaped clusters, since DBSCAN is based on the density of objects in the
feature space. Furthermore, the two objects in the origin and top right of the database are
identified as outliers (see the red circles in Fig 3.3(e)).
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Adaption of Basic Clustering Concepts to Perfusion Data
The medical scope of this thesis is the analysis of tumor perfusion data. The presented al-
gorithms will be compared regarding their suitability for the underlying data. The results are
listed in Table 3.1, and the criteria: global optimum, automatic extraction of cluster number,
the cluster shape, and outlier detection are explained in the following. With respect to the
clinical requirements, the employed clustering technique always needs to produce the same
results and find the global optimum instead of a local optimum. Local optima are produced
due to the order of the processed objects. For example, the k-means algorithm may not find
the global optimum due to the random initial k seeds. The next criterion covers the number of
clusters. Contrast-enhanced tumor data sets exhibit very different concentration time-curves
and each tumor is different from others. Thus, a pre-defined amount of clusters is not feasible.
Furthermore, the amount of clusters would depend on malignancy since malignant tumors are
in general more heterogeneous than benign ones, requiring more clusters for an appropriate
subdivision of the tumor tissue. However, malignancy of a tumor is not always known and
sometimes it is the goal of the clustering to predict this malignancy and not vice versa. The
third criterion deals with the cluster shape. Clusters should be arbitrarily shaped and a restric-
tion to convex clusters would be misleading, since the tumors strongly vary in shape, size, and
attributes. Hence, the disadvantages of grid-based methods become apparent. For example
the cluster borders of a clustering result extracted with STING are aligned to the bottom layer
grid granularity and consist of horizontal or vertical pieces only. The last criterion is assigned
to the detection and identification of outliers. Outlier detection favors the evaluation of tumor
perfusion data since motion artifacts could cause outliers in these type of data. As a first result,
density-based concepts seems best suited when considering the basic clustering concepts.
Table 3.1: Suitability of the basic clustering algorithm concepts for medical tumor perfusion
data based on four empirical criteria.
Partitioning
concepts
Hierarchical
concepts
Grid-based
concepts
Density-based
concepts
Global
maximum
no yes yes yes
Automatic
no. of clusters
no yes yes yes
Cluster
shape
convex arbitrary box-shaped arbitrarily
Outlier
detection
no no no yes
3.2.2 Advanced Clustering Concepts
Advanced clustering concepts are designed to cope with various challenges. First, the concept
of probabilistic model-based clustering approaches is explained, recall Figure 3.2. Next, ad-
vanced techniques for the clustering of high-dimensional data are described. This is followed
by a brief description of clustering of graph and network data and concluded by a short intro-
duction of clustering with constraints. Afterwards, the adaption to perfusion data is described.
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Fuzzy and Probabilistic Model-Based Clustering Algorithms
Fuzzy and probabilistic model-based clustering concepts contain objects and clusters where
an object can be part of multiple clusters. This is in contrast to the previously discussed basic
concepts where each object of the database exclusively belongs to one cluster. Fuzzy concepts
or probabilistic model-based concepts replace this binary membership with a probability, i.e.,
an object belongs with a certain probability to each cluster. A fuzzy clustering is a fuzzy set
of clusters and the object’s membership probability lies in the interval [0,1]. Thus, a fuzzy
clustering is also referred to as soft clustering. The quality of a fuzzy clustering, i.e., how
well a fuzzy clustering fits a database, can be assessed by analyzing the sum of the squared
distances to all cluster centers weighted by the degrees of membership that the object belongs
to this distance.
The probabilistic model-based clustering concept is similar to the fuzzy clustering concept. A
probabilistic cluster C is defined via a probability density function f . Hence, for an object o
of the database, f (o) is the relative likelihood that an instance of C appears at the location of o
in the feature space. Thus, the complete database is interpreted as finite sample of the possible
instances of the clusters. Consequently, probabilistic model-based cluster analysis aims at
determining a set of k probabilistic clusters with k probability density functions that most likely
generated this database. Similar to the fuzzy approach, each object has a certain membership of
each of the clusters. In theory, the probability density function covers background knowledge
of the specific application and may be of arbitrary complexity. Practically, these functions
are modeled with parametrized distributions, e.g., a Gaussian distribution. The quality of
a probabilistic model-based clustering can be assessed by extracting the likelihood that all
objects of the database were generated with the probability density functions weighted by the
membership degrees.
For example, the expectation maximization (EM) algorithm [Dempster et al., 1977] can be
employed as framework for fuzzy clustering or probabilistic model-based clustering. It con-
sists of two steps: the expectation step and the maximization step. In the first step, objects
are assigned to clusters based on the current fuzzy clustering or the current parameters of the
probabilistic density functions. In the maximization step, the new clustering is determined.
For fuzzy clusterings, the sum of membership-weighted squared distances for each object is
minimized. For probabilistic model-based clusterings, the expected likelihood is maximized
by adjusting the parameters of the employed distributions. These steps are iterated until the
clustering cannot be further improved due to the converging of the clustering or a sufficiently
small change of the clustering. Hence, the EM algorithm only detects a local optimum.
Clustering of High-Dimensional Data
The clustering of high-dimensional data is often affected by noise in many dimensions of the
feature space. Hence, the similarity measure may be strongly influenced or even dominated
by the noise in certain dimensions. Therefore, the clustering of high-dimensional data aims at
the detection of meaningful clusters and their embedding space. Two general concepts exist to
reduce the high-dimensional data space: the subspace clustering concept and the reduction of
the dimensionality. Representatives of the first class aim at cluster detection in subspaces of
the full feature space, whereas the representatives of the second class aim at the generation of
a new lower dimensional feature space.
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The subspace clustering idea can be further divided into bottom-up and top-down approaches.
Bottom-up methods start with the analysis of low-dimensional subspaces and analyze only
high-dimensional subspaces that are expected to hold meaningful clusters. Top-down ap-
proaches start with the high-dimensional, complete attribute space and recursively search in
lower dimensional subspaces. For example, the subspace clustering SUBCLU algorithm [Kail-
ing et al., 2004] employs the same density-based concepts like the DBSCAN approach and
carries out a bottom-up method. That means, if a subspace without any meaningful clusters is
detected, this subspace is not included in any further cluster analysis.
For dimensionality reduction, the original dimensions are combined or transformed into a new
feature space. A common approach is the application of a principal component analysis (PCA)
since it accounts for possible correlated attributes of the objects. The PCA yields an orthog-
onal linear transformation of the feature space into a new data space such that the greatest
variance of the database is expressed by the first dimension - the first principal component.
The second dimension is defined by the second principal component, which is orthogonal to
the first principal component and expresses the second greatest variance possible. Due to the
reduced correlation, only a few principal components are necessary to cover the major part
of the database’s variance, e.g., 95%, yielding a transformed feature space with a much lower
dimensionality. In the projected feature space, a standard clustering algorithm can be applied
and the clustering result is back-projected in the high-dimensional feature space afterwards.
Clustering of Graph and Network Data
Clustering of graph and network data plays an important role in visual analytic tasks due to
its wide-spread use in online social networks or the World Wide Web in general. Hence, a
special challenge arise from the lack of different attributes. In general, only the objects are
given as graph vertices and the relationships between them via connecting edges form the set
of attributes. Clustering concepts for graph and network data aim to identify clusters such
that vertices within a cluster are similar to each other, i.e., all vertices are well connected and
vertices of different clusters are not similar to each other, i.e., they are connected in a much
weaker way. Mostly, the clustering is carried out either by dimension reduction or by a search
for well-connected components, like the structural clustering algorithm for networks (SCAN)
algorithm [Xu et al., 2007]. Similar to DBSCAN, the SCAN algorithm defines core vertices
in dense graph parts and grows clusters from these.
Clustering with Constraints
Clustering with constraints allow for special relationships in the database and incorporate ad-
vanced domain knowledge via hard constraints and soft constraints. Hard constraints maintain
a certain relationship, e.g., the must-link constraint. If a must-link constraint is assigned to two
objects o1 and o2 then o1 and o2 must be grouped into the same cluster. Hard constraints have
to be taken into account during the clustering process. For example, the COP-k-means algo-
rithm [Wagstaff et al., 2001] works similar as the general k-means algorithm, but maintains the
must-link constraints during initialization of the cluster centers first and prevents a must-link
constraint violation during cluster center assignment by carrying out the nearest feasible cen-
ter assignment, afterwards. Due to conflicting hard constraints, it is sometimes impossible to
fulfill all hard constraints. Therefore, soft constraints assign a certain penalty for violated hard
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constraints of a specific clustering result. Thus, the clustering process becomes an optimiza-
tion problem where the penalties have to be reduced and the clustering quality score has to be
maximized. An example was presented by Davidson and Ravi [2005] with the Constrained
Vector Quantization Error (CVQE) algorithm, which is based on k-means.
Adaption of Advanced Clustering Concepts to Perfusion Data
Further challenges of the clustering of perfusion data arise from the high-dimensionality of the
feature space. Therefore, advanced cluster techniques may be useful, see Table 3.2. Hence, a
fuzzy or probabilistic model-based approach is rejected since this thesis focuses on an exclu-
sive tumor subdivision. Thus, the clinical expert can better interpret an exclusive subdivision.
In addition, the tumor voxels underlay an unknown distribution, which can not be easily pre-
dicted due to tumor heterogeneity. When it comes to the dimensionality of the feature space, a
dimensionality reduction or subspace clustering may be favorable. Dependent on the amount
of extracted perfusion parameters, the feature space may exhibit more or less dimensions.
However, there will be in general no benefit obtained by applying a concept for clustering of
graph or network data, but the clustering with constraints may be well suited. In detail, the
tumor data should be grouped in regions of spatially connected voxels. Thus, a hard constraint
could prevent the merging of objects into a cluster if the objects are not spatially connected.
Table 3.2: The suitability of the advanced clustering concepts for medical perfusion data.
Useful for clustering of
tumor perfusion data?
Fuzzy and probabilistic
model-based
no
Clustering of
high-dimensional data
yes
Clustering of graph and
network data
no
Clustering with
constraints
yes
As a result of this informative comparison, the following concepts will be explained in more
detail:
• the density-based clustering concepts, including DBSCAN, OPTICS, and SUBCLU
(Sect. 3.3),
• the statistical analysis of attributes, including the dependency of attributes and the PCA
for dimension reduction based on the redundancy of attributes (Sect. 3.4),
• the clustering in the spectral domain, including the dimension reduction (also described
in Sect. 3.4), and
• the hierarchical clustering approach region merging (Sect. 3.5) combined with the con-
straint that only spatially connected voxels can be grouped.
Due to the complexity and the wide-spread use for data mining and knowledge discovery in
databases, a multitude of clustering concepts exists. The reader is referred to [Han et al.,
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2011] for a more comprehensive discussion about clustering concepts considering different
application areas.
3.3 Density-Based Clustering
Density-based clustering methods merge objects into regions, if they have a high density in
the database’s feature space. The most wide-spread approach is the Density Based Spatial
Clustering of Application with Noise (DBSCAN), developed by Ester et al. [1996]. The Sub-
space Clustering (SUBCLU) [Kailing et al., 2004] algorithm employs the density concepts of
DBSCAN in subspaces of the feature space. The Ordering Points To Identify the Clustering
Structure (OPTICS) [Ankerst et al., 1999] algorithm will be introduced as third concepts.
3.3.1 DBSCAN
The DBSCAN approach is based on the density of objects. The density of an object o is
the number of objects (including o) in the ε-neighborhood of o in the feature space, see the
illustration in Figure 3.4. Based on their densities in the ε-neighborhoods, and a parameter
minPoints, objects are classified into core objects, border objects, and outliers (see Fig. 3.4):
• core objects have at least a density of minPoints,
• border objects have a smaller density than minPoints, but can be found in the ε-
neighborhood of a core object, and
• outliers have a smaller density than minPoints and are not in any ε-neighborhood of a
core object
o
p q
r
(a) (b)
Figure 3.4: Illustration of the object classification based on the density of the ε-neighborhood.
In (a), the density of object o is depicted. The density equals seven, i.e., the number of objects
(including o) in the ε-neighborhood of o. In (b), the objects p with density three, q with
density five, and r with density seven, are depicted. By setting the parameter minPoints to six,
r is identified as core object. Since q and p have a smaller density than minPoints, they are not
classified as core objects. However, q is in the ε-neighborhood of r, making q a border object.
The object p is classified as outlier and q and r form a cluster.
For the DBSCAN algorithm, the following relationships have been defined (w.r.t. a given ε
and minPoints) [Ester et al., 1996]:
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• The object p is directly density-reachable from object q if p lies inside the ε-neighborhood
of q and q is a core object.
• The object p is density-reachable from q if q is a core object, and there is a chain of
objects p1, . . . , pn with p1 = q and pn = p such that pi+1 is always directly density-
reachable from pi.
• The object p is density-connected with object q if there is another object o such that p
and q are both density-reachable from o.
The density-connectivity, density-reachability, and direct density-reachability are illustrated
in Figure 3.5. Finally, a density-based cluster is a set of density-connected objects that is
maximal regarding the density-reachability, i.e., all density-connected objects of the database
are contained in the cluster.
p
q
r
p
q
o
p
q
minPoints = 5 minPoints = 5 minPoints = 5
(a) (b) (c)
Figure 3.5: Illustration of the relationships between objects. In (a), the object p is directly
density-reachable from object q, but q is not directly density-reachable from p. In (b), p is
density reachable from r, but r is not density-reachable from p. In (c), the objects p and q are
density-connected to each other via object o.
DBSCAN creates clusters from a database by starting with an arbitrarily chosen object p from
the database, see the Algorithm 1. Next all objects that are density-reachable from p w.r.t. ε
and minPoints are retrieved via the ExpandCluster function, see Algorithm 2. If p is a core
point, i.e., p has a density≥minPoints, a cluster is extracted by proceeding with p’s neighbors.
Alternatively, if p is a border point or an outlier (and no points are density-reachable from p)
then DBSCAN proceeds with the next (unvisited) object from the database.
Algorithm 1 Pseudocode DBSCAN from [Ester et al., 1996]. SetOfObjects is either the whole
database or a discovered cluster from a previous run.
1: function DBSCAN(SetOfObjects, ε , minPoints)
// SetOfObjects is UNCLASSIFIED
2: ClusterId := nextId(NOISE)
3: for i← 1 to SetOfObject.size do
4: Object := SetOfObjects.get(i)
5: if Object.ClusterId = UNCLASSIFIED then
6: if ExpandCluster(SetOfObjects, Object, ClusterID, ε , minPoints) then
7: ClusterId := nextId(ClusterId)
8: end if
9: end if
10: end for
11: end function
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Algorithm 2 Pseudocode ExpandCluster from [Ester et al., 1996].
1: function EXPANDCLUSTER(SetOfObjects, Object, ClusterId, ε , minPoints):Boolean
2: seeds := SetOfObjects.regionQuery(Object, ε)
3: if seeds.size < minPoints then
4: SetOfObjects.changeClusterId(Object, NOISE)
5: return FALSE
6: else
// All Objects in seeds are density-reachable from Object
7: SetOfObjects.changeClusterId(seeds,ClusterId)
8: seeds.delete(Object)
9: while seeds , /0 do
10: currentO := seeds.first()
11: result := SetOfObjects.regionQuery(currentO,ε)
12: if result.size ≥ minPoints then
13: for i← 1 to result.size do
14: resultO := result.get(i)
15: if resultO.ClusterId ∈ {UNCLASSIFIED,NOISE} then
16: if resultO.ClusterId = UNCLASSIFIED then
17: seeds.append(resultO)
18: end if
19: SetOfObjects.changeClusterId(result,ClusterId)
20: end if // UNCLASSIFIED or NOISE
21: end for
22: end if // result.size ≥ minPoints
23: seeds.delete(currentO)
24: end while // result.size , minPoints
25: return TRUE
26: end if
27: end function
The main advantage of DBSCAN is the detection of arbitrarily shaped clusters based on the
density of objects in the feature space. Hence, the number of clusters is automatically deter-
mined during the clustering process. Also, the clustering result is in general deterministic.
Exceptional the assignment of border points, each run will obtain the same core points in the
same clusters and the same outliers. The identification of outliers is an important advantage
of the DBSCAN. A limitation of this method is the restriction to similar dense areas for clus-
ter detection. If two two clusters exist, one with much lower density than the other, DBSCAN
may not detect both. This initial condition is illustrated in Figure 3.7 of the next section. There
will also be an appropriate solution presented, provided with the OPTICS algorithm.
3.3.2 OPTICS
OPTICS can be interpreted as a generalization of the DBSCAN algorithm where an ordering
of objects is created instead of a clustering [Ankerst et al., 1999]. This ordering of objects
comprises information that represents density-based clustering results with multiple parameter
choices and effectively replaces the ε parameter with a maximum search radius. Thus, also
clusters with different densities can be identified.
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The algorithm requires the input parameters ε and minPoints. However, ε is an upper thresh-
old value and different neighborhood sizes are considered. Furthermore, OPTICS employs
the concepts of an object’s core distance and reachability distance, which are illustrated in
Figure 3.6 and explained in the following:
• The core distance of object p is the smallest distance ε ′ between p and an object from its
ε-neighborhood such that p is a core object. If p exhibits a density less than minPoints,
it is not a core object and its corresponding core distance is undefined.
• The reachability distance of an object q to the object p is the maximum of the core
distance of p and the Euclidean distance between p and q. If p is not a core object, the
reachability distance is not defined.
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Figure 3.6: Illustration of the core and reachability distances. In (a), the core distance ε ′ of
object p is illustrated, w.r.t. minPoints and ε . In (b), the reachability distances of objects r and
q to p are depicted.
In contrast to a general clustering approach, OPTICS extracts an ordering of the objects Or-
deredFile (in combination with each object’s core distance and reachability distance) instead
of the explicit assignment of objects to clusters. For the ordering, OPTICS starts with an arbi-
trary object of the database and determines all neighbors in the object’s ε-neighborhood, see
Algorithm 3. Sorted by their reachability distance, the object and its neighbors are stored in
a priority queue (starting with the smallest reachability distance). Now, the priority queue is
processed such that the first element is analyzed with the ExpandClusterOrder function and
stored in the ordering structure, see Algorithm 4. Hence, the object’s neighbors are extracted
and sorted (with respect to their reachability distance) into the queue. If the reachability dis-
tances of objects, which are already contained in the queue, will improve due to the processing
of the queue’s first element, these reachability distances will be updated, see the function Or-
derSeeds::update in Algorithm 5. If the priority queue is empty, the next, yet unprocessed,
object of the database will be analyzed. This procedure maintains the complete extraction of
an entire cluster before the next cluster is extracted.
The ordering structure can be visually presented with a reachability diagram, which depicts
the exact ordering of the points, see Figure 3.7(b). The y-values illustrate the reachability dis-
tances for objects, which are ordered along the abscissa. The diagram’s valleys are clusters
and outliers are characterized by an increased reachability distance. To extract a cluster struc-
ture with a certain ε ′-neighborhood, a user-defined threshold for ε ′ is applied (see red line in
Fig. 3.7). This line separates outliers (exhibiting reachability distances larger than ε ′) from
clusters (valleys between outliers). In practice, the clustering result is extracted via DBSCAN
clustering from the ordering structure for a given ε ′ with ε ′ ≤ ε .
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Algorithm 3 Pseudocode OPTICS from [Ankerst et al., 1999].
1: function OPTICS(SetOfObjects, ε , minPoints, OrderedFile)
2: OrderedFile.open()
3: for i← 1 to SetOfObjects.size do
4: Object := SetOfObjects.get(i)
5: if not Object.Processed then
6: ExpandClusterOrder(SetOfObjects, Object, ε , minPoints, OrderedFile)
7: end if
8: end for
9: OrderedFile.Close
10: end function
Algorithm 4 Pseudocode ExpandClusterOrder from [Ankerst et al., 1999].
1: function EXPANDCLUSTERORDER(SetOfObjects, ε , minPoints, OrderedFile)
2: neighbors := SetOfObjects.neighbors(Object, ε)
3: Object.Processed := TRUE
4: Object.reachabilityDistance := UNDEFINED
5: Object.setCoreDistance(neighbors, ε , minPoints)
6: OrderedFile.write(Object)
7: if Object.coreDistance , UNDEFINED then
8: OrderSeeds.update(neighbors, Object)
9: while not OrderSeeds.empty() do
10: currentObject := OrderSeeds.next( )
11: neighbors := SetOfObjects.neighbors(currentObject, ε)
12: currentObject.Processed := TRUE
13: currentObject.setCoreDistance(neighbors, ε , minPoints)
14: OrderedFile.write(currentObject)
15: if currentObject.coreDistance , UNDEFINED then
16: OrderSeeds.update(neighbors, currentObject)
17: end if
18: end while
19: end if
20: end function
The advantages of OPTICS are similar to DBSCAN: arbitrarily shaped clusters can be detected
and outliers can be identified. The main advantage is the extracted ordering of objects. Instead
of one global parameter setting, different ε values can be set to extract the clustering result
based on the reachability distances diagram (recall Fig. 3.7). Hence, this diagram also features
a 2D presentation of high-dimensional databases. However, like most clustering algorithms,
OPTICS may exhibit difficulties when it comes to clustering of high-dimensional data sets due
to the lack of adequate similarity functions in these feature spaces.
3.3.3 SUBCLU
The main idea of the SUBCLU approach is the analysis of subspaces of the high-dimensional
parameter space [Kailing et al., 2004]. As it was already discussed in Section 3.2.2, high-
dimensional feature spaces complicate the clustering process due to the hardened process of
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Algorithm 5 Pseudocode OrderSeeds::update from [Ankerst et al., 1999].
1: function ORDERSEEDS::UPDATE(neighbors, CenterObject)
2: cdist := CenterObject.coreDistance
3: for each Object ∈ neighbors do
4: if not Object.Processed then
5: newRdist := max(cdist , CenterObject.dist(Object))
6: if Object.reachabilityDistance = UNDEFINED then
7: Object.reachabilityDistance := newRdist
8: insert(Object, newRdist)
9: else
// All Objects in seeds are density-reachable from Object
10: if newRdist < Object.reachabilityDistance then
11: Object.reachabilityDistance := newRdist
12: decrease(Object, newRdist)
13: end if
14: end if
15: end if
16: end for each
17: end function
finding meaningful clusters and appropriate similarity functions. Hence, the SUBCLU algo-
rithm is based on the assumption that meaningful clusters of high-dimensional data can be
found in some cluster subspaces.
In more detail, the subspaces of the feature space of the database are analyzed with the density-
based concepts that were introduced for the DBSCAN algorithm. Adapting the formal defini-
tions to a subspace S of the high-dimensional feature space, a density-connected set (w.r.t. ε
and minPoints) is defined: a set of objects is a density-connected set in S if all objects of the
set are density-connected in S with each other. The density-connected sets are monotonic. For
example, if C⊆DB is a density-connected set of objects of the database DB in the subspace S,
then C is also a density-connected set in any subspace T ⊆ S, see also Figure 3.8. This mono-
tonicity may not hold for clusters, since clusters have to be maximal w.r.t. density-reachability,
see the detailed description of SUBCLU and the density-based definitions in [Ester et al., 1996]
and [Kailing et al., 2004], respectively. Thus, SUBCLU first detects density-connected sets in
all 1D subspaces of the high-dimensional feature space with DBSCAN, see Algorithm 6. Next,
if a subspace does not contain any density-connected set and thus any density-connected clus-
ter, this subspace is excluded from further analysis. For all detected clusters in the subspaces,
SUBCLU checks if these clusters are also contained in the next higher dimensional subspace,
see Algorithm 7.
The advantages of the SUBCLU algorithm are the same advantages associated with the DB-
SCAN algorithm since it is closely related to this approach. Additionally, SUBCLU allows
for clustering in subspaces and is suitable for high-dimensional feature spaces. However, a
disadvantage is the global parameter choice. Hence, the same values for ε and minPoints are
employed independent from the number of dimensions of the feature space. Naturally, objects
are more dense in low dimensional spaces than in high-dimensional spaces. Thus, appropriate
small ε and minPoints values for the low dimensional space might be inappropriate for the
high-dimensional spaces.
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Algorithm 6 Pseudocode SUBCLU from [Kailing et al., 2004].
1: function SUBCLU(SetOfObjects, ε , minPoints)
// Step 1: Generate all 1D clusters
2: S1 := /0 // Set of 1D subspaces containing clusters
3: C1 := /0 // Set of all sets of clusters in 1D subspaces
4: for each a1 ∈ Attributes do
// set of all clusters in subspace ai
5: C{ai} := DBSCAN(SetOfObjects, {ai}, ε , minPoints)
6: if C{ai} , /0 then // at least one cluster in subspace ai
7: S1 := S1∪{ai}
8: C1 := C1∪C{ai}
9: end if
10: end for each
// Step 2: Generate (k+1)D candidate subspaces
11: k := 1
12: while Ck , /0 do
// Step 2.1: Generate (k+1)D subspace candidates
13: CandSk+1 = GenerateCandidates(Sk)
// Step 2.2: Test candidates and generate (k+1)D clusters
14: for each cand ∈CandSk+1 do
// Search kD subspace of cand with minimal number of objects in the clusters
15: bestSubspace := mins∈Sk∧s⊆cand∑Ci∈Cs |Ci|
16: Ccand := /0
17: for each cluster ∈CbestSubspace do
18: Ccand :=Ccand∪ DBSCAN(cluster, cand, ε , minPoints)
19: if Ccand , /0 then
20: Sk+1 := Sk+1∪ cand
21: Ck+1 :=Ck+1∪Ccand
22: end if
23: end for each
24: end for each
25: end while
26: end function
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(a) Example Database (b) Reachability Diagram (c) Clustering Result
Figure 3.7: Illustration of the OPTICS’ reachability diagram and cluster extraction. In (a),
a 2D example database is presented that was artificially generated for illustration purpose.
Hence, three clusters can be intuitively perceived, see dashed ellipses. Note that the cluster at
the top exhibits a higher density than the cluster at bottom right. In (b), reachability distances
for each object in the extracted ordering are displayed. The user-defined threshold ε ′ was set
to 100 and this threshold yields three clusters (yellow-green, orange, and cyan colored) that
are separated by outliers (gray colored). Naturally, the outliers exhibit highest reachability
distances. As it can be inferred from (b), the cyan cluster is more dense than the orange one
(see the smaller reachability distances). In (c), the resulting clustering based on ε ′ is depicted
with the same color scheme. Outliers are furthermore marked with circles.
3.4 Statistical Analysis of Attribute Dependency and
Dimensional Reduction
In contrast to the subspace clustering, many concepts aim at the construction of a new and
lower dimensional feature space. A dimensionality reduction concept like the PCA is based on
the assumption that many features interfere with each other or measuring somehow the same
system variables. In this case, a certain redundancy occurs when extracting the attributes. To
be more precise, descriptive perfusion parameters extracted from concentration-time curves in
the setting of tumor diagnosis based on perfusion MRI often correlate. The correlation can
be present because the amount of contrast agent concentration influences several perfusion
parameters at once. This section provides important background information for the analysis
of redundancy between two parameters, followed by the description of the PCA and spectral
clustering.
3.4.1 Redundancy of Two Attributes
To characterize the redundancy between two attributes, two approaches are employed: the
extraction of the correlation coefficient and the covariances [Han et al., 2011]. Both measures
depend on the mean and the variance of the objects’ attributes. Hence, the mean x of a certain
attribute x of n objects of the database, is also referred to as expected value E(x) of x. It is
calculated by:
x = E(x) =
∑ni=1 xi
n
, (3.1)
where xi denotes the value of attribute x for the ith object.
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Figure 3.8: Illustration of the monotonicity of density-connected sets with minPoints = 4.
In (a), the objects p and q are density-connected via o in the 2D subspace spanned by the
attributes A and B. Therefore, they are also density-connected via o in each 1D subspace A
and B. In (b), the objects p and q are not density-connected in the 1D subspace B. Thus, they
are also not density-connected in the 2D subspace AB. However, they are density-connected
via o in the 1D subspace A. (Adapted from [Kailing et al., 2004].)
The sample variance σ2 of the attribute x can be expressed by:
σ2 =
1
(n−1)
n
∑
i=1
(xi− x)2 (3.2)
Hence, we interpret the objects of our database as samples of a collected data set, e.g., breast
tumor perfusion data sets in a clinical workflow from the population. On the contrary, the
variance σ∗2 = 1n ∑
n
i=1(xi−x)2 should be employed when the sample would include the whole
population. The equations for σ∗ and σ differ only in the n−1 and n divisor. Furthermore, σ
is called the sample standard deviation. The same holds for σ∗.
The Correlation Coefficient
The correlation coefficient determines how strong two attributes x and y of n objects are corre-
lating. The correlation coefficient, also called Pearson’s product moment coefficient, is defined
by:
rx,y =
∑ni=1(xi− x)(yi− y)
nσxσy
=
∑ni=1(xiyi)−nx y
nσxσy
. (3.3)
The values of rx,y lie in the interval of [−1,1]. Hence, values> 0 indicate a positive correlation,
i.e., the values of x increase as the values of y increase and values < 0 indicate a negative
correlation, i.e., the values of one attribute decrease as the values of the other attribute increase.
An rx,y value of 0 indicates no correlation between the two attributes.
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Algorithm 7 Pseudocode GenerateCandidates from [Kailing et al., 2004]. Sk is the set of
subspaces
1: function GENERATECANDIDATES(Sk)
// Step 2.1.1: Generate (k+1)D candidate subspaces
2: CandSk+1 := /0
3: for each s1 ∈ Sk do
4: for each s2 ∈ Sk do
5: if s1.attr1 = s2.attr1&& . . .&&s1.attrk−1 = s2.attrk−1&&s1.attrk < s2.attrk
then
6: insert{s1.attr1, . . . ,s1.attrk,s2.attrk} into Candk+1
7: end if
8: end for each
9: end for each
10: // Step 2.1.2: Prune irrelevant candidate subspaces
// Step 2.1.1: Generate (k+1)D candidate subspaces
11: for each cand ∈CandSk+1 do
12: for each s ⊂ cand with |s|= k do
13: if s < Sk then
14: delete cand from CandSk+1
15: end if
16: end for each
17: end for each
18: end function
The Covariance of Attributes
The covariance Cov of numeric data is the second possibility to assess how similar two at-
tributes change together in probability theory and statistics. It is defined as
Cov(x,y) = E((x− x)(y− y)) = ∑
n
i=1(xi− x)(yi− y)
n
. (3.4)
For further characterization, Cov(x,y) can be expressed as:
Cov(x,y) = E(x · y)− x y. (3.5)
Interpreting the last equation, a positive value of Cov(x,y) indicates the following relationship.
If x is larger than its expected value x, then y is likely to be larger than y. Contrary, a negative
value of Cov(x,y) equals the relationship that one attribute is above its expected value as the
other attribute is below the expected value. If x and y are independent regarding their correla-
tion, then Cov(x,y) equals 0. However, the covariance covers a linear relationship. Thus, if the
attributes x and y may exhibit a certain relationship (e.g., a non-linear dependency), the value
of Cov(x,y) can be equal to 0.
Covariance and correlation coefficient exhibit the following relationship:
rx,y =
Cov(x,y)
σxσy
(3.6)
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Furthermore, the variance σ2 equals the covariance covering two identical attributes (Cov(x,x)).
3.4.2 PCA for Dimensional Reduction
The PCA is an orthogonal transformation from the original feature space into a new feature
space of equal dimension. The new feature space is spanned by the principal components.
The first principal component equals the first axis of the new feature space and expresses
the maximum variance possible among all options for this first axis. The second principal
component is perpendicular to the first one and expresses the possible maximum of the data’s
variance under the constraint to be perpendicular to the first principal component. This holds
also for the following principal components such that all principal components are mutually
perpendicular.
A PCA can be analytically determined by maximizing the variances expressed by the principal
components. For a statistical setting of a database with n objects with m attributes, the PCA
can be carried out by exploiting the attributes’ covariances. Therefore, the covariance matrix
Σ is extracted. The element in the ith row and jth column (Σ)i, j represents the covariance of the
values of attribute i and attribute j, i.e., (Σ)i, j =Cov(i, j). The m attributes yield a covariance
matrix with dimension m×m. From Σ, the normalized eigenvectors and eigenvalues are ex-
tracted. Next, they are ordered by eigenvalue, from highest to lowest, yielding the components
in order of significance. The ordered eigenvectors form the principal components. To obtain
the positions of the objects in the new feature space, the attribute values are shifted such that
their mean lies in the origin. Next, they are multiplied with the principal components. The
centering around their means is inevitable for the transformation into the new space, which is
also automatically carried out by Σ.
Since the principal components are ordered by significance, i.e., the amount of variance they
are covering, it is in general sufficient to employ only the first few principal components to
construct a new feature space. Thus, the dimension of the feature space can be effectively
reduced with only a small loss of information. Clustering is then carried out in the lower
dimensional feature space and the clustering result is assigned to the original data.
Due to the dependency on the covariance, PCA is sensitive to the relative scaling of the original
variables. Increased importance will be assigned to attributes with larger domain ranges than
to attributes with smaller domain ranges. To reduce the influence of the attributes’ domain
ranges, the attribute values are normalized such that each attributes domain range covers the
same range. Different normalization techniques exist, for example the min-max normalization
and the z-score normalization. The first one maps the values of attribute x lying in the interval
[xmin,xmax] to the new values x′ in the range [x′min,x′max]:
x′ =
x− xmin
xmax− xmin (x
′
max− x′min)+ x′min. (3.7)
Z-scoring maps the values x to the new values x′ by applying the mean x and the standard
deviation σx:
x′ =
x− x
σx
. (3.8)
Thus, the values of x′ have a mean equal to 0 and a variance equal to 1. However, the PCA can
only detect linear dependencies between the variables.
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The PCA is illustrated with the flea beetle database. This database contains 74 samples with
7 attributes and was published by [Lubischew, 1962]. The first attribute determines the type
of flea beetle and equals one of the three different types of chaetocnema: ch. concinna, ch.
heptapotamica, and ch. heikertingeri. The six remaining attributes (units are given in brackets)
cover:
• D1: the size of the first joint of the foot of the first leg [µm],
• D2: the size of the second joint of the first tarsus [µm],
• D3: maximum width of the head between the external edges of the eyes [0.01mm],
• D4: maximum width of the aedeagus in the fore-part [µm],
• D5: front angle of aedeagus [in 7.5◦], and
• D6: aedeagus width from the side [µm].
Since they express physiological features, a certain redundancy can be expected.
The feature space reduction with the PCA is illustrated in Figure 3.9. In Figure 3.9(a), the
covariance matrix Σ of the attributes D1−D6 is shown, where z-scoring was applied to the
original attributes. Thus, each original attribute exhibits variances equal to 1, see diagonal en-
tries of Σ. Higher values for the covariance values of two attributes are highlighted with a gray
background. The percentage variances of the principal components are listed in Figure 3.9(b).
Note that the first three principal components cover 90% of the overall data variance. In Fig-
ure 3.9, the database’s feature space is visualized. For each different type, a different color
was chosen (orange was assigned to ch. concinna, cyan to ch. heptapotamica, and green to ch.
heikertingeri). In Figures 3.9(c)-(d), 3D scatterplots are presented, employing the attributes
D1−D3 or D4−D6, respectively. In Figure 3.9(e) only the first three principal components
are employed. Cluster algorithms can be employed in the new constructed 3D feature space
and three well separated clusters can be obtained. Note that the color mapping is only based
on the beetle type, no clustering approach was carried out.
3.4.3 Clustering in the Spectral Domain
In spectral clustering, the clustering is reformulated as a graph cut problem. The objects of the
database are considered as nodes of a connected graph. The similarity of two objects’ features
is expressed via the weight of their connecting edge. A graph cut is a partition of the graph’s
nodes into two disjoint subsets which are joined by at least one edge. For spectral clustering,
these cuts should partition the graph such that edges between different groups (i.e., clusters)
have very low weights and edges within the same cluster have high weights. It is approximated
with the eigenvectors and eigenvalues of a specific matrix: the Laplacian matrix. Thus, the
original data points are mapped into a lower dimensional space. In this new representation,
clusters can be easier separated (regarding the high-dimensional space) by applying simple
clustering techniques like k-means.
In the following, the spectral clustering is briefly explained. For a more detailed review, see
the tutorial of Von Luxburg [2007]. First, a weighted, undirected graph is constructed from
the initial database with n objects. Hence, each graph node represents an object and each
edge represents the similarity between two objects based on a symmetric and non-negative
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Figure 3.9: Illustration of the PCA over the flea beetle data set [Lubischew, 1962]. In (a),
Σ of the attributes D1−D6 is presented. In (b), the percentage variances expressed by the
principal components pc1 - pc6 are listed. In (c), (d), and (e), 3D scatterplots are presented
where orange was assigned to ch. concinna, cyan to ch. heptapotamica, and green to ch.
heikertingeri. In (c), the 3D subspace comprising the features D1-D3 is depicted. In (d), the
subspace of features D4-D6 is shown. In (e), the new feature space of pc1-pc3 is depicted.
similarity function, e.g., the Euclidean distance function. The similarity between two nodes oi
and o j is employed as weight wi j. The object’s oi degree di is extracted as:
di =
n
∑
j=1
wi j (3.9)
Next, a Laplacian matrix L is constructed from the graph. L is based on the degree matrix D
and the weighted adjacency matrix W , see [Von Luxburg, 2007] for various variants. Here, D
is the diagonal matrix with degrees d1, . . . ,dn on the diagonal and W = (wi, j)i, j=1...n. As it is
stated in the tutorial by Von Luxburg [2007], an unique definition of the exact graph Laplacian
does not exist. Different approaches exist, for example the normalized spectral clustering
according to Ng et al. [2002], which is also referred to as Ng-Jordan algorithm.
Hence, a normalized Laplacian matrix is constructed based on W and D and a spectral decom-
position is performed. Based on a pre-defined k, the k biggest eigenvalues and corresponding
eigenvectors u1, . . . ,uk are extracted. Then, the matrix U containing u1, . . . ,uk as columns is
constructed. The matrix T is extracted from U by normalizing the rows to transform the ob-
jects into the spectral space: the object yi corresponds to the ith row of T . Now, the clustering
can be carried out in the space spanned by T and the objects y can be clustered, e.g., with the
k-means algorithm. The final cluster results are projected back such that the clustering result
of objects x is yielded.
The main advantage of the spectral clustering approach for tumor perfusion data is the influ-
ence of the local neighborhood. Hence, a modification of the similarity function that deter-
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Algorithm 8 Pseudocode for the Ng-Jordan algorithm [Ng et al., 2002] from [Von Luxburg,
2007].
1: Input: Similarity matrix S ∈ Rn×n, number k of clusters to construct.
2: Construct a similarity graph and let W be its weighted adjacency matrix.
3: Compute the normalized Laplacian Lsym.
4: Compute the first k eigenvectors u1, . . . ,uk of Lsym.
5: Let U ∈ Rn×k be the matrix containing the vectors u1, . . . ,uk as columns.
6: Form the matrix T ∈ Rn×k from U by normalizing the rows
that is set ti j = ui j/
√
∑k u2ik.
7: For i = 1, . . . ,n let yi ∈ Rk be the vector corresponding to the ith row of T .
8: Cluster the points yi (i = 1, . . . ,n) with the k-means algorithm into clusters C1, . . . ,Ck.
9: Output: Clusters A1, . . . ,Ak with Ai =
{
j|y j ∈Ci
}
.
mines the weights is carried out. With the modified similarity function, e.g., the Gaussian
similarity function
s(oi,o j) = exp
(
−||oi−o j||
2
2σ2
)
, (3.10)
the neighborhood size is controlled with the parameter σ . Then, a similarity equal to zero is
assigned to spatially non-connected voxels yielding only spatially connected clusters.
3.5 Region Merging
Region merging is a basic concept to extract homogeneous regions of an image. The algorithm
comprises the following steps: initially, each pixel forms a single region. Next, two adjacent
regions are merged into a new region if they fulfill a certain homogeneity criterion. The algo-
rithm converges if no pair of adjacent regions exists that fulfills this criterion anymore. Hence,
the homogeneity criterion also defines the termination condition. Although originally associ-
ated with the 2D digital image processing, this concept can be interpreted as agglomerative
hierarchical clustering where each region corresponds to a cluster.
For a 3D tomographic medical data set, voxels are clustered and the homogeneity criterion
is replaced by the similarity function. The merging of adjacent regions is modeled by a hard
constraint. Region merging is a straight-forward approach and thus easy to understand and im-
plement. The result of the region merging usually depends on the order in which the regions are
merged. Advanced concepts include the split-and-merge algorithm, which employs a multi-
scale-strategy and combines region splitting and merging, or the statistical region merging
concept [Nock and Nielsen, 2004].
3.6 Conclusion
In this chapter, the reader was acquainted with the process of clustering to detect meaningful
groups of data. The categorization of clustering is a challenging aspect since clustering con-
cepts are often adapted to the specific problem and many clustering algorithms combine more
than one clustering concept. Therefore, in the first part of this chapter, a short description of
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basic and advanced clustering techniques was presented. In combination with medical imaging
of perfusion data, different aspects were compared to identify promising clustering concepts
for this purpose.
The selected concepts were presented in more detail in Sections 3.3-3.5. Hence, the de-
mand for arbitrarily shaped clusters and the ability of the detection of outliers, strongly favors
density-based approaches. The DBSCAN algorithm is one of the most often employed clus-
tering algorithm in literature and closely related to SUBCLU and OPTICS. Further, statistical
characterization of the redundancy of attributes, the PCA for dimensionality reduction, and
spectral clustering was presented. When considering lots of perfusion parameters, the con-
cept of dimension reduction is in particular interesting. The region merging approach, a rather
simple approach for clustering, has the strong advantage of including the hard constraint of
spatially connected data. The region merging approach allows for the creation of spatially
connected regions, an advantage in clustering of tomographic image data.
When applied to medical perfusion data and the right initial conditions, clustering yield
grouped voxels with similar perfusion characteristics. Thus, a group of automatically deter-
mined voxels redeems the manual ROI placement of the clinician or the biomedical researcher.
Further, it reduces the intra- and inter-observer variability, which is the main motivation for
employing clustering to medical perfusion data. In the next chapter, an overview of related
work including clustering approaches of medical (perfusion) image data is provided.
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4 Visual Analysis of High-Dimensional
Clustered Medical Image Data
This chapter is dedicated to the state of the art of visual analysis techniques for medical per-
fusion data sets. Due to the time dimension and the diagnosis-induced grouping of voxels to
region of interests (ROIs), this chapter covers a number of research areas. The following con-
cepts contribute to this topic: the visualization of high-dimensional and time-varying data, the
combination with clustering of these visualizations, as well as multiple linked views, including
scatterplots and parallel coordinate plots to explore the high-dimensional data, see Figure 4.1.
In Section 4.1, these concepts are presented and illustrated with current state of the art ap-
proaches. Hence, the breast and brain perfusion magnetic resonance imaging (MRI) data can
be interpreted as time-varying data, as well as high-dimensional data (with a set of derived
perfusion parameters, as described in Sect. 2.1.2). The voxels are interpreted as objects of
a database and their perfusion parameter values or contrast agent concentration at different
points in time are assigned to the attributes yielding a high-dimensional feature space. Further,
each data set contains a set of voxels and due to noise and motion artifacts, the evaluation of
contrast enhancement kinetics of single voxels is not feasible. Therefore, clinical evaluation
involves grouping of voxels into ROIs. Related concepts of grouping or clustering of voxels for
the visual exploration is also covered in Section 4.1. The section ends with specific concepts
for the visualization of medical perfusion data, i.e., breast and brain perfusion data.
VisualzExplorationzand
AnalysiszofzTumors
inzPerfusionzMRI
ClusteringzofzHigh-
DimensionalzData
VisualizationzofzHigh-
DimensionalzData
MultiplezLinked
Views
Figure 4.1: The main visualization research areas that influence the visualization and explo-
ration of tumor perfusion MRI data.
Afterwards, related work for the clinical evaluation of breast tumors and brain tumors with
focus on DCE-MRI and DSC-MRI is presented and selected concepts are discussed in more
detail. Section 4.2 covers the detection and the classification of breast lesions in DCE-MRI.
Section 4.3 contains related work for quantitative perfusion parameter-based differentiation
between low grade gliomas and high grade gliomas for DSC-MRI as well as a short discussion
of the optimal ROI size for glioma evaluation.
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This chapter ends with a short summary that highlights important aspects of the medical image
interpretation and visual analysis-based exploration.
4.1 Visual Analysis and Visualization of
High-Dimensional Data
The visualization of a data set, e.g., the set of voxels of a tumor with different attributes, is
the process which generates a visual representation of this data set. Medical image data sets
become larger and more complex. To improve and support the radiologist’s work, advanced
methods including visual analytic solutions are promising. Thus, a focus is set on visual
analysis and visualization of these data sets. The visualization of high-dimensional data, i.e.,
medical image data, can be carried out with two different approaches:
1. Dimension reduction via clustering is employed for the high-dimensional data. Next,
visualizations are generated for the low-dimensional clustering results.
2. Multiple linked views are applied to the high-dimensional data. Hence, attribute sub-
spaces can be explored in a 2D or 3D way. Each subspace exploration is linked such that
the user can extract subspaces of the whole data set.
Therefore, in Section 4.1.1, related work for the visualization and clustering of medical high-
dimensional data is presented. In Section 4.1.2, state of the art for visual analysis and ex-
ploration of high-dimensional data based on multiple linked views is provided. Finally, in
Section 4.1.3, visualization techniques especially for perfusion datasets are presented. For a
comprehensive overview for the area of visual data mining with special focus on visual ana-
lytics, the reader is referred to [Keim et al., 2008].
4.1.1 Clustering of Medical High-Dimensional Data
This section provides examples of appropriate adoptions of clustering algorithms to medical
image data with focus on medical perfusion data. As it was illustrated in Figure 4.1, the dif-
ferent research areas are overlapping. Therefore, in Section 4.1.2 the multiple linked views
frameworks are described. Related work for clustering of high-dimensional data in combina-
tion with visualization of high-dimensional data is presented afterwards.
For example, an important application area for clustering is the analysis and visualization of
functional MRI (fMRI) data. In general, peaks in the histogram of all voxels’ signal intensities
of a medical data set often represent different tissue types and are well suited to detect impor-
tant signal intensity ranges. These ranges are important for further visualization. However,
in fMRI data, histogram peaks may represent overlaps of tissue types that are not particularly
interesting. Therefore, Maciejewski et al. [2009] employed clustering to analyze the gradient
versus the intensity histogram space. Furthermore, cluster analysis was carried out to generate
transfer functions for this type of data by Maciejewski et al. [2013].
Diffusion tensor MRI data forms another important medical application area for clustering.
In the work by Moberts et al. [2005] fiber tracts were clustered to provide a visualization
for neurosurgeons. O’Donnell and Westin [2005] adapted spectral clustering to identify fiber
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tract correspondences over a population of brains. Tiwari et al. [2009] employed hierarchi-
cal spectral clustering to magnetic resonance spectroscopy to supplement MRI. Thus, they
could automatically identify suspicious regions on the prostate in the spectroscopy data. In
addition, clustering (of curvature-related measures) was successfully employed to detect re-
gions of the colon for a further polyp detection in virtual colonoscopy by Zhao et al. [2006].
Schultz and Kindlmann [2013] presented the Open-Box Spectral Clustering, see Figure 4.2.
This interactive framework for spectral clustering in medical image analysis applications sug-
gested parameter values and provided immediate feedback to support the user. Furthermore,
the high-dimensional feature space was mapped to the three-dimensional data space. Thus,
the complex parameter choices for spectral clustering could be effectively supported. The ap-
proach by Marrocco et al. [2012] was adapted to conventional X-ray mammography. They
carried out a watershed transform to define areas of microcalcifications that form ROIs. Next,
they input the ROIs’ geometrical and textural features to decision tree classifiers, which filter
out uninteresting ROIs. The remaining regions are clustered into spatially contiguous clusters.
Similar to DCE-MRI perfusion data, dynamic nuclear image data of the heart allows for ex-
traction of time-activity curves per voxel. Tönnies et al. [2003] employed region merging to
cluster voxels with similar time-activity curves. Furthermore, they employed a similarity cri-
terion based on a reduced set of features. This reduced feature set was obtained via a principal
component analysis (PCA).
Clustering of medical image data is closely related to the visualization of high-dimensional
data since the clustering often serves as dimension reduction method. Further, the clustering
allows for an intelligent grouping of the data and the detection of the most relevant informa-
tion. Zhang et al. [2006] et al. presented a method to visualize gene clusters in 3D. First,
they used the spring model to locate genes within a cluster into InfoCubes. Afterwards, they
employed the same method to allocate the InfoCubes in 3D space. Their algorithm avoids
the space partition problem. When transferred to tomographic perfusion MRI data, it must
be stated that clusters could be entwined around each other such that this approach becomes
inappropriate. The approach by Quigley [2001] deals with large data sets and generates hier-
archical compound graphs. The clusters are represented as a graph where the nodes act as the
clusters. Yang et al. [2003] presented a system for the processing of DNA microarray data.
They introduced a space-undivided and a space-divided 3D gene plot. In the first plot, every
gene is assigned to a sphere and the cluster membership is color-coded. The second plot splits
the 3D space into cubes and puts the clusters into these cubes. In the first case, clusters seem
to be huge point clouds and in the second case, no spatial information about the clusters exists.
Aono and Kobayashi [2011] developed a visual interface for non-technical users to understand
the output from clustering algorithms. Their algorithm displays clusters which are projected
on a 3D subspace based on the user’s keyword input. Thus, the computed recommendations
for the 3D visualization cannot present the spatial relationships.
Similar to DCE-MRI perfusion data, dynamic nuclear image data of the heart allows for extrac-
tion of time activity curves per voxel. Tönnies et al. [2003] employed region merging to cluster
voxels with similar time-activity curves. Furthermore, they used a similarity criterion based
on a reduced set of features. This reduced feature set was obtained via a principal component
analysis (PCA). The approach by Marrocco et al. [2012] was adapted to conventional X-ray
mammography. They carried out a watershed transform to define areas of microcalcifications
that form ROIs. Next, they input the ROIs’ geometrical and textural features to decision tree
classifiers, which filtered out uninteresting ROIs. The remaining regions were clustered into
spatially contiguous clusters.
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(a) (b)
Figure 4.2: The open-box framework for interactive spectral clustering (Image adapted and
reprinted from [Schultz and Kindlmann, 2013] c© IEEE 2013 with kind permission from IEEE).
In (a), the framework is depicted and in (b), the parameter choices were automatically applied
for the clustering of other patients.
Since the clustering concepts for dimension reduction may contain a loss of spatial informa-
tion in the high-dimensional space, different approaches were presented to visualized these
high-dimensional data in combination with the clustering results. The concepts overlap with
concepts of visualizing high-dimensional data in general. In particular, they are also combined
with multiple linked views. Therefore, these concepts are presented in the next section.
4.1.2 Multiple Linked Views
Multiple linked views are a well-established information visualization tool [Wong and Berg-
eron, 1997]. Hence, the views provide different portions of the data and thus allow for ex-
ploration of relationships between different attributes. Furthermore, the user can select some
portion of the data, e.g., by placing a ROI in the first view, and the contained objects are
dynamically highlighted in the other views. For example, the WEAVE (workbench environ-
ment for analysis and visual exploration) system [Gresh et al., 2000] links scientific views
(represented by multidimensional statistical representations) by brushing facilities applied to
scatterplots. The SimVis framework [Doleisch et al., 2003] extends the WEAVE framework
and also employs scatterplots and parallel coordinates plots. Hence, interaction is possible via
smooth brushing [Doleisch and Hauser, 2002]. An example is provided at the end of this sec-
tion where the SimVis framework was successfully employed for analysis of cerebral perfusion
MRI data sets to assess ischemic stroke by Oeltze et al. [2009]. The most important and most
common views of such multiple linked frameworks are listed in this section:
• The first part contains related work for scatterplot views.
• The second part presents parallel coordinates plots.
• The third part describes the Radviz view.
• The fourth part lists general approaches for the visualization of (clustered) high-dimensional
data within a multiple view framework.
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The Scatterplot View
Scatterplots [Wong and Bergeron, 1997] are an established technique to visualize objects in
an n-dimensional space where each axis of the space corresponds to a dimension of the n-
dimensional feature space. Naturally, only 2D and 3D scatterplots can be intuitively perceived.
Mostly, the scatterplot covers a 2D plane where the horizontal and vertical coordinates equal
to two of the feature space dimensions. A scatterplot matrix [Cleveland, 1985] comprises
all combinations of two dimensions from the feature space. Kosara et al. [2004] presented the
VoxelPlot, a 3D scatterplot that interactively links scientific and information visualization with
multiple views similar to the WEAVE system [Gresh et al., 2000]. Sanftmann and Weiskopf
[2009] introduced the illuminated scatterplot where shape perception is improved by applying
a dedicated illumination technique to the 3D scatterplot’s point cloud representation. Piringer
et al. [2004] mapped the distance to color and the point size of the scatterplots. These ap-
proaches only employed color or shading to the data objects to represent the type of cluster. In
contrast, Healey et al. [2001] included contextual cues in the final 3D scatterplot-based visu-
alizations. Furthermore, the scatterplot concept has been extended to continuous scatterplots
by Bachthaler and Weiskopf [2008] to account for spatially continuous input data instead of
discrete data sets.
The Parallel Coordinates Plot
The parallel coordinates plot [Inselberg and Dimsdale, 1990] employed vertical axes for each
dimension of the feature space. In general, all axes are parallel to each other and arranged
in a 2D view. The objects are presented as line segments where each line segment connects
two attributes of the object. The work by Theisel [2000] introduced free-form curves instead
of line segments for connection of points on adjacent axes. First, visual clutter was reduced.
Second, the replacement of line segments by curves provided more space between two ad-
jacent axes and more information like correlation between more than two dimensions could
be encoded. Matkovicˇ et al. [2007] applied color to 2D parallel coordinate plots to highlight
similar curves. Furthermore, the illustrative parallel coordinates presented by McDonnell and
Mueller [2008] applied artistic rendering techniques to convey a large amount of informa-
tion. They employed edge-bundling through splines to visualize so-called branched clusters,
opacity-hints to support cluster density perception, opacity, shading effects as well as silhou-
ettes and shadows. Wegenkittl et al. [1997] presented 3D parallel coordinates plots for the
scientific visualization of high-dimensional data based on the trajectories of high-dimensional
dynamical systems which form a data set of a smooth-dimensional flow. As a last example, the
pargnostics approach by Dasgupta and Kosara [2010] included screen-space metrics like line
crossings, crossing angles or overplotting, to quantify the different visual structures in parallel
coordinates plots and to construct an optimized display of the plot.
The Radviz View
Further visualization techniques of high-dimensional data exist, like the radial coordinate vi-
sualization (Radviz) and multi-dimensional scaling. The Radviz approach was presented by
Hoffman et al. [1997] to classify DNA sequences. Hence, for each dimension of the feature
space, a line emanates radially from the center of the circle and terminates at the perimeter
where the special end points form equally distanced anchor points. The objects of the data set
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are then arranged in the circle center by attaching springs to the object and the anchor points.
Hence, the spring constant is assigned to the (normalized) attribute value of the object for the
specific anchor point, i.e., specific feature. The data points are placed at the positions where
the spring forces sum up to zero. Multidimensional scaling comprises visualization techniques
that place objects in an n-dimensional feature space in a lower dimensional space (like 2D or
3D) such that the objects’ distances are preserved as much as possible.
Visualization of (Clustered) High-Dimensional Data with Multiple Linked Views
Since the clustering process for dimension reduction may contain a loss of spatial information,
Linsen et al. [2008] presented a surface extraction approach that includes spatial information
of multifield clustered data. Hence, boundary surfaces are extracted and semi-transparently
visualized in a 3D star coordinate layout to reveal nested clusters. Poco et al. [2011] employed
a least square projection to map high-dimensional data to 3D visual spaces. Their framework
allowed for the visualization of multidimensional non-spatial data and integrates the feature
space of multi-variate spatial data. Both approaches employed surface representations for their
cluster results.
The DimStiller framework presented by Ingram et al. [2010] allows for analysis and dimen-
sionality reduction of high-dimensional data. Hence, the user can define workflows that can be
re-used for different databases. Tatu et al. [2012] provided a subspace and search visualization
approach where not only one subspace is created, but a candidate set of subspaces. Also, the
brushing concept was employed for high-dimensional data such that the user can jointly study
the structure of the dimensions space as well as the distribution of data items with respect to
the dimensions by Turkay et al. [2011a]. The combination of parallel coordinates and large
time-varying data can be visually explored with meta parallel coordinates, a parallel coordi-
nates plot based on perceptually motivated visual metrics [Dasgupta et al., 2012]. Another
visualization technique for large, time-dependent data was introduced by Walker et al. [2012]
where the parallel coordinates are combined with spherical coordinates. For more information
about parallel coordinates, the survey by Heinrich and Weiskopf [2013] is recommended. The
TiMoVa framework supported domain experts during model selection in time series analysis
through an interactive visual interface [Bögl et al., 2013]. The approach by Krstajic et al.
[2011] visualized large and dynamic event data sets with so-called CloudLines. Their tech-
nique revealed visual clusters in a compressed view of multiple time series and also included
interactive distortion techniques for an individual data item analysis. Zhao et al. [2011] pre-
sented the ChronoLenses framework for the visual analysis of time series. For a closer look on
visual methods for analyzing time-oriented data, the reader is referred to Aigner et al. [2008].
The framework by Younesy et al. [2013] allowed for visual analysis of epigenomic data includ-
ing grouping of the data by k-means clustering or the querying based on presence or absence
of signals in different epigenomic experiments. For the interactive visual analysis of temporal
cluster structures, Turkay et al. [2011b] presented two novel visualization techniques, the tem-
poral cluster view and the temporal signatures, to analyze and evaluate temporal clusters. The
approach by Hadlak et al. [2013] allows for clustering of temporal attributes for visual analysis
of dynamic networks. Hence, the supergraph is visualized in combination with the clustered
nodes that share a similar trend over time. The Microarray Time-Series Explorer framework
was presented by Craig et al. [2012], and is dedicated for exploratory analysis of large scale
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microarray time series data. The work by Zachow et al. [2009] employed the SimVis frame-
work for visual analysis of nasal air flow. Hence, the attribute views of this framework, e.g.,
the parallel coordinates plot, curve views of the temporal data, or scatterplots, were linked with
each other and the user can highlight certain attributes via brushing and linking. In summary,
the visualization of (clustered) high-dimensional data with multiple linked views is an active
research area. A comprehensive overview of the visualization of high-dimensional data is pre-
sented in Chapter 6 in the visualization book of Schumann and Müller [2000]. Furthermore,
the survey by Kehrer and Hauser [2012] holds an important overview about visualization and
visual analysis of multi-faceted scientific data.
4.1.3 Visualization of MRI Perfusion Data
In this section, the visualization of perfusion data is described in more detail. Therefore, it is
divided into three parts:
• The first part introduces commercially available software workstations for perfusion
data.
• The second part introduces the three-time-point (3TP) method in more detail, since this
method has been employed for the techniques developed in this thesis.
• The third part holds related work for the visualization and visual analysis of perfusion
MRI data.
Commercially Available Software Workstations for Perfusion
Many commercially available perfusion software systems comprise these basic visualization
techniques. The CADstream software1 provides colored parameter maps and highlights voxels
with a relative enhancement (RE) value above a given threshold. Hence, the color repre-
sents the post-initial change of the voxel’s RE curve. A washout curve is color-coded red,
a plateau curve is color-coded green, and a continuous enhancing curve is coded blue. Fur-
thermore, the percentage of curve types in comparison to the whole lesion is presented. As
a prerequisite step, the radiologist must manually mark the lesion or define a ROI that con-
tains the whole lesion [Lehman et al., 2006]. The SIEMENS Syngo, Neuro Perfusion Soft-
ware allow for evaluation of brain tumors. Hence, the concentration time curve as well as
color-coded parameter maps are provided. The nordicICE software package2 allows for direct
co-registration of anatomical and functional brain data sets. Furthermore, the extraction of
quantitative perfusion parameters is supported and the parameter maps are presented in 2D
color-coded views [Bjørnerud, 2003].
The 3TP Breast Software Packacke
The 3TP breast software package was employed in the approach by Hauth et al. [2006a].
Hence, the curve shape is mapped to color and the RE of the contrast agent is mapped to
1Product of Confirma, Kirkland, USA; www.confirma.com (10/01/2013)
2Product of NordicNeuroLab, Bergen, Norway; www.nordicneurolab.com (12/08/2013)
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intensity. This is based on the 3TP method introduced by Degani et al. [1997] and illustrated
in Figure 4.3.
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Figure 4.3: Mapping of the 3TP classes to colors and intensity.
In Figure 4.4, the software interface is depicted. A limitation of this software package is
the missing assessment of lesion heterogeneity. Also, besides the percentage distribution of
the nine clusters over the whole tumor no additional information about cluster attributes is
available. In Section 4.2.2, related studies that employ this software package for automatic
feature breast classification are presented.
Visualization and Visual Analysis of MRI Perfusion Data.
First, the visualization of perfusion data is described. Afterwards, the visual analysis is pre-
sented.
Visualization of MRI Perfusion Data. For the specific application area of perfusion data
sets, the general evaluation approaches comprises conventional techniques, like cine-movies,
subtraction images, color-coded parameter maps as well as more sophisticated visual analysis
methods [Preim et al., 2009]. Cine-movies describe an animation of 2D views of the perfusion
MRI data sets through all time steps of the acquisition. They are well suited to detect en-
hancement patterns of the contrast agent. Subtraction images show the contrast enhancement
or contrast concentration differences between two points in time, revealing contrast enhanc-
ing regions and non-enhancing tissue. In general, color-coded parameter maps for perfusion
MRI map the voxel values of a single parameter to color. These maps represent a 2D slice of
the data set. Based on these parameter maps, the radiologist can identify ROIs with similar
parameters and extract time-intensity curves from these ROIs.
Kohle et al. [2002] presented a new approach for volume visualization of breast DCE-MRI
data. A color mapping for the highlighting of perfusion abnormalities and the closest vessel
projection to add depth information to maximum intensity projections are employed. En-
glmeier et al. [2004] also employed a mapping of parameters to color and intensity, but the
65
4 Visual Analysis of High-Dimensional Clustered Medical Image Data
(b) 3TP Image
22px
6.7%
55px
16.8%
64px
19.6%
30px
9.7%
7px
2.1%
26px
8.0%
28px
8.6%
67px
20.5%
28px
8.6%
(c) 3TP Report Card
Summary Statistics: Area
Region Area Colored:
Region Area Total:
3.04 cm
6.60 cm
2
2
(a) Subtraction MRI
Figure 4.4: Illustration of the 3TP color-coded image (Image adapted and reprinted
from [Hauth et al., 2008] c© 2007 Elsevier Ireland Ltd with kind permission from Elsevier). In
(a), the subtraction image of breast DCE-MRI reveals a contrast-enhancing lesion in the left
breast (see arrow). In (b), the 3TP color-coded image is presented where the lesion has been
encircled (see yellow outline). Furthermore, the software employed in the study provides the
3TP report card that presents the total number and percentages of the nine 3TP classes, i.e.,
the color hue and color intensity of the voxels in the encircled area, see (c).
user has to infer the parameter value from the associated color and intensity component. Oeltze
et al. [2008a] combined color with glyphs to map more than one perfusion parameter to convey
information about the coronary heart disease based on myocardial perfusion MRI. Hence the
glyph combined color, shape and orientation to map the information, similar to color icons,
which were introduced by Levkowitz [1991]. A further approach employed glyphs for visual
exploration of cerebral perfusion MRI, including multi-resolution glyphs to improve readabil-
ity and different glyph shapes [Oeltze et al., 2008b]. For the state of the art about glyphs, the
reader is referred to the taxonomy-based glyph design by Maguire et al. [2012]. Also, isolines,
height fields, or orientations of textures might be employed to combine several parameters
within a single image, see the survey of visual exploration and analysis of perfusion data for
more detail [Preim et al., 2009]. Here, for example, the application of colored height fields
for the analysis of myocardial perfusion data was presented. Hence, the descriptive perfusion
parameter peak enhancement was mapped to height, and washin was mapped to color. As
a second example, the usefulness of movable viewing lenses [Bier et al., 1993], also called
Magic Lenses, was demonstrated for breast perfusion and cerebral perfusion MRI. Hence, one
parameter value was presented as context visualization, and the lens visualized another param-
eter as focus map to allow for a multi-parameter exploration.
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Visual Analysis of MRI Perfusion Data. Medical image data sets become larger and more
complex. The study by Lundström and Persson [2011] characterized the visual analytic tasks
in diagnostic imaging. They stated that the increasing complexity of medical image data in-
duces an increasing demand for visual analytic solutions. Their study revealed that the key
issue remains the diagnosis of primary and secondary findings. Albeit their work identified
the diagnosis of primary and secondary findings in the image data in an efficient way as key
issues, the determination of shape, size, and relative position of different parts of the anatomy
were identified as important component of a radiologist’s image review work
As a result, advanced methods including visual analytic solutions are required to improve and
support the radiologist’s work. The Profile Flag approach is an example for a more advanced
exploration approach for breast MRI perfusion data. It was presented by Mlejnek et al. [2006]
and allowed for the intuitive probing and annotation of temporal data. The visualization of
the temporal curves is closely connected to the rendering of the anatomic structure of the data
without removing any parts thereof. Mostly, a preselection of voxels or a segmentation is cre-
ated, as a basis for further analyses. Coto et al. [2005] employed enhancement scatterplots of
the pre-contrast intensity and the RE for such a preselection in breast DCE-MRI data. They
developed the MammoExplorer - a multidimensional view framework comprising these tech-
niques. The user can select voxels of interest for a visual exploration of the breast perfusion
data set where cutaway views reveal the suspicious breast tumor embedded in its surrounding
tissue. The exploration can also be improved by brushing and linking. This is similar to the
work by Oeltze et al. [2007] where brushing and linking was also applied to perfusion data
sets. This was carried out with the SimVis framework, presented by Doleisch et al. [2003] (re-
call Sect. 4.1.2). Furthermore, they carried out correlation analysis and a PCA for dimension
reduction and analysis of the inter-parameter relations for descriptive perfusion parameters.
Related to this work, Oeltze et al. [2009] presented a visual analysis of longitudinal cerebral
perfusion data sets to evaluate ischemic stroke. Again, they employed the SimVis framework.
The exploration of the brain was carried out to assess how much of the brain tissue is affected
by an ischemic stroke and if the tissue is irreversibly damaged (no contrast agent will arrive)
or if it is tissue-at-risk (delayed contrast agent washin). Hence, the authors brushed over the
first two principal components of a PCA carried out over the descriptive perfusion parame-
ters. They reported that the first and second principal components reflect the magnitude of
enhancement and the time to enhancement, respectively. With the brushing, brain tissue with a
delayed washin (increased time to enhancement) and only little contrast agent arriving (small
magnitude of enhancement) could be selected. Applied to three consecutive scans of a stroke
patient revealed a decreased amount of infected brain tissue, indicating that the tissue-at-risk
benefited from the thrombolytic therapy that was carried out between the scans.
Similar to the adaption of the SimVis framework to medical image data, Blaas et al. [2007] pre-
sented a system for analyzing and exploring medical multifield data and integrated techniques
from pattern analysis to enhance the data exploration process. The software assistant MeVis-
CardioPerfusion by Kühnel et al. [2006] allowed for analysis of cardiac MR perfusion data.
Hence, the evaluation of myocardial tissue for diagnosis and assessment of severity of car-
diac stroke is supported. The work by Hennemuth et al. [2007] extended this framework with
different exploration modes based on the evaluation of perfusion parameters, enhancement
curves, and user-defined thresholds in automatically selected regions. Then, a more accurate
detection of distorted regions of the left ventricle was possible. In [Preim and Botha, 2013], an
extensive description including state of the art for perfusion data visualization and analysis is
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provided. Finally, the PhD-thesis by Oeltze [2010] “Visual Exploration and Analysis of Per-
fusion Data” with focus on brain and cardiac perfusion MRI for assessment of ischemic stroke
and heart attacks comprehensively aggregates important techniques for perfusion data sets.
The thesis at hand is closely related to this work. However, the strong application-oriented
methods (including the clinical research question about importance of tumor heterogeneity),
the large collection of data sets as well as integration of sophisticated clustering and classifi-
cation approaches are the fundamental differences.
4.2 Evaluation of Breast Tumors in DCE-MRI Data
This section focuses on breast DCE-MRI from a clinical point of view. When compared to
conventional X-ray mammography, breast perfusion DCE-MRI exhibits high sensitivity, but
only a moderate specificity. Thus, a crucial task is to improve this specificity by means of
computer-based classification approaches and the automatic classification into benign and ma-
lignant tumors is an active clinical research area. As a prerequisite, the lesions have to be
detected in the DCE-MRI data set. Lesion detection approaches are listed in Section 4.2.1.
Afterwards, the classification of breast lesions is analyzed in more detail in Section 4.2.2.
Therefore, the related studies are roughly categorized based on the features that were em-
ployed for the classification: features that mainly cover kinetic analysis, features covering the
lesion margin and morphology, and the combined features of both aspects.
4.2.1 Breast Lesion Detection in DCE-MRI Data
Due to the principle of DCE-MRI, suspect lesions are identified as contrast-enhancing lesions.
Therefore, the enhancing lesion can be approximated with a primitive volume growing algo-
rithm.
In general, subtraction images allow for the identification and the extraction of enhancing
lesions. Also, the RE values of voxels can be employed for a primitive segmentation. Lucas-
Quesada et al. [1996] introduced two semi-automatic methods for the segmentation of breast
lesions in DCE-MRI data. The first approach is based on temporal correlation, whereas the
second approach employs a multi-spectral analysis to generate a feature map. Chen et al.
[2006a] proposed a fuzzy c-means algorithm followed by binarization and optimization steps
to automatically segment tumors. Hence, the user had to select a ROI on which further analy-
sis is carried out. They compared the fuzzy c-means lesion detection with a volume-growing
method and with a reference segmentation that was manually extracted by an expert radiolo-
gist. They reported better results for the first mentioned technique. In [Ertas¸ et al., 2007], the
lesion segmentation was carried out by generating a normalized maximum intensity-time ratio
projection of the data set. Behrens et al. [2007] proposed a method combining region growing
and morphologic operations on subtraction images of the breast.
For further reading, the survey on real-time breast lesion characterization in DCE-MRI by Suri
et al. [2006] is recommended. Hence, additional techniques for tumor detection and analysis
are presented as well. However, this thesis focuses more on the lesion characterization and
exploration than the lesion detection itself.
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4.2.2 Classification of Breast Lesions in DCE-MRI Data
In many approaches, the lesion detection and the classification process are interleaved. There-
fore, some of the following approaches also include the lesion detection as a prerequisite step.
The state of the art of breast tumor classification comprises various feature sets on which the
classification is carried out. These feature sets are linked to:
• the kinetic contrast enhancement,
• the texture of the tumorous tissue in the medical MRI data,
• the tumor’s boundary and morphology, and
• a combination thereof.
Each of these four aspects will be discussed in more detail in the following. However, the
automated image analysis methods do not only aim at the extraction of the relevant information
from breast perfusion MRI but also at the reduction of the inter-observer variability [Chen
et al., 2007]. Thus, a more accurate and consistent image interpretation is possible, which
is very important due to the absence of standardized interpretation guidelines in the clinical
routing of breast lesion imaging.
Classification with Focus on Kinetic Analysis
For the extraction of kinetic features, the strong variations of different tumor parts have to be
taken into account. That means, a tumor is a heterogeneous lesion containing different tissue
parts with different perfusion characteristics. To reduce the influence of outliers, a set of voxels
is selected and their RE curves are analyzed. Furthermore, averaging over similarly perfused
tissue parts is possible. Thus, in general a preselection of voxels has to be carried out.
Chen et al. [2006b] employed a fuzzy c-means clustering algorithm to the segmented 3D breast
lesion to obtain clusters that describe prototypic curves. This was an extension of their previous
work Chen et al. [2006a]. Next, the prototypic curve with the highest initial enhancement, i.e.
the highest washin, was chosen to be the representative characteristic kinetic curve (CKC)
of the lesion. Classification was carried out by applying the receiver operating characteristic
(ROC) curve analysis to four features of the CKC: the descriptive perfusion parameters peak
enhancement, time to peak, washin rate, and washout rate. The classification result based
on the CKC was compared with a second and third classification. The second classification
was carried out on features that were extracted from the whole lesion’s average curve. The
third classification was carried out on features extracted from a ROIs average curve, where the
ROI was manually placed by an experienced radiologist. As a result, the first classification
yielded better results than the second one. It yielded similar results to the third classification.
As conclusion, the automatically determined CKC had a better discriminating power than the
whole lesion’s average curve.
The work by Baltzer et al. [2009] compared the classification result when taking the whole
lesion instead of a single curve into account. Hence, the authors employed two features de-
scribing the curve types:
1. The initial contrast enhancement of the RE curve was classified into significant, < 50%;
intermediate, 50%−100%; strong, > 100%.
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2. The curve shape after initial contrast enhancement was classified (based on the differ-
ence of the last RE value and the RE value after initial contrast enhancement) into con-
tinuously increasing > 10%; plateau stable RE ±10%; washout > 10%.
This is similar to the 3TP classification, recall Figure 4.3. Classification was carried out via
ROC analysis by employing only the most suspect curve based on highest washin, or the
feature distribution percentage of the whole lesion. Furthermore, a logistic regression analysis
was carried out based on the combined features of the most suspect curve and the whole lesion.
As a result, the integration of the whole lesion improved the specificity when compared to
analysis of the features of the single most suspect curve, but no statistical significance for this
finding was found. Note that this stands in contrast to the previous study [Chen et al., 2006b],
where the CKC achieved best classification results.
As it was already described, the 3TP method by Degani et al. [1997] extracted nine classes
of RE curves, recall Figure 4.3. Hauth et al. [2006b] applied this method for classification
purposes by combining the extracted classes per lesion and the whole class distribution per
lesion. In the study by Hauth et al. [2008], this work was extended, and next to the 3TP
method, pharmacokinetic model-derived variables are employed, recall the example in Fig-
ure 4.4. To extract the pharmacokinetic parameters vascular permeability and extracellular
volume fraction, the Tofts model [Tofts and Kermode, 1991] was adapted to the data sets. Fea-
ture extraction was carried out over the whole 3D lesion and a 2D part of a lesion. The 2D
part was extracted by considering the 2D slice of the DCE-MRI data set where the lesion’s di-
ameter was maximal. As a result, the kinetic and pharmacokinetic features showed significant
differences between benign and malignant lesions, and the 3D analysis achieved better results
than the 2D analysis.
The study by Williams et al. [2007] comprised a classification based on the kinetic features:
presence or absence of threshold enhancement of 50% and 100% minimum thresholds; peak
of initial enhancement and the percentage distribution of curve shape (washout, plateau, and
increasing) of the whole lesion. The initial peak enhancement value was extracted from the
most suspicious curve (with washout > plateau > persistent w.r.t. suspiciousness, and highest
initial enhancement). The presence of the threshold enhancement was very sensitive for ma-
lignancy compared to the manual evaluation of an experienced radiologist, whereas the initial
peak enhancement and the curve distribution did not demonstrate further improvements.
Classification with Focus on Lesion Margin and Morphology
Numerous studies comprise a DCE-MRI breast cancer classification with integration of lesion
margin and morphology. As it was stated in Section 2.1.2, ill-defined margins and irregular
morphologies are indicative for malignancy. Usually these features are combined with kinetic
analysis. Liang et al. [2012] carried out a classification based on lesion shape and lesion mar-
gin. However, these features are extracted from the minimum volume-enclosing ellipsoid of
lesions that are segmented manually. The study by Wedegärtner et al. [2001] focused on lesion
morphology by employing the features lesion shape, irregularity of contour, homogeneity of
contrast enhancement, and presence of ring enhancement. As a result, the morphological cri-
teria were useful features, but prone to errors due to a high inter-observer variability. Hence,
a standardization of the terminology of the morphological features could solve this problem.
The morphologic lesion analysis is also discussed by Behrens et al. [2007] in more detail,
including a summary of important morphology features presented in literature. The authors
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highlight the strong influence of the preceding processing, image resolution and applied pro-
tocols for the extraction of these features and demand a thorough evaluation for a larger scale
of data to truly assess their discriminative power.
Classification with Combined Features
A combination of texture, morphology, and kinetic features for DCE-MRI classification is
promising since malignant tumors are associated with rim or heterogeneous enhancement due
to necrosis and fibrosis mainly in the tumor center, and thus an angiogenetic activity predomi-
nantly at the periphery [Buadu et al., 1996]. Texture and morphologic features were combined
in the study by Nie et al. [2008]. As a result, benign lesions showed a rounder shape and
smoother margins than benign ones, which can be assessed with the morphologic feature com-
pactness. The texture features were associated with heterogeneity patterns and enhancement
intensity. They could be successfully employed since the malignant lesions were more hetero-
geneous in terms of these features. Gibbs and Turnbull [2003] focused on texture features for
classification, including the entropy and the sum entropy. When combining them with lesion
size, average time to peak of the lesion, and patient’s age, a diagnostic accuracy of 0.92± 0.05
(approximated with area under curve analysis) was achieved.
Chen et al. [2007] also employed texture features for classification. Instead of a slice-wise
analysis of the texture features (extracted from 2D slices), they employed a volumetric analy-
sis, which is reported to achieve better results. Sinha et al. [1997] combined kinetic features
with boundary and texture features. They also included the patient’s age in the feature set.
Best values for sensitivity and specificity were achieved by combing the three feature classes
and including the patient’s age. When a restriction to only one feature class was carried out,
boundary features were identified as best suited, followed by kinetic features and texture fea-
tures. This is similar to the work by Chen et al. [2004], who combined morphology features,
kinetic features and the time course of contrast enhancement variation over the whole lesion.
They reported better results for automatic classification when compared to results based on
manual evaluation of experienced radiologists. However, Fusco et al. [2012] performed man-
ual tumor segmentation and then studied different subsets of region features: dynamic ones,
spatio-temporal ones, and texture features. They showed that the subset of dynamic features
achieved highest discriminative power.
Wiener et al. [2005] combined morphologic features and kinetic features based on the 3TP
classification. Okafuji et al. [2008] analyzed lesions that were detected as circumscribed
masses on conventional mammography. For classification of these lesions in DCE-MRI, the
rim enhancement, the heterogeneity of enhancement, the washout dynamic pattern, and com-
binations thereof were considered, revealing an increased importance of the washout dynamic
pattern.
The scoring system that was first described by Fischer et al. [1999] - the Göttinger score - com-
prises pre-defined choices for initial peak signal intensity increase, signal intensity in the late
contrast phase, lesion margin, lesion shape, and contrast material kinetics. For each feature,
a certain amount of points is assigned. These points are summed up as score. Classification
is then carried out via a cut-off value for this score. They reported sensitivity, specificity, and
accuracy rates for the DCE-MRI-based evaluation of 93%, 65% and 85%, respectively. They
tested their approach with a database containing 548 breast lesions.
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An interesting combination of kinetic and texture features was introduced by Karahaliou et al.
[2010]. They extracted three parameter maps of the breast lesion based on the three kinetic
parameters: initial enhancement, post-initial enhancement, and signal enhancement ratio. Af-
terwards, they applied texture analysis to the parameter maps to assess the lesion’s hetero-
geneity. Best classification results were achieved with the signal enhancement ratio map. In
addition, the multi-center study introduced by Schnall et al. [2006] showed the importance of
the combination of features from morphology and kinetic enhancement. They concluded that
the multivariate models comprising feature assessment have a diagnostic accuracy superior to
that of qualitative characterization of the kinetic enhancement in breast DCE-MRI. Stoutjes-
dijk et al. [2005] reported a considerable inter-observer variability for kinetic and morphologic
enhancement features. In their study, different observers evaluated breast DCE-MRI lesions
and chose attributes from a standardized terminology. Furthermore, the manual ROI placement
was identified as major source of variability for the extraction of kinetic features.
A short summary of the presented classification studies will be presented in Section 4.4 at the
end of this chapter. Also, the most important aspects for this thesis will be expressed. The next
section focuses on the evaluation of brain DSC-MRI data of longitudinal glioma studies.
4.3 Evaluation of Low and High Grade Gliomas in
DSC-MRI Data
The main focus of this thesis is not the diagnosis and evaluation of brain tumors in general, but
the analysis of gliomas in DSC-MRI data, especially the differentiation of high grade gliomas
(HGGs) from low grade gliomas (LGGs). This is motivated by the importance of DSC-MRI
for tumor differentiation rather than detection [Covarrubias et al., 2004]. In clinical research
regarding neurological impairments, longitudinal studies are becoming more and more impor-
tant [Ashburner et al., 2003]. For the evaluation of LGGs and HGGs, the evaluation of the
relative cerebral blood volume (rCBV) is a clinical research focus. It is an important indicator
for a patient’s survival and gliomas with high rCBV values have a significantly faster progres-
sion time [Law et al., 2008]. Since patients with LGGs may transform to HGGs at some point
in time, these patients are commonly subject to a life long MRI-based monitoring. To detect a
transformation from an LGG into an HGG, computer-aided methods are employed to analyze
the acquired medical image data.
For longitudinal studies, rCBV maps of different acquisitions have to be compared, which is a
complex and exploratory analysis task due to the absence of standardized intensity values and
the high variability of MRI scanners and patient data. When taking a series of perfusion data
(in the context of a longitudinal study) into account, the complexity gets even higher. As one
challenge, inter-voxel correspondence has to be established between scans of different time
steps. This is further complicated by tumor growth and increasing tumor heterogeneity. At
last, MRI scans from longitudinal studies are acquired over a period of several years and thus
employ different scanning protocols, image resolutions, and sequence parameters. This is in
contrast to cohort studies, e.g., the SHIP study [Völzke et al., 2011] where many patients are
examined in a short time period and extra care is taken to avoid image parameter changes. Cur-
rently, longitudinal studies are assessed with software intended for the diagnosis of a patient
at one point in time. Hence, no dedicated support for longitudinal studies, i.e., normalization
of image data and visual comparison of data from different points in time, is provided. In
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the work of Steenwijk et al. [2010], visual analysis techniques were applied to cohort study
image data to explore parameters across patients. So far, visual analysis has seen limited use
in medical research, although many applications would strongly benefit from these methods
due to the magnitude and heterogeneity of the data.
This section introduces important studies that examine the suitability of perfusion parameters
for differentiation between glioma type in its first part. The second part covers more general
concepts, like the optimal ROI size or the tumor heterogeneity.
4.3.1 Evaluation of Perfusion Parameters for Glioma Grade
Differentiation
When focusing on perfusion MRI of the brain, many studies have shown that rCBV highly
correlates with the tumor grade [Law et al., 2004] and can be employed for differentiation
between LGGs and HGGs [Shin et al., 2002, Law et al., 2003, Hakyemez et al., 2005, Em-
blem et al., 2008, Law et al., 2008]. For evaluation of gliomas, a representative ROI is placed
and the average rCBV values of the ROI are analyzed. However, a gold standard for a cut-off
value between LGGs and HGGs of a ROI’s average rCBV value is still missing [Bjørnerud and
Emblem, 2010]. Shin et al. [2002] identified 2.93 ml / 100 g as best rCBV cut-off value, and
Hakyemez et al. [2005] 1.98 ml / 100 g for differentiation between LGGs and HGGs. Covarru-
bias et al. [2004] suggest an rCBV value of 1.5 ml / 100 g and Law et al. [2003] 1.75 ml / 100 g
as cut-off value. These cut-off values are reported to have high sensitivity but low specificity
by Emblem et al. [2008]. They suggest cut-off values between 3.75− 5.58 ml / 100 g after
minimizing the number of glioma grade misclassification and maximizing the average sen-
sitivity and specificity Law et al. [2007] propose an rCBV histogram analysis. They extract
14 different measures from the normalized histogram based on the method described in [Ge
et al., 2001]. A ROI is used to mark the tumor voxels (not a single hot spot) and features
like the mean, median and standard deviation are extracted from the ROI’s histogram. The
histogram-derived features yields similar results to conventional rCBV ROI-based analysis
w.r.t. the correlation with glioma grade. Likewise, Friedman et al. [2012] propose a similar
method. Again, histogram-based rCBV features are compared with the maximal rCBV value
of a ROI within the brain tumor. In addition, they also examined the results from specialist and
non-specialist operators. They reported that for the feature extraction with highest correlation
to tumor grade (with their semi-automatic approach) no specialized operator was necessary.
Despite the widespread application of the perfusion parameters cerebral blood flow (CBF) and
mean transit time (MTT) in stroke imaging, the concepts of these parameters have not been
as fully studied in the context of brain tumor perfusion analysis as has CBV [Covarrubias
et al., 2004]. However, the studies by Shin et al. [2002] and Hakyemez et al. [2005] did
not only employ CBV but also CBF. They reported significant differences of CBF between
LGG and HGG. Other studies employed the tumor permeability extracted from T1-weighted
permeability imaging [Roberts et al., 2000] and extracted from T ∗2 DSC-MRI [Provenzale
et al., 2002]. They report strong correlation of permeability and tumor grade. However, the
study by Law et al. [2004] compared the correlation of rCBV and permeability with the tumor’s
grade. They identified rCBV to be a more significant predictor for high-grade gliomas than
permeability. In another study, Law et al. [2006] carried out different approaches for tumor
grade differentiation, including rCBF as well as rCBV. Again, they identified rCBV as best
predictor of glioma grade. Järnum et al. [2010] compared a 3D pseudo-continuous arterial spin
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labeling technique with the DSC-MRI to cope with the susceptibility artifacts. They employed
the nordicICE software package (recall Sect. 4.1.3) and extracted CBF parameter maps for
both sequences, see Figure 4.5. They reported a good correlation between the parameter maps.
Thus, they suggested 3D pseudo-continuous arterial spin labeling technique as an alternative
for patients with renal failure since no contrast agent injection is needed.
Figure 4.5: Patient with glioblastoma in the frontal lobes (Image reprinted from [Järnum et al.,
2010] c© 2009, Springer-Verlag with kind permission from Springer Science and Business
Media). On the left, the T1 sequence reveals the contrast enhance glioblastoma. The images
ASL CBF and DSC rCBF show the CBF and rCBF parameter maps for the arterial spin
labeling sequence (gray scale) and the DSC-MRI sequence (color coding), respectively. On
the right, the rCBV parameter map from the DSC-MRI sequence is presented.
4.3.2 Influence of ROI Size and Heterogeneity Evaluation
This part focuses on two important aspects when evaluating brain tumors in DSC-MRI data
beyond the parameter based evaluation:
• the optimal placement of ROIs and
• the tumor’s heterogeneity.
For ROI placement, rCBV parameter maps are analyzed. In general, color coding highlights
rCBV values higher than 1.25 ml / 100 g [Covarrubias et al., 2004]. The ROI is placed such
that highest spatially connected rCBV values - the hot spot - are included with exclusion of
brain vessels. This method is therefore called hot spot method. However, it suffers from
inter-observer variability. Furthermore, different recommendations about the optimal ROI’s
size exist [Wetzel et al., 2002]. For example, Hakyemez et al. [2005] employed the hot spot
method with at least 16 pixels in their study, whereas Bisdas et al. [2009] recommended 6×6
pixels. In the study by Wetzel et al. [2002], different methods for creating a representative ROI
regarding intra- and interobserver reproducibility were analyzed. Best results were achieved
if each observer selects four ROIs (with radius 1.8 mm) and applies the maximum averaged
CBV value for glioma grading. However, LGGs do vary regarding their size as well as their
amount and extent of foci with high rCBV. Furthermore, Emblem et al. [2008] presented a
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histogram analysis of rCBV heterogeneity leading to increased diagnostic accuracy and inter-
observer agreement. Lupo et al. [2005] extracted the spatial heterogeneity of a brain tumor’s
concentration-time curves to further distinguish microvasculature characteristics.
4.4 Concluding Remarks
This chapter illustrated the different aspects that influence the visual analysis of MRI perfu-
sion data with respect to brain and breast tumors. Inherent to this problem is the grouping of
voxels into regions. Furthermore, the set of tumor voxels can be interpreted as set of objects
in a high-dimensional feature space. Such data is in general visualized by representing (lower
dimensional) clustering or examined via multiple linked views that allow for interactive explo-
ration of different subspaces of the data. Most techniques consist of one (or all) approaches.
They reduce the high-dimensional space to a lower dimensionality (e.g., via clustering), they
employ multiple and interactively linked views with an interaction between the attribute space
and the physical domain (e.g., via brushing), or they try to visualize all variables at once
(e.g., by glyphs). However, visualization and exploration of high-dimensional data sets re-
mains a challenging task due to the missing spatial information in the low-dimensional space.
Furthermore, problems with visual clutter or non-intuitive presentations of the derived low-
dimensional space might occur.
Section 4.2 provided related work for breast cancer detection and classification in DCE-MRI
perfusion data. Since breast perfusion DCE-MRI has a high sensitivity, but only moderate
specificity when compared to conventional X-ray, an important goal of breast cancer evaluation
is an automatic classification into benign and malignant lesions to increase the specificity.
Due to its high importance, many breast cancer classification studies exist that are based on
features extracted from DCE-MRI data. Morphological criteria are useful features but suffer
from inter-observer variability due to a missing standardization of terminology. In summary,
studies with combined textural, morphology, and kinetic features are superior to conventional
manual analysis by experienced radiologists for breast cancer classification.
Important Breast Cancer Classification Aspects. For this thesis, the following aspects
are of great importance for breast cancer classification:
1 Kinetic features are very important for automatic breast tumor classification (recall
Sect. 4.2.2). Features extracted of the most suspect curve are better suited than fea-
tures from an averaged curve of the whole lesion and it is important to detect this most
suspicious curve [Chen et al., 2006b]. However, features of the whole lesion (instead of
the averaged curve of the whole lesion), like curve shape distribution, further improve
the classification result [Baltzer et al., 2009, Williams et al., 2007].
2 The heterogeneity of malignant breast lesions is very important for breast classification
and was employed in the studies by Issa et al. [1999], Gibbs and Turnbull [2003], Chen
et al. [2007], Ertas¸ et al. [2007], Nie et al. [2008], Karahaliou et al. [2010]. The hetero-
geneity analysis based on regions of the breast lesion was carried out in the last study.
This region analysis is also part of the third aspect. Furthermore, the heterogeneity anal-
ysis is not part of current commercially available workstations.
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3 A region-based analysis seems to be most appropriate for extracting relevant features
since the data sets are noisy by nature. The importance of a ROI-based analysis can also
be referred from the first aspect since additional features of the whole lesion or a part
of the lesion improve classification results. However, different recommendations for the
optimal ROI size and placement exist, ranging from 3-4 pixels to the whole enhancing
lesion [Mussurakis et al., 1997, Kuhl et al., 1999, Kuhl, 2007]. Thus, the inter-observer
variability is a substantial limitation for manual placement.
4 Many studies employ perfusion parameters for kinetic feature analysis. For example,
pharmacokinetic parameters are extracted in the studies by Hauth et al. [2008] and En-
glmeier et al. [2004]. Also descriptive perfusion parameters are employed, mostly the
parameters peak enhancement, time to peak, washin and washout [Sinha et al., 1997,
Chen et al., 2006b, Hauth et al., 2006a,b, Williams et al., 2007]. Furthermore, the 3TP
method is part of many studies. This method basically comprises the features washin
and washout.
5 Although manually derived morphologic features have been successfully employed for
classification, their usefulness is hampered by a lack of standardized terminology. Thus,
an automatic estimation of morphologic features is not an aim of this thesis. However,
the analysis of a breast tumor’s morphology should be supported in a qualitative way.
Important Aspects For Evaluation of Longitudinal Brain Tumor Studies. In contrast
to breast perfusion MRI, the evaluation of brain perfusion MRI does not aim at an automatic
identification of benign or malignant lesions. Instead, the clinical research focus lies on the
differentiation of gliomas. Since the grade of gliomas is important for a patient’s survival pro-
gression time, many studies evaluate the dependency of the quantitative perfusion parameter
CBV and the tumor grade. Therefore, an important part of clinical research is the evaluation
of longitudinal studies that cover the transformation from LGGs to HGGs. That implies the
following aspects:
6 For longitudinal studies, different perfusion acquisitions have to be compared, which
is a complex and exploratory analysis task due to the absence of standardized intensity
values and the high variability of MRI scanners and patient data. When taking a series
of perfusion data (in the context of a longitudinal study) into account, the complexity
gets even higher.
7 The exploration with visual analysis techniques within multiple linked views aims at
evaluating single perfusion studies. However, specific support for longitudinal studies is
needed for the comparison of different points in time – taking into account that imaging
parameters may have changed.
General Aspects For Evaluation of Breast Tumor DCE-MRI Studies and Longitudi-
nal Brain Tumor DSC-MRI Studies. For both clinical aspects, the following aspects are
important:
8 The inter- and intra-observer variability is a limitation of many evaluation methods. Ex-
isting approaches are often limited to certain samples, slices or parts of the data set.
Therefore, this thesis aims at evaluation of the whole lesion with focus on the most
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suspect tumor part. This includes a subdivision of the tumor via clustering and an ap-
propriate representation of the clustering result.
9 So far, visual analysis has seen limited use in medical research, although in many appli-
cations the magnitude and heterogeneity of the data would strongly benefit from these
methods. This aspect comprises the visual analysis of tumor heterogeneity.
The next chapters present dedicated methods that include the given aspects for evaluation of
breast and brain tumor perfusion data.
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5 2D Visual Exploration of Breast
Tumor Perfusion Data
In this chapter, the PerfusionAnalyzer, a framework for the visual exploration of breast DCE-
MRI perfusion data is presented. The PerfusionAnalyer is a software prototype that integrates
conventional views such as parameter maps or subtraction images as well as new developed
techniques. As concluded by the previous chapter, the evaluation of the tumor’s enhance-
ment kinetics and its predictability for malignancy is a major research focus when evaluating
breast perfusion data. Hence, the evaluation of the tumor’s enhancement kinetics demands an
appropriate exploration of this specific kind of data.
Integrated in the PerfusionAnalyzer, the basic 2D visualization techniques are presented that
allow for a precise evaluation of breast DCE-MRI perfusion data. In Section 5.1, the Perfusio-
nAnalyzer framework is described in more detail. Afterwards, in Section 5.2, the embedded
breast tumor detection and delineation is explained. For a voxel-wise exploration, a novel
glyph-based visualization technique is introduced in Section 5.3. The glyphs are designed to
simultaneously map washin and washout of the contrast enhancement. Next, the automatic
grouping of voxels into regions is explained in Section 5.4, including dedicated methods how
to explore the generated regions. Both approaches focus on the exploration of kinetic features.
Their appropriateness is demonstrated with a small case study in a qualitative way.
After these kinetic-oriented exploration techniques, two approaches will be explained that
cover the tumor’s morphology and histopathology. The first technique is a novel exploration
for the investigation of breast tumor boundaries: the FileCardBrowser View, described in Sec-
tion 5.5. Finally, the PerfusionAnalyzer framework is extended with a combined T1-T2 view,
improving the differential diagnosis by the clinical expert during breast cancer diagnosis, see
Section 5.6. The described methods aim at an improved 2D visualization and exploration of
the data. The 3D visualization techniques are covered in the next chapter.
5.1 The PerfusionAnalyzer
The PerfusionAnalyzer was developed for the visual exploration of breast tumors. This frame-
work comprises multiple linked views dedicated to breast perfusion DCE-MRI. State of the
art for multiple linked views designed for high-dimensional data was generally presented in
Section 4.1. In Section 4.1.3, the focus was set on perfusion data in particular. Furthermore,
this framework was developed based on the aspects 1 , 3 , 4 , and 5 .
The graphical user interface with the main exploration views is depicted in Figure 5.1. The
standard exploration covers the T1 source image, the subtraction view, 2D parameter maps,
and a diagram panel to visualize relative enhancement (RE) curves of a single voxel or a ROI.
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These views are in parts known from conventional workstations. Furthermore, novel glyph-
based visualizations are created and a region-based analysis of the tumor is provided. These
approaches will be described in the following sections in more detail. The 2D parameter maps
also includes the three-time-point (3TP) parameter view based on the work by Degani et al.
[1997]. Hence, the curve shape is mapped to color (red for washout curve, green for plateau
curves and blue to increasing curves) and the initial RE to intensity, recall Figure 4.3.
Figure 5.1: The PerfusionAnalyzer framework with a collection of 2D views. Beyond standard
views like the source image, the subtraction image or a 2D color-coded parameter map of RE
values, novel visualization techniques are integrated. (Medical image data is courtesy of U.
Preim, Municipal Hospital Magdeburg, Germany.)
The PerfusionAnalyzer comprises the visual exploration of breast data to identify a lesion as
well as to segment the lesion. Furthermore, visual analysis techniques to extract important
kinetic or morphologic features are included. The PerfusionAnalyzer is a software prototype
embedded in the MeVisLab framework1 and implemented in C++, supported by OpenGL and
VTK.2 Hence, a motion correction routine was integrated that based on the combination of
rigid and elastic registration [Rueckert et al., 1999]. The lesion detection and in turn delin-
eation from background is described in the next section. The region division was realized via
MATLAB.3
However, the software is not optimized for speed which leads to long computation times for
the analysis of larger lesions. This issue can be tackled with some adapted preprocessing steps
in future work. Hence, it is still in the state of a research prototype, e.g., careful workflow-
adapted user interface is missing.
1Product of Fraunhofer MEVIS; www.mevislab.de (12/08/2013)
2The Visualization Toolkit, New York, USA; http://www.vtk.org/ (12/08/2013)
3Product of the MathWorks, Natick, USA; www.mathworks.de/products/matlab/ (12/08/2013)
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5.2 Breast Tumor Detection in DCE-MRI
For the automatic detection of breast tumors in breast DCE-MRI perfusion data, many ap-
proaches have been proposed in the last two decades. In the previous chapter, the most impor-
tant and most related approaches have been listed, recall Section 4.2. Mostly, a preselection of
voxels or a segmentation is created as a basis for further analysis, like automatic breast cancer
classification.
The major focus of the PerfusionAnalyzer is rather the lesion segmentation than the visual
exploration and analysis of the segmented lesion. Therefore, a basic volume growing algorithm
is employed. The software prototype needs a one-click user interaction to mark a seed point
inside the tumor tissue. Next, a region growing selects all voxels that are spatially connected
to the marked seed point with RE values ≥ 60% at the first time step after the early post
contrast phase. The early post contrast phase is the phase after contrast agent bolus injection,
which is usually characterized by a strong uptake of RE values. After this early phase, the
contrast agent enhancement is particularly interesting since contrast agent washout can occur,
which is indicative for malignancy, recall also Section 2.1.2. Voxels with RE values < 60%
were considered to belong to the surrounding normal tissue. The RE threshold was defined
according to [Kuhl et al., 1999], but the user can change it to adapt it to the data. This limit
was established for each lesion. However, the threshold applies only to the border voxels of the
tumor. Voxels in the internal space could have values below this threshold, for instance due to
necrosis. The radiologist was allowed to edit the segmented lesion by adjusting a rectangular
ROI. Thus, the clinical expert could exclude tissue not belonging to the tumor, for instance
vessels. In Figure 5.2, an example illustrates RE of voxels forming a contrast-enhancing mass
Region%Growing%to%
Select%Voxels
One%Click%to%Pick%
Enhancing%Lesion
Source%Image
Subtraction%Image
50%
0%
RE%Image
>%250%t%=%0
t%=%2
t%=%2 t%=%2
t%=%2 t%=%2
t%=%2
Figure 5.2: Illustration of the tumor segmentation. At first, a one-click user interaction is
necessary to pick the lesion. Afterwards, region growing selects all spatially connected voxels
with a user-defined minimum RE value at the first time step after the early post-contrast phase.
(Medical image data is courtesy of U. Preim, Municipal Hospital Magdeburg, Germany.)
This basic segmentation was carried out with an experienced radiologist for a total of 146
small breast lesions yielding satisfying results for all data sets. Small refers to tumors with
a maximum slice diameter ≈ 7− 8 mm. Such small tumors are often metastases of an exist-
ing primary tumor. Due to present contrast enhancement even for these small tumors, they
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can be better assessed with DCE-MRI than X-ray mammography. Also, the PerfusionAna-
lyzer segmentation was less time-consuming than manual segmentation. However, for future
work, a method that automatically detects supplying vessels or vessel-like structures could be
integrated.
5.3 Glyph Visualization
The main drawback of existing approaches, especially color-coded parameter maps, is the
missing information about curve shapes. Parameter maps mostly assign only one parameter
to color, or combine different color hues, whereas the clinical expert must mentally assign
the mix of colors to the amount of enhancement and curve shape. Inspired by existing glyph
maps, like the 3TP method, a new glyph map was developed and the two most important
attributes for kinetic evaluation are mapped: the washin (the amount of contrast agent at a
certain point in time) and the curve course (increasing curve, plateau curve, or washout curve).
The glyphs are covering aspects 1 and 4 . To convey as much information as possible, each
voxel is depicted with a glyph. The amount of RE at a certain point in time is color-coded by
employing a hue, lightness, and saturation (HLS) color space. To account for the range of the
RE values, two thresholds are defined: Tdown for the minimum RE and Tup for the maximum
RE value. The color coding is restricted to suspicious enhancement. Thus, Tdown = 60% and
Tup = 250% are defined as default values according to [Kuhl et al., 1999]. Color coding is
carried out by assigning red to RE values greater or equal to Tup and blue to values equal to
Tdown. In between, the H value, i.e., the color hue, is extracted via linear interpolation based on
Tup and Tdown, see Figure 5.3(b). For context information, voxels exhibiting values < Tdown,
are mapped to gray. Their brightness is proportional to the voxels’ RE values. However, Tdown
and Tup can be adapted for visual analysis. For example, if the sensitivity shall be increased,
Tdown must be decreased.
Very Strong RE
Washout Curve
Strong RE
Increasing Curve
Moderate RE
Plateau CurveIncreasing
Curve
Plateau
Curve
Washout
Curve
(a) Brightness Assignment (b) Color Assignment
(H;L;S) = (240;50;100)
(H;L;S) = (0;50;100)
(H;L;S) = (120;50;100)
(c) Examples
Figure 5.3: Voxel-wise mapping of RE and RE curve shape to glyphs (image adapted from
[Glaßer et al., 2009]). The curve shape determines the L component (a), whereas the RE
value determines the hue of the glyphs (b). In (c), glyphs with different RE curve shapes and
RE values are presented.
The curve shape of each voxel is classified based on the 3TP method [Degani et al., 1997,
Furman-Haran et al., 2001]. Therefore, an RE change in the interval ±10% during washout
will be interpreted as plateau, whereas RE changes higher than 10% and lower than −10% are
considered as increasing and decreasing curve, respectively. Mapping of the RE curve shape
is realized by applying a 3×3 kernel for brightness modification. The S component (from the
HLS color space) of each glyph’s color is assigned to 1, since only fully saturated colors for
highlighting of the lesion’s enhancement are used, see Fiure. 5.4. In contrast to [Englmeier
et al., 2004, Hauth et al., 2006b], the RE and the RE curve shape can be directly interpreted
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from the corners and the center of each glyph. Although the visualization is a little less intuitive
more information is provided, which may be important for special cases like a lesion with
moderate enhancement but present washout curves. Furthermore, this technique was designed
for clinical practice. Hence, the repeated practical use of this technique accounts for the low
intuitiveness.
(a) (b)
Figure 5.4: Glyph-based visualization of two lesions. In (a), a benign lesion with high RE
values (red colors) and mostly increasing curves (see brighter centers of glyphs) is depicted.
In (b), malignancy is indicated by red glyphs (strong washin) with darker centers (washout
curve shape), see the center of the lesion.
When compared to the 3TP method [Degani et al., 1997], the glyph technique allows for a more
detailed differentiation between different enhancement kinetics, as demonstrated in Figure 5.5.
At the moment, the presented color scale reflects the rainbow color scale. This is motivated by
existing workstations in the clinical practice, which also employ this color scale. However, the
rainbow color scale is not recommended in visualization due to the lack of perceptual ordering
or its uncontrolled luminance variation [Borland and Taylor, 2007]. Nevertheless, the rainbow
color scale is composed from fully saturated colors is well known and established in clinical
practice and allows for visual clustering (e.g., a ROI that consists of red voxels can be easily
visually separated from other voxels). Since the glyph-based view is intended to provide a
quick overview in clinical practice instead thorough analysis in clinical research, the rainbow
color scale is chosen.
5.4 Visual Exploration Based on Region Merging
As concluded in Section 5.3, a single voxel-based analysis may provide a fast overview, but
single voxels could be outliers and suffering from noise, motion, or blurring artifacts. There-
fore, in clinical practice, the radiologist places a ROI in the tumor tissue and qualitatively
evaluates the shape of the averaged RE curve. If the ROI extraction should be carried out with
a computer-aided framework, it is necessary to group similarly perfused voxels into regions.
Due to a tumor’s heterogeneity, it is not feasible to subdivide the tumor in equally sized parts.
For a subdivision of a tumor, i.e., the grouping of voxels into regions, various approaches exist,
see the different clustering algorithms in Chapter 3 as well as related work about clustering of
medical data in Chapter 4. A rather straightforward approach is region merging where neigh-
bored regions are merged together, as long as they fulfill some well-defined similarity criterion.
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(d) Glyph View (e) 3TP View (f) Comparison
(a) Source Image (b) Subtraction Image (c) RE Parameter View
Figure 5.5: Comparison of the glyph-based view implemented in the PerfusionAnalyzer and
the 3TP view. In (a), a small lesion is marked in the source image. In (b) and (c), the sub-
traction and color-coded RE view is provided, respectively. In (d), the glyph view is presented.
Voxels with high enhancement (reddish colors) and washout curves (darker glyph centers) are
selected to form a ROI. In (e), the 3TP view is shown. Again, voxels with high enhancement
(bright colors) and washout curves (reddish colors) are selected. In (f), the selection are com-
pared. The ROI that is based on the glyph view, is more homogeneous w.r.t. the enhancement
kinetics than the ROI from the 3TP view (see green and turquoise color-coded voxels) . Het-
erogeneous ROIs exhibit distorted averaged RE curves. (Medical image data is courtesy of U.
Preim, Municipal Hospital Magdeburg, Germany.)
The region merging approach has two advantages: it is easy to understand for the clinical ex-
pert and it produces spatially connected regions of voxels. A region merging approach must be
adapted to breast DCE-MRI such that regions with similar perfusion characteristics form ROIs.
Hereby, noise is suppressed through averaging the voxel intensities in the regions and artifacts,
i.e., motion or blurring, are not reinforced. Tumorous regions, exhibiting different perfusion
characteristics, are kept apart in order to avoid that malignant tumor tissue is neglected because
of surrounding benign tissue. The region merging approach is covering aspects 3 and 4 .
5.4.1 Adaption of Region Merging to Breast DCE-MRI
For a successful adaption of the region merging approach to breast DCE-MRI, voxels with
similar perfusion characteristics have to be grouped into regions. Therefore, the following
steps have to be carried out:
• Quantification of kinetic enhancement.
• Definition of a distance function based on the quantified kinetic enhancement to steer
the merging process.
• Definition of a stopping criterion for the merging procedure.
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After choosing a quantification of kinetic enhancement and in turn a distance function (in-
cluding a similarity criterion) region merging is employed to arrange the voxels into regions.
Initially, each voxel is a separate region. Iteratively, the most similar, adjacent regions are
merged until the requirements of the stopping criterion are met.
Quantification of Kinetic Enhancement
For the quantification of kinetic enhancement, different approaches exist, recall Section 4.2.
For a classification based on kinetic features, the three most widespread approaches cover:
quantification based on the 3TP classes via the 3TP method (recall the studies by Hauth et al.
[2006a] and Lehman et al. [2006]), quantification based on pharmacokinetic parameters (e.g.,
the studies by Englmeier et al. [2004] and Hauth et al. [2008]), and the quantification based
on descriptive perfusion parameters (e.g., the studies by Sinha et al. [1997] and Williams et al.
[2007]). In cooperation with clinical experts, discussions yield a first trend for the last option
due to the straightforward extraction of the descriptive perfusion parameters in comparison
to pharmacokinetic parameters. Another reason is the temporal resolution of the underlying
data. Hence, the employed data sets exhibit five to six time steps, which hardens a model
fitting that would be required for pharamcokinetic parameter extraction. A disadvantage of the
3TP method is the restriction to nine classes. Descriptive perfusion parameters like integral or
washout allow for a more differentiated characteristic of kinetic enhancement.
Definition of a Distance Function
For characterization of lesion enhancement kinetics, the descriptive perfusion parameters
washin, washout, PE, and TTP are employed. Since no ground truth for a grouping of vox-
els is available, different constellations are tested. The parameters are employed for feature
vectors~v. A distance function that assigns a similarity between region R1 and region R2 is ap-
proximated with the Pearson correlation coefficient (recall Eq. (3.3) in Sect. 3.4.1) of the two
feature vectors ~v1 and ~v2 of R1 and R2. For the evaluation of descriptive perfusion parameters,
z-scoring was applied (recall Eq. (3.8) in Sect. 3.4.2).
The following feature vectors −→v3 f and −→v4 f were integrated in the PerfusionAnalyzer:
−→v3 f (R) =
 washin(R)washout(R)
PE(R)
 , (5.1)
where R denotes the region, washin denotes the average washin value, washout denotes the
average washout value, and PE denotes the average peak enhancement value of all voxels
contained in R.
−→v4 f (R) =

washin(R)
washout(R)
PE(R)
T T P(R)
 , (5.2)
where TTP denotes the average TTP value of all voxels of the region R. Thus, the TTP com-
ponent implies a stronger focus on the curve shape, since washout curves have a significantly
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smaller TTP than continuously enhancing curves. For a better estimation of the feature vectors,
a comparison with the 3TP method is also provided in the following.
Definition of a Stopping Criterion
Based on the region merging concept, the most similar, adjacent regions are merged until
the maximal similarity of all regions falls below a pre-defined threshold or the number of
regions is reduced to a pre-defined number. To account for varying tumor sizes and varying
heterogeneity, a pre-defined number of regions is not applicable. Since the distance function is
based on the Pearson’s correlation, a minimum value Pmin for this correlation is defined. Thus,
the merging terminates if all remaining adjacent regions exhibit a similarity lower than Pmin.
Naturally, the region merging result strongly depends on the right choice of Pmin. For example,
a Pmin value that is too small yields only one region - the complete tumor. If the value is too
high, each voxel would form a single region. To support the user, a stopping criterion has to
be automatically provided by the PerfusionAnalyzer.
For an optimal value of Pmin, the region merging results for the two feature vectors−→v3 f and −→v4 f
are compared. In addition, a comparison with the 3TP method is provided. With −→v3 f , −→v4 f , and
the 3TP method three sets of regions S3 f , S4 f and S3t p are obtained:
• S3 f denotes the set of regions, extracted with the 3D feature vector −→v3 f ,
• S4 f denotes the set of regions, extracted with the 4D feature vector −→v4 f , and
• S3t p denotes the set of regions, extracted with the 3TP method.
The number of regions contained in S3 f and S4 f strongly depends on the assigned value to Pmin.
The lower Pmin, the more regions will be merged and less regions will remain. For extraction
of an optimal Pmin, the region merging was applied to a set of 20 breast DCE-MRI lesions,
containing 10 small and 10 big lesions. Hence, small refers to lesions only detectable in the
MRI perfusion scan (due to their contrast enhancement) and big to lesions that were already
classified as primary tumor in the conventional X-ray mammography. The sets S3 f and S4 f
were created for the Pmin-values 0.9− 0.99 (with a step size 0.01) and 0.999, see Figure 5.6.
Qualitative analysis of the results with an experienced radiologist indicates that Pmin should
be at least 0.95. For Pmin values of 0.97−0.99, there are small changes in the average region
number and region size (see marked area in Fig. 5.6). For this reason, a value of 0.99 as
minimum value for the Pearson correlation is suggested in the PerfusionAnalyzer.
Comparison with Respect to Number of Regions
To assess the quality of −→v3 f , −→v4 f , and the 3TP method, an overview of the comparison of the
total number of regions #RN of S3 f , S4 f , and S3t p is presented in Figure 5.7. For both tumor
sizes, the average number of regions in S3t p is the smallest, which may result from the finer
division of the tumor based on the region merging method. Moreover, in average, S3 f contains
more regions than S4 f albeit the difference is smaller than the difference between S4 f and S3t p.
As depicted in Figure 5.7, S3 f contains the most regions that consist of one voxel only.
In general, a few larger regions are easier to analyze than a highly fragmented segmentation
result with many small regions. Thus, S4 f and S3t p seem to be more appropriate, whereas
S4 f provides a finer subdivision for the early contrast agent accumulation and employs local
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Figure 5.6: Influence of Pmin (image adapted and reprinted from [Glaßer et al., 2010] c© 2010,
Elsevier, with kind permission from Elsevier). For Pmin values of 0.9, only a few, large regions
exist, which is not satisfying for heterogeneous tumors. With increasing Pmin, a finer division
is achieved that means more regions with a smaller average region size are extracted. The best
results are achieved for values 0.95−0.99. Smaller values do not provide enough regions. The
step from 0.99 to 0.999 causes a significant increase of regions and decrease of region size.
information. If only regions are considered that contain more than one voxel, similar results
for these two methods are obtained. The small regions (containing only one voxels) are at the
tumor’s boundary. Hence, the clustering suffered from motion artifacts and blurring. Thus,
their RE curve is distorted and there are no similar voxels in the neighborhood. As it was
stated in Chapter 4, a ROI for further diagnosis should at least contain three voxels.
Comparison with Respect to Washout Curve Shape
In clinical practice, a ROI with an average washout curve is rated as very indicative for ma-
lignancy. Therefore, the number of regions #RW with a washout curve shape in S3 f , S4 f , and
S3t p is compared. As shown in Figure 5.8, for larger tumors, S4 f exhibits less regions with a
washout curve than S3t p in 6 of 8 cases, whereas two tumors do not exhibit any regions with
a washout curve. For smaller tumors, S4 f has more regions with washout curve in 7 of 10
cases. In average, S4 f exhibits more regions with washout curve and containing only 1 voxel
than S3t p. A very important fact is the influence of the feature vector −→v4 f , see Figure 5.8.
S3 f provides less regions with washout curves than S4 f . More critical, in 13 of 20 cases, no
washout regions are existing in S3 f which may caused by merging of regions with different
curve shapes in the intermediate and late post-contrast phase.
The comparison of the part of the tumor that is covered by the regions with washout curve
yields similar results. The percentaged size for this part of each tumor is similar for S3t p and
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Figure 5.7: Comparison of the region number RN for each set S3 f , S4 f , and S3t p for larger
tumors (a) and smaller tumors (b) (image adapted and reprinted from [Glaßer et al., 2010]
c© 2010, Elsevier, with kind permission from Elsevier). Blue is assigned to RN(S3 f ), green is
assigned to RN(S4 f ) and red is assigned to RN(S3t p). The overall region number is presented
with bright colors. Dark colored bars indicate the number of regions with size equal to 1 voxel
for each set. In addition, the average number of regions µ(#RN) is presented.
S4 f with an average difference of 1.89%. The percentaged size of the part covered by washout
regions of S3 f is in average 12.65% smaller than the part of S4 f .
In conclusion, the set S4 f extracted with the region merging applying the feature vector −→v4 f
in combination with a minimum Pearson correlation value Pmin = 0.99 yields better results
than S3 f . It achieves equally suited results to S3t p but a finer subdivision of the early contrast
agent accumulation. These parameter choices are employed as default values in the Perfusio-
nAnalyzer. During evaluation of the region merging results, all regions have been taken into
account, since the clustering result itself has been rated. However, if such a region is employed
as ROI for further clinical diagnosis, only regions with a minimum voxel size or a minimum
percentage size w.r.t. the whole tumor is employed. For this purpose, in Chapter 7, different
approaches for the identification of the most suspect region from a clustering result will be
presented.
5.4.2 Visual Exploration of Region Merging Result
For a visual exploration of the region merging result, the PerfusionAnalyzer provides a prim-
itive 2D slice view, see Figure 5.9. Hence, further analysis is only applied to regions with a
certain minimum size, e.g. at least 3 voxels or 1% of the lesion’s size. This minimum size can
be adapted by the user, depending on the level of detail the user is interested in.
For a more detailed analysis of the resulting regions, two diagram-based presentations are
provided. First, a quantitative analysis is supported with the RE curve diagram. Second, the
perfusion parameter-based qualitative evaluation with the change diagrams provides informa-
tion of the lesion’s heterogeneity as well as the perfusion characteristics of each region.
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Figure 5.8: Comparison of the number of regions with an average washout curve for each set
S3 f , S4 f , and S3t p for larger tumors (a) and smaller tumors (b) (image adapted and reprinted
from [Glaßer et al., 2010] c© 2010, Elsevier, with kind permission from Elsevier). Blue is
assigned to S3 f , green is assigned to S4 f , and red is assigned to S3t p. With bright colors
the overall region number with an average washout curve is presented. Dark colored bars
indicate the number of washout curve exhibiting regions with size equal to 1 voxel for each
set. In addition, the average number of regions µ(RN) is presented.
Region Merging Result
Figure 5.9: Example of 10 axial slices of a small tumor with color coding of the 11 largest
regions, extracted with the region merging method (image adapted from [Glaßer et al., 2009]).
Gray is assigned to the remaining regions for the visual separation of surrounding tissue that
does not belong to the tumor.
Region-Based Quantitative Analysis in the RE Curve Diagram
For quantitative analysis of the region merging result, i.e., the enhancement kinetics of each
region, the average RE curves are provided in the RE curve diagram. The region merging
yields n regions Ri, i = 1 . . .n, and the whole lesion L as the combination of these regions, see
Figure 5.9 for an example of a slice-based view. In Figure 5.10, the average RE curve of L
and its regions Ri is depicted. The RE curves are classified into steady, plateau, and washout
curves with the adaption of Eq. 2.3 in Section 2.1.2. For information about the region size, the
percentaged size of each region in relation to the whole tumor as well as the size of the tumor
itself are depicted.
Since washout curves are associated with increased tumor malignancy, RE curves with a
washout shape are highlighted with an increased line width. On the contrary, the line width
could also be adapted to a region’s reliability, as depicted in Figure 5.10(b). The reliability
or homogeneity of a region is approximated via a ranking based on the region’s perfusion pa-
rameters’ standard deviation in relation to the whole lesion. Regions with smaller standard
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deviation values get smaller ranks, i.e., they are more homogeneous. The slice-based view and
the RE curve diagram view are linked and assignment of colors is consistent in both views.
The RE curve diagram is linked with an interactive slice view, where each region is color coded
according to the average RE curve. To avoid visual clutter, the user can define the number of
presented regions, e.g. the user can choose the n largest regions, all regions that contain at
least n voxels or all regions with a minimum percentaged size of n% in relation to the whole
tumor.
(a) RE Curve Diagram (b) RE Reliability Curve Diagram
Point in Time Point in Time
Figure 5.10: For each larger region, an average RE curve is created. The average RE curve
of the overall lesion (including voxels that belong to smaller regions) is depicted in gray and
indicates a washout curve shape (image adapted from [Glaßer et al., 2009]). The most suspi-
cious region R3 is classified as washout curve and an increased line width is assigned to it (a).
The line width can also be adapted to each region’s reliability (b).
Parameter-Based Qualitative Analysis in the Change Diagram
In addition to the quantitative evaluation of the RE curve diagram, a qualitative region-wise
analysis of the enhancement kinetics is provided in the change diagram. For a fast overview
and visual distinction, the measure Ci j is established. Ci j characterizes the change of the aver-
age descriptive perfusion parameter value µi of the descriptive perfusion parameters Pj, ( j ∈ {
PE, TTP, Integral, UpSlope, DownSlope }) of each region Ri. The change of µL
(
Pj
)
is set in
relation to the average values for the whole lesion µL
(
Pj
)
.
Since the parameters PE and Integral describe the washin and thus a certain amount of contrast
agent accumulation, they are considered as quantitative descriptors. Hence, the relative amount
of change (see Eq. (5.3)) is employed, since the comparison should indicate trends instead of
providing absolute differences of these descriptors. UpSlope and DownSlope are derived from
the same RE curve and can be simply compared by difference (see Eq. (5.4)). TTP describes
the point in time where PE is achieved. Since breast DCE-MRI data sets typically contain
5−6 time steps, the difference of L and region R j is normalized with the number of time steps
tn (see Eq. (5.5)).
Calculation of Ci j , i = 1 . . .n, for j ∈ {PE, Integral}:
Ci j =
µi(Pj)−µL(Pj)
µL(Pj)
·100, (5.3)
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for j ∈ {U pSlope,DownSlope}:
Ci j = µi(Pj)−µL(Pj), (5.4)
and for j = TTP:
Ci j =
µi(Pj)−µL(Pi)
tn
·100. (5.5)
An example for the change diagram is provided in Figure 5.11. Hence, color coding is synchro-
nized with the RE curve diagram and the slice view (see Fig. 5.9 and Fig. 5.10). In conclusion
of Eq. (5.3)-(5.5), the values of µL
(
Pj
)
are set at zero along the abscissa. Different perfu-
sion characteristics of a region in comparison to L are indicated by higher bars (considering
the absolute height), whereas similar characteristics are indicated by smaller bars (considering
the absolute height). In Figure 5.11, the regions R1, R2, R3, and R5 indicate suspicious en-
hancement kinetics, since they exhibit a stronger washin (in terms of parameters PE, Integral,
UpSlope) and an earlier and stronger washout (high negative magnitudes for DownSlope, TTP)
in comparison to the whole lesion.
Change Diagram
Figure 5.11: The change diagram for the lesion depicted in Fig. 5.9 and Fig. 5.10 (image
adapted from [Glaßer et al., 2009]). The regions R1, R2, R3, and R5 are very suspicious due
to the stronger washin (higher bars for PE, Integral, UpSlope) and a stronger washout (high
magnitude for DownSlope, TTP) in comparison to the whole lesion.
5.4.3 A Case Study for the Visual Exploration based on Glyphs and
Regions
In this section, the visual exploration is demonstrated with a small case study. When analyzing
a breast tumor with focus on kinetic enhancement, the clinical expert evaluates the presence of
regions with strong washin and washout behavior. First, the glyph-based visualization serves
as an overview of the lesion. Tumor parts with washout curves, which are indicative for ma-
lignancy, should be analyzed in more detail. Thus, the region merging approach is carried out
and the lesion is divided into a number of similarly perfused regions. Next, the clinical expert
starts the exploration with the quantitative analysis with the RE curve diagram to determine
a suspicious tumor part. Next, the search for similarly perfused regions is carried out with
the change diagram, which allows for a qualitative region-wise analysis of the enhancement
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(a) RE Curve Diagram (b) Change Diagram
Point in Time
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Figure 5.12: Analysis of regions with similarly perfused voxels (image adapted and reprinted
from [Glaßer et al., 2010] c© 2010, Elsevier, with kind permission from Elsevier). In (a), the
RE curve diagram of the 10 largest regions is presented. For each region, the percentaged
size and the curve type is depicted. The curve of the whole tumor is visualized in gray. The
most suspicious regions R1, R2, and R10 exhibit curves that are classified as washout curve. In
(b), the change diagram is presented, which allows for further characterization (color coding
is synchronized with the RE curve diagram). The regions R1 and R2 have a strong and rapid
washin (higher bars for PE, Integral, UpSlope) and a strong washout (high magnitude for
DownSlope, TTP) in comparison to the whole tumor. R10 has only a moderate washin, since
there are smaller values for PE and Integral. Moreover, in the change diagram, the region R9
can also be classified as suspicious, since this region exhibit the same trends like R1 and R2
(compare dark blue, medium blue, and red colored bars).
kinetics. Further diagnosis and treatment like core needle biopsy can then be adapted to the
identified spatially connected regions with suspicious enhancement kinetics.
The case study contains seven different malignant and benign lesions L1-L7 and their histo-
pathologic reports, listed in Table 5.1. For each lesion, the results have been approved by a
clinical expert. In Figure 5.13, the different views, i.e., the glyph view, the region merging
result, the RE curve diagram and the change diagram are provided.
Lesion L1. The region merging result for L1 contains 826 voxels and 11 main regions.
The glyph-based overview (see Fig. 5.13) indicates malignancy with strong RE and washout
curves. In the RE curve diagram, the region R3 is classified as washout. Five regions with
an average plateau curve exist and a strong heterogeneity can be observed. By analyzing the
Table 5.1: Listing of all lesions and their histopathologic reports.
Lesion ID Histopathologic Report
L1 Malignant multicentric, invasive lobular carcinoma.
L2 Benign lesion.
L3 Malignant moderate differentiated invasive lobular carcinoma,
contains small lobular carcinoma in situ.
L4 Malignant moderate differentiated invasive ductal carcinoma.
L5 Malignant inflammatory cancer.
L6 Malignant mucinous carcinoma, contains benign fibroadenoma.
L7 Benign lesion with fibroadenomas.
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Figure 5.13: Case Study with a glyph-based overview and the region map for representative
slices (left), the RE curve diagram (center), and the change diagram (right) (image adapted
from [Glaßer et al., 2009]). For the larger lesions L5 and L6, zooming is necessary for glyph
interpretation (see inlays).
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change diagram, R3 contains a strong washin (maximum PE, Integral, UpSlope) and washout
(higher negative magnitude for DownSlope and earlier TTP) in comparison to the whole le-
sion. In combination with the washout curve, R3 is highly suspicious and indicates malignancy.
Moreover, the change diagram reveals suspicious regions with an average plateau curve R1, R2,
and R5, which exhibit similar attributes to R3 in comparison to the whole lesion. The suspicion
of malignancy is confirmed with the histopathologic report of L1.
Lesion L2. The segmentation result contains a lesion with 1311 voxels and eight regions.
The glyph-based overview indicates continuous enhancement for many voxels. All regions
exhibit an increasing curve. The change diagram reveals that the regions differ in terms of PE,
Integral, and UpSlope, which is caused by different amounts of contrast agent washin. They
do not differ in terms of washout due to the very small changes for TTP and DownSlope. No
regions with suspicious average RE curve exist, indicating a benign lesion, which is confirmed
by the report in Table 5.1.
Lesion L3. The segmentation yields a small lesion with 330 voxels and five regions. The
glyph-based overview reveals suspicious enhancement kinetics for R1. R1, with a size of 50%
and a washout curve, indicates malignancy, whereas other regions are continuously enhancing.
The change diagram indicates similar perfusion characteristics of R2-R5 and strengthens the
suspicion of R1, since R1 exhibits the strongest washout. The indications are confirmed with
the report in Table 5.1.
Lesion L4. The segmentation contains a lesion with 710 voxels and nine regions. Although
the glyph-based visualization reveals voxels with suspicious washin and washout kinetics, al-
most all regions exhibit an average increasing curve in the RE curve diagram. Furthermore,
only moderate RE (up to 160%) can be observed. The largest region R1 exhibits a plateau
curve. The change diagram shows the lesion’s heterogeneity with different lesion enhance-
ment kinetics. Especially the washout characteristics confirm R1 as suspicious region, because
it strongly differs from the other regions as well as the whole lesion. Although no washout
curves exist, heterogeneity and general washout perfusion parameter values indicate malig-
nancy, which is confirmed by the report.
Lesion L5. The glyph-based overview reveals an inflammatory lesion with irregular con-
tours, indicating inflammatory breast cancer. The segmentation for this specific cancer yields
a huge (more than 120.000 voxels), highly fragmented lesion. The largest region R1 contains
only 16% of the lesion’s voxels, since many very small regions exist. The RE curve and
change diagram exhibit heterogeneous regions and many washout curves. The indication of
malignancy is confirmed in Table 5.1.
Lesion L6. For L6, the segmentation leads to a large (4522 voxels), highly fragmented lesion.
The glyph-based overview indicates moderate enhancement, with some small areas containing
suspicious curve courses. The RE curve diagram does not reveal a washout RE curve, but it
exhibits a strong heterogeneity. Furthermore, R2 and R4 are classified as plateau. The change
diagram illustrates the lesion’s heterogeneity and suspicious perfusion parameter values of R2
and R4. Both regions strongly differ from the whole lesion, thus indicating malignancy. The
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suspect is confirmed by the histopathologic report. L6 does contain smaller benign lesions,
which may have caused regions with an average increasing RE curve shape.
Lesion L7. The segmentation as well as the glyph-based overview yield a small, enhancing
lesion (290 voxels) containing only three regions. Two are continuously enhancing and one
(R3) is characterized by a plateau. R3 has a strong RE (up to 300%) but does not exhibit
any significant washout characteristic. This is strengthened by the change diagram, which
reveals strong differences during washin (in terms of PE, Integral, UpSlope), but almost no
differences during washout. The non-existence of characteristic washout kinetics indicates a
benign lesion, which is confirmed in Table 5.1.
5.5 The File-Card-Browser View
Next to kinetic features, many studies aim at the evaluation of morphological features for
lesion characterization, although a standardized terminology is missing. As it was stated by
the aspect 5 regarding breast tumor evaluation in Section 4.4, the evaluation of morphologic
features should be supported in a qualitative way.
Axial Slices
Adjacent Axial Slices Stellated Tumor Parts
Figure 5.14: In the conventional 2D view, the lesion’s morphology is hard to interpret. On
the left, it is not clear if the parts (marked with an arrow) stem from a stellated boundary
or just from the 2D view. On the right, the stellated parts of the tumor boundary are paral-
lel to the current viewing direction and could be missed (image adapted and reprinted from
[Glaßer et al., 2011] c© 2011, Springer-Verlag, with kind permission from Springer Science
and Business Media).
Therefore, the morphologic evaluation was not employed for an automatic classification pro-
cess but instead a further view was integrated in the PerfusionAnalyzer: the File-Card-Browser
View (FCB View). The FCB View was developed to account for the limitations of axial slice-
based 2D view. Similar to a conventional file card browser, the FCB View provides 2D views,
which can be rotated around the tumor via multiplanar reformation (MPR) views. In general,
an MPR view is a 2D intersection plane with the 3D medical tomographic data sets with ar-
bitrarily orientation. Furthermore, MPR views were also adapted to special diagnostic tasks,
such as the diagnosis of vascular diseases yielding curved multi planar reconstructions [Kan-
itsar et al., 2002]. In clinical practice for breast tumor evaluation, stellated parts of a tumor’s
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boundary may not be recognizable in the standard slice-based view, e.g., the axial slice view,
see Figure 5.14. An additional MPR view could reduce misinterpretations.
The extraction of the MPR views depends on the tumor extent and consists of three steps,
illustrated in Figure 5.15.
pc1
pc2c Rotation
of MPRs
(a) (b) (c) (d)
Figure 5.15: Creation of the FCB View (image adapted and reprinted from [Glaßer et al.,
2011] c© 2011, Springer-Verlag, with kind permission from Springer Science and Business
Media). At first, the lesion and the lesion mask is identified and extracted with one click in
the axial slice-based source view (a) or the RE view (b). In (b), the voxels of the tumor with
RE values > 50% are color coded. The tumor mask is provided in (c). Also, pc1 and pc2
are depicted. The MPR plane is generated with the vectors pc1 and pc2. The vector pc1 is
employed as rotation axis, see (d). (Medical image data is courtesy of U. Preim, Municipal
Hospital Magdeburg, Germany.)
The FCB View was tested with 20 DCE-MRI breast tumor data sets from the Breast Tumor
Database 2009. This study will be explained in more detail in Section 7.1. The lesion iden-
tification and segmentation process was carried out with the PerfusionAnalyzer, as it was de-
scribed in Section 5.2. In contrast to previous described methods, an isotropic voxel size was
desired for the MPR generation. The isotropic voxel size is achieved by resampling with a
Lanczos kernel (carried out with MeVisLab).
For the first step, the binary mask of the tumor is extracted from the segmented lesion. In the
second step, the centroid c of the tumor mask is computed. The center c is approximated as
mean position of the masked voxels. In the last step, a principal component analysis (PCA) is
applied. The PCA is carried out over the set of 3D voxels that belong to the tumor mask. The
first and second principal components pc1 and pc2 are extracted. Thus, pc1 and pc2 correspond
to the two 3D main directions of the tumor. Next, the MPR plane is generated based on the
plane spanned by pc1 and pc2, see Figure 5.15(c). For the generation of the FCB View, the
first vector pc1 is employed as rotation axis. Subsequently, the next MPR planes are generated
by rotating pc2 around pc1 with origin at the tumor center c. The MPR plane is again spanned
by pc1 and the rotated pc2 vectors. Thus, the MPR planes are adjusted to the tumor’s main
directions. The user can rotate around 180◦ for a complete overview of the tumor’s boundary,
see Figure 5.15(d). In case of sphere-shaped tumors, the tumor’s main extents are quite similar.
However, the FCB View employs the perpendicular principal components and the FCB View-
based exploration reveals the round boundary as well.
For an informal and qualitative evaluation, the FCB View was created and visually compared
to the conventional slice view. In Figure 5.16, the results are provided by the four examples C1
- C4. For each case, nine adjacent slices in the conventional slice-based view are presented. In
contrast, nine adjacent slices are presented of the same tumor with the FCB View. Color cod-
ing is applied to map the RE values to color (the same color scale as introduced in Sect. 5.3).
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The first case C1 presents a small, round benign tumor. As it is depicted, the FCB View also
reveals a round boundary. In the second case C2, a more stellated tumor can be observed in
the conventional slice-based view. With the FCB View, two almost non-connected parts of the
tumor become visible. Thus, the FCB View yields more details for understanding the tumor’s
morphology and is therefore more appropriate than the conventional slice view. The example,
C3 serves as representation for different tumor parts with different enhancing characteristics.
Although both views present a tumor with an irregular boundary, the FCB View reveals two
similarly perfused regions (visualized with similar reddish color coded contrast enhancement
kinetics and marked with arrows), whereas the conventional view could not show these spa-
tially connected and similarly perfused parts. Similarly perfused regions of a tumor are nec-
essary for evaluating the tumor’s heterogeneity as well as further diagnosis like core needle
biopsy. The example C4 illustrates the improved boundary evaluation. The conventional view
reveals parts of the tumor that seem to be suspicious (see arrows). These parts are caused due
to 2D axial slice-based view, because the FCB View reveals an almost round boundary.
Case C3 Case C4
Case C1
Conventional 2D View FCB View
Case C
Conventional 2D View FCB View Conventional 2D View FCB View
2
Conventional 2D View FCB View
Figure 5.16: Four example cases C1, C2, C3, and C4 of the database (image adapted and
reprinted from [Glaßer et al., 2011] c© 2011, Springer-Verlag, with kind permission from
Springer Science and Business Media). On the left, nine adjacent slices in the conventional
slice-based view are presented. On the right, nine adjacent slices of the same tumor with the
FCB View are shown. Due to the generation process, the slices of the different techniques are
not identical, i.e., they cover not the exact same portion of the data. For mapping of RE, color
coding is applied.
In 2 of 20 cases, the center c was not optimally located due to a very strong stellated and
irregular morphology. In these cases, the FCB View could not provide the desired improved
overview. However, such irregularly shaped tumors can be already evaluated in the conven-
tional slice-based view and do not need further evaluation with an additional MPR view.
As a result, the FCB View is adapted to each tumor, regarding the tumor’s spatial extent.
Furthermore, it provides additional information about the tumor’s morphology and boundary.
Additionally, different parts, e.g., two spatially non-connected foci, can be identified. This
holds also for different tumor parts that exhibit similar contrast agent accumulations. The
FCB View method aims at additional improvement and completion of the conventional axial
slice-based view instead of substitution of this clinical evaluation method.
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5.6 Combination of T1- and T2-Weighted Breast MRI Data
The PerfusionAnalyzer features the analysis of breast perfusion DCE-MRI data. Hence, it
strongly focuses on the T1-weighted sequence. For differential diagnosis in the early lesion
detection process, the radiologist also takes the T2 sequence into account, as it was briefly de-
scribed in Section 2.1.2. Lesions are recovered by time-consuming manual spatial correlation
of both images, i.e., the radiologist has to mentally register the images and locate the lesion
from the first image sequence in the second sequence. A simultaneous evaluation could re-
duce this time and effort, but a co-registration of the T1 and T2 sequence would be necessary.
Disagreement of T1- and T2-weighted sequences of a single patient results primarily from pa-
tient motion. Unlike motion correction of a single DCE-MRI T1-weighted scan, the sequence
co-registration must not only account for patient movement, but also for the different image
resolutions as well as intensity distributions.
(a) Combined Breast MRI View
(b) RE View
(c) Overlay
Figure 5.17: Joint visualization of T1- and T2-weighted MRI sequences. In (a), the subtraction
view of an T1-weighted DCE-MRI data set is depicted. A known primary tumor exists and
the clinical expert has to evaluate if the tumor has spread. Therefore, all suspicious lesions
have to be evaluated, see the marked one. With the PerfusionAnalyzer, the clinical expert can
change the background to the RE color-coded parameter map, see (b). Next, the integrated
magic lens displays the T2 data set as overlay and reveals hyper intensity indicating a cyst, see
(c). (Medical image data is courtesy of U. Preim, Municipal Hospital Magdeburg, Germany.)
In cooperation with Fraunhofer MEVIS4, a deformable image registration method was adapted
to T1 and T2-weighted MR images of the breast. To support the approach, a landmark-based
evaluation was carried out within the PerfusionAnalyzer. Therefore, a clinical expert marked
identical structures (small enhancing lesions or characteristic parenchyma patterns) in both
sequences. The landmarks were the input for the image registration. The method respects
differences in resolution, anisotropy and intensity characteristics. It was developed by Tobias
Böhler and is part of his PhD thesis [Böhler, 2011].
4Fraunhofer Institute for Medical Image Computing MEVIS; www.mevis.fraunhofer.de; (12/01/2013)
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In addition to the landmark-based evaluation, a view for the co-registered T2 image was in-
tegrated in the PerfusionAnalyzer. Thus, the clinical expert can evaluate both sequences si-
multaneously with a magic lens, see the examples in Figures 5.17 and 5.18. This view is just
an optional extension and it remains future work to include other modalities or results. For
example, first findings of the evaluation of the conventional X-ray mammography could be
integrated and presented to the clinical expert.
(a) (b) (c) (d)
Figure 5.18: Joint visualization of T1- (a) and T2-weighted (b) MRI sequences (image adapted
and reprinted from [Böhler et al., 2011] c© 2011, Springer-Verlag, with kind permission from
Springer Science and Business Media). Note the varying image resolutions and intensity distri-
butions. The RE parameter map of (a) reveals a small enhaning lesion, see (c) and the arrow.
When combined with a lens that shows the T2 view in (d), hypo-intense tissue is depicted,
indicating malignancy. (Medical image data is courtesy of U. Preim, Municipal Hospital
Magdeburg, Germany.)
5.7 Summary of 2D Visual Exploration of Breast Tumor
Perfusion Data
In this chapter, the PerfusionAnalyzer, a software prototype covering multiple linked views,
with the integrated 2D visual exploration techniques for the evaluation of breast tumor perfu-
sion data was presented. Beyond standard views, e.g., color-coded 2D parameter maps of RE
values or subtraction views, also novel visualization techniques were integrated. The lesion
detection and delineation was implemented with a volume growing method.
The voxel-wise glyph-based visualization allows for a fast overview of data sets. It avoids
interpolation and distortion due to average RE curves but is prone to outliers. The classification
of the voxel’s RE curve is carried out via the adapted 3TP method. As an advantage, the glyphs
visualize more different RE values than the adapted 3TP method, which only differentiates the
RE values of the early post-contrast phase into three groups.
An automatic subdivision of a suspicious tumor into different regions is established with the
region merging method. This approach reduces the influence of outliers. The similarity func-
tion is based on a feature vector consisting of descriptive perfusion parameter values. Hence,
each region contains voxels with similar perfusion characteristics. An advantage is the con-
nectivity of the remaining regions compared to other classification techniques, e.g., the 3TP
method, that neglect spatial connectivity. The clinician is not only interested in the malignancy
of special tumor parts but also in the localization of these parts for further treatment. Since a
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region contains similarly perfused voxels, the distortion of the average RE curve of the ROI as
well as the inter-observer variability concerning the ROI’s placement is reduced. The number
of regions and the diversity of the corresponding RE curves provide valuable information of
the physiological heterogeneity of the tumor and reveal benign and malignant parts inside the
whole tumor.
In general, the glyph-based voxel-wise overview as well as the region-wise quantitative and
qualitative evaluation with the RE curve diagram and the change diagram provide additional
information about the tumor enhancement kinetics and thus its malignancy. This is particularly
useful, since breast tumors can contain benign and malignant parts at the same time. Moreover,
it is possible, that no washout curve can be observed at all. Hence, the clinical expert has to de-
cide about further diagnosis and treatment. A drawback of the region merging is the influence
of noise on small regions. Hence, this influence is higher than on larger regions. Although
the results are satisfying for the tested lesions, the correlation threshold should be adapted to
account for this issue and it is left for further investigation in future work. Also, when analyz-
ing a local neighborhood, regions could be automatically classified as reliable or unreliable.
Adequate visualization techniques should be developed to represent this information.
With the PerfusionAnalyzer, the evaluation of a suspicious tumor has been improved, since the
radiologist could focus on suspicious regions and avoid the error-prone and time-consuming
manual ROI placement. The selection of the suspicious regions could include numerous re-
gions, depending on the tumor’s heterogeneity and size, but it is still faster than the manual
ROI placement method. The selection is carried out with the RE curve diagram by choosing
the largest region that exhibits strong contrast agent accumulation in the early post-contrast
phase and an average RE curve with a washout shape. Furthermore, the analysis of the RE
curve diagram and change diagram allows for a finer exploration of the data set, in comparison
to the nine classes derived with the 3TP method. Similar trends in terms of the descriptive
perfusion parameters are determined by analyzing the trends in the change diagram. The re-
gion number in relation to the tumor size provides information about a tumor’s heterogeneity,
which could be indicative for malignancy.
Beyond the kinetic evaluation, a new MPR view was designed and integrated to account for
the tumor’s morphology. The FCB View is adapted to each tumor, i.e., it creates a new MPR
plane that is adapted to the tumor’s extent. The presented comparison and examples illustrated
the main advantages of this method: the improved boundary evaluation as well as the identifi-
cation of spatially connected and similarly perfused regions. The first advantage allows for a
better evaluation of the tumor’s morphology, whereas the second one is important for further
treatment planning. Therefore, the kinetic evaluation can be combined with this additional
technique.
A further extension is the combination of T1- and T2-weighted MRI sequences of the breast.
The joint inspection of both sequences is important for differential diagnosis when evaluating
breast cancer. In particular, it allows to distinguish between benign cyst-type and malignant
lesions. However, in routine diagnostics both images are regarded independently and an im-
mediate image registration is prevented due to patient motion and tissue deformations. With
the integrated lens view, the radiologist can visually combine the MRI sequences for a faster
diagnosis without the effort of mentally integrate both images.
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6 3D Visual Exploration of Breast
Tumors and Clustering Results
The visualization of 3D scenes supports the perception of spatial information. Especially to-
mographic data, like MRI, are well suited for this kind of visualizations. However, 3D visual-
izations have to deal with occlusions, e.g., when outer parts hide inner parts. Furthermore, the
biomedical expert is experienced with evaluating 2D parameter maps and subtraction views
since these are widely employed in clinical routine. In Section 6.1, the region merging result
of the PerfusionAnalyzer is explored with the SimVis framework by Doleisch et al. [2003].
This framework with multiple linked views was presented in Section 4.1.2. In Section 6.2, a
more general 3D view of breast data sets is presented. However, for visual exploration and
analysis of tumor data, region of interests (ROIs) should be employed instead of the complete
whole lesion analysis and a well-suited 3D visualization is missing, recall Chapter 4. The so-
lution to this problem is presented in Section 6.3: the 3D ClusterView. Although this view was
initially developed for breast tumor perfusion studies, it can be adapted to brain tumor data as
well since it processes any clustering result extracted of medical tomographic image data.
6.1 3D Exploration via Brushing and Linking
As first step towards 3D visualization, the ROIs that were extracted with the region merging
method integrated in the PerfusionAnalyzer, were adapted to the SimVis framework. Thus, an
overview of the breast tumor is provided, see Figure 6.1. The 3D exploration of the region
merging result is based on aspect 8 of Chapter 4. Hence, an interactive feature definition is
carried out in the attribute views, e.g., the parallel coordinates view, the curve view and the
scatterplot view.
The exploration was carried out in the following way. First, the exploration is restricted to
voxels that exhibit a relative enhancement (RE) value greater than a certain threshold, e.g.,
50% after the early post contrast phase. This selection was carried out via brushing in the curve
view (see turquoise rectangle at the third time step in Fig. 6.1(d)), and the result is presented in
Figure 6.1(a). Hence, only a volume of interest is depicted and the selected voxels in the curve
view are mapped to color based on the voxel values for peak enhancement or the different
regions.
The second exploration also takes the curve shape into account. For example, a similarity brush
to highlight voxels with a fast washin and washout, i.e, a decreasing RE curve, is applied. The
similarity brush selects curves that exhibit similar gradients like the two blue parallelograms,
where the parallelograms’ heights define the size of the similarity interval (see Fig. 6.1(e)). As
it is depicted in Figure 6.1(b), many spatially not connected voxels are highlighted.
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The third exploration example is based on the region merging result. In the scatterplot diagram
in Figure 6.1(f), the regions are arranged based on their ID (the regions are ordered by size and
the largest region is assigned to ID 1) and their average RE curve shape. A brush selects regions
with small IDs, i.e., larger regions, and a washout curve shape. As a result, the clinical expert
yields a portion of the data that contains the most malignant part of the tumor (Fig. 6.1(c)).
This part is important for further diagnosis like core needle biopsy.
Region ID
timei timeti e
RERE
background increasing plateau washout
Curve Classification
(a) (b) (c)
(f)(e)(d)
Peak Enhancementeak E hancement Peak Enhancement
Region ID
Figure 6.1: Visual comparison of the exploration of the tumor’s most suspicious part (image
adapted and reprinted from [Glaßer et al., 2010] c© 2010, Elsevier, with kind permission from
Elsevier). In the top row, a volume of interest of a breast DCE-MRI data set is depicted. At
the bottom row, the corresponding selections are visualized. In (d), all voxels RE ≥ 50% at
the first point in time after the early post-contrast phase are selected in the curve diagram
(see turquoise rectangle at the third time step) yielding the enhancing lesion in (a). In (e), a
similarity brush highlights voxels with a fast washin and washout in (b). The similarity brush
selects curves that exhibit similar gradients like the two turquoise parallelograms. The paral-
lelograms’ heights define the size of the similarity interval. In (b), many small not connected
voxels are selected. In (f), regions with an average washout curve are selected, yielding a few
regions in (c).
As an intermediate result, a 3D region-based analysis is well suited to visually detect the most
malignant tumor part. For a better spatial orientation, context visualization of the breast is
needed, which is described in the next section.
6.2 Adaption of Transfer Functions for 3D Breast
Visualization
For the spatial overview of a breast tumor DCE-MRI data set, a direct volume rendering visu-
alization was integrated in the PerfusionAnalyzer, i.e., with the MeVisLab platform1 supported
1Product of Fraunhofer MEVIS, Bremen; www.mevislab.de (12/08/2013)
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by OpenGL and VTK.2 Examples are provided in Figure 6.2. The generation of the 3D view
comprises two steps. First, the breast shape is visualized as gray-colored background visual-
ization for context information. Second, the contrast agent enhancing tumor is visualized as
focus object.
For the visualization of the breast, the DCE-MRI data set is employed. A 3D Sobel filter
is applied to highlight the air-tissue boundary. In a preprocessing step, Gaussian filtering
reduces the influence of outliers and noise. A threshold is employed to mask voxels with
Sobel gradient values smaller than this threshold. Afterwards, a ramp window function (from
dark gray to light gray) is assigned to the remaining voxel values, yielding a gray shaded
context visualization of the breast shape. This threshold can be adapted by the user.
The highlighting of the tumor or any other enhancing tissue is based on the RE extracted from
the breast DCE-MRI data set. The RE values of the first post-contrast time step are employed.
Furthermore, the descriptive perfusion parameter integral is extracted. Voxels that exhibit high
RE values, but low integral values are classified as outliers and are mapped to full transparency.
They may arise due to noise or motion artifacts. The threshold for low integral values forms the
second user-defined input. Finally, the remaining voxels are mapped to color by employing a
ramp window function covering blue (for low enhancement, i.e., 60%, red, orange, and yellow
for higher RE values (RE ≥ 250%).
(a) (b) (c)
Figure 6.2: Examples of three breast DCE-MRI data sets visualized with the PerfusionAna-
lyzer. The tumors are highlighted, whereas the surrounding tissue and the skin is provided
as context information. (Medical image data is courtesy of U. Preim, Municipal Hospital
Magdeburg, Germany.)
The presented view aims at a spatial overview of the breast as well as its enhancing lesions.
For a diagnostic evaluation, this view does not provide sufficient information. However, the
3D view does only require two parameter choices to yield satisfying results.
6.3 The 3D ClusterView
Clinical diagnosis of perfusion data sets aims at the identification of areas that exhibit similar
characteristics. Therefore, clustering is applied to the perfusion data sets to group objects with
2The Visualization Toolkit, New York, USA; http://www.vtk.org/ (12/08/2013)
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similar attributes, e.g., voxels representing certain tissue types. The appropriateness of a clus-
ter algorithm depends on the medical problem and image parameters. To improve the adoption
of a clustering to a specific problem, the biomedical expert has to evaluate the quality of the
clustering result like the topology of the clusters and the spatial orientation of the structure
that has been decomposed. The 3D ClusterView in the PerfusionAnalyzer is a new clustering
visualization that is tailored to tumor cluster results. The tumor voxels are represented such
that geometric tubes visualize cluster connections. The spatial information about the voxel
positions in the tomographic data set is provided as well. The 3D ClusterView provides the
amount of clusters, cluster size, amount of outliers, and – most important – the spatial extent
and the orientation of the resulting clusters.
The motivation for developing this view is the need for improved interpretation of a cluster-
ing result (e.g., number and size of clusters or their spatial relationship) right after clustering
was carried out. In contrast to 2D scatterplots or 2D visualization techniques, a 3D scatterplot
clustering visualization allows for a quick spatial overview. A 3D scatterplot has the great ad-
vantage of showing one additional data dimension compared to conventional 2D scatterplots.
On the other hand, the data exploration requires more user interaction, since only two position
attributes can be presented simultaneously on the 2D screen. As it was listed in Section 4.1,
no appropriate 3D scatterplot visualization is available for the specific view of clustered tomo-
graphic data. In literature, a direct presentation of clustering results usually involves surface
representation or a visualization of a reduced high dimensional space. Naturally, only limited
spatial information about the clusters and the cluster elements is available due to the dimension
reduction.
In contrast, clustering results of medical tumor data cover voxels with an explicit spatial po-
sition.To support the spatial perception in the 3D ClusterView, and to fulfill aspect 8 , spe-
cial geometric primitives, i.e., tubes, were developed to visually represent the connection of
clusters. The orientation and attributes of these primitives are very well adapted to the 3D
scatterplot. The 3D ClusterView comprises the following parts:
1. A center point-oriented projection of a tumor into a sphere model. Hence, different
spheres represent different neighbor layers.
2. A 3D scatterplot visualization for breast clustering employing the sphere model and
featuring well adapted geometric primitives to present the clustering structure.
3. Selected shading styles to enhance the different parts of the scatterplot parts.
4. A perception-based color mapping to enhance visual differentiation between the clusters.
The steps of the 3D ClusterView generation are presented in Figure 6.3. At step I, the neigh-
borhood model is extracted (described in Sect. 6.3.1). At step II, the voxel size and tumor
extent is determined (see Sect. 6.3.2). At step III, the voxels are projected onto spheres (re-
fer to Sect. 6.3.3), and the cluster elements are connected with their associated cluster center
points via tubes (presented in Sect. 6.3.4). Also, the spheres are reshaped according to the
tumor’s extent. A legend that is based on the necklace map is added to the 3D visualization.
It provides additional information about the clusters and is described in Section 6.3.5. Finally,
the assignment of color and shading styles is presented in the last part of this section. The
extraction of clusters and the generation of surface meshes was realised with MATLAB.3 The
final presentation and the necklace map legend were created with MeVisLab.
3Product of the MathWorks, Natick, USA; www.mathworks.de/products/matlab/ (12/08/2013)
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Figure 6.3: Scheme of the cluster visualization pipeline. The example holds five voxels, each
forming its own cluster. In step I, a sphere model is created that holds all voxels of the tumor.
In step II, the voxel dimensions are adapted to the image resolution. A principal component
analysis yields the main directions of the tumor. In step III, the 3D clustering visualization is
generated by positioning the voxels onto spheres. The sphere-shaped visualization is adapted
to the main tumor extents that are approximated with the principal components.
6.3.1 Neighborhood Model for Voxel Ordering
Given a voxel in a 3D tomographic data set, the corresponding neighbors are defined as adja-
cent voxels that share
• a face (yielding 6 neighbors),
• an edge (yielding 18 neighbors),
• or a vertex (yielding 26 neighbors).
For the 3D ClusterView, the edge-based neighborhood relationship is employed. See Fig-
ure 6.4 for an illustration of the edge-based neighborhood in the 2D case. In the 3D case,
a voxel with position p(i, j,k) has 18 neighbors. The neighborhood structure is built by an
iterative process: First, an initial voxel vinit is chosen by employing the centroid of the tumor
T . If the centroid is not part of the tumor due to an irregular tumor shape, its nearest neighbor
contained in the tumor is chosen. As a result, the first layer L1 of the neighborhood structure
contains only vinit . The second layer L2 includes the neighbors vi ∈ T of vinit that are also
part of the tumor. For simplicity, Neigh(v) denotes the neighbors of v in T . The i-th layer can
be written as:
Li =
⋃
v∈Li−1
Neigh(v) \ Li−1. (6.1)
The i-th (with i > 1) layerLi comprises a maximum of 4(i−1)(5i−6) + 2 elements.
(a) (b) (c)
Figure 6.4: Illustration of the edge-based neighborhood in 2D space. The initial voxel in (a),
has four neighbors in (b), which in turn have eight neighbors excluding the initial voxel in (c).
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(a)
(b)
1
2
(c)
Figure 6.5: Illustration of the sphere projection. The method starts with the initial voxel (cyan
color-coded), see (a). Next,L1 is determined and the intersection point of the line constructed
by the initial voxel and an element of L1 with the circle is calculated, see (b). In (c), the
intersection points of the second layerL2 are obtained.
6.3.2 Integration of Voxel and Tumor Extent
The voxel extent is determined by the image matrix that defines the image plane resolution,
i.e., the voxel’s width and height. The voxel’s depth is set down by the slice thickness, which
usually differs from the image plane resolution in medical image data sets. In a preprocessing
step, the voxel’s depth vz is rescaled such that the voxel’s width and height equal uniform
length.
The tumor extent is characterized with a principal component analysis (PCA). The voxel’s x,
y, and z indices serve as input, and z was rescaled with vz. Hence, the principal components
match the eigenvectors of the covariance matrix that was constructed for the PCA. With the
three eigenvalues corresponding to the three principal components, the tumor’s three main
extents are obtained.
6.3.3 Projection onto a Sphere
After the extraction of the neighborhood structure, the cluster visualization is built up. Each
layer of neighborhood information is projected onto a sphere. Therefore, a sphere of radius
r = i2 is translated to the initial voxel, i.e., the centroid. Afterwards, the intersection point of
the sphere with the line, constructed by the initial voxel and an element in the ith layer Li, is
determined. In detail, the voxel is translated such that the initial voxel lies in the origin. Given
the midpoint qij of v j ∈Li, the intersection point pij is calculated by:
pij = q
i
j
√
r2
(qij)2
. (6.2)
See Figure 6.5 for an illustration in 2D.
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6.3.4 Connection of Cluster Elements and Their Associated
Midpoints
To support the perception of clustered elements, all elements are connected with their asso-
ciated midpoints. The connections, shaped like tubes, are motivated by the natural model of
neurons and their dendrites as well as blobby surfaces [Blinn, 1982]. The cluster visualization
connects the start points, i.e., the extracted positions for each voxel, with the end point, i.e.,
the cluster center, by smooth organic linkage. Hence, the algorithm comprises three steps.
At the first step, the start point and the end point are connected with a straight line. As an
optional step, several equidistant points on the line are added. Afterwards, the normalized
vector, pointing from the origin to the start point, is scaled to one tenth of the length from the
end point to the start point. This vector is added to the points on the line. The scaling changes
linearly to zero such that the first points are larger translated than the last ones. This approach
yields a bending of the tubes and reduced visual clutter. The second step is about generating
a cubical spline to connect the end point and the start point via the middle points. The third
and last step generates a Frenet frame around the curve. Afterwards, this frame is employed to
generate a tube around the curve. Inspired by the following formula:
thick(x) = radius
(
1 −
(x
d
)2)2
, (6.3)
a function which determines the thickness of the tube at every point is generated. Let r1 be
the radius of the sphere at the start position, r2 the radius of the sphere at the end point, and
d denotes the distance between the start and the end position. Furthermore, r′ is defined as
r′ = 0.25min(r1,r2). Then, the thick(x) function with x ∈ [0,d] can be written as:
thick(x) =

(r1− r′) ·
(
1− (4xd )2)2+ r′ if x≤ d4
(r2− r′) ·
(
1−
(
4(d−x)
d
)2)2
+ r′ if x≥ 34 d
r′ otherwise.
(6.4)
The construction of thick(x) ensures a smooth change from r1 for x = 0 to r2 for x = d. First,
the value thick(x) decreases smoothly from r1 to r′ for x ∈ [0,d/4] and keeps its value r′ for
x ∈ [d/4,3d/4]. For x > 3d/4 the function smoothly increases to the value r2. In Figure 6.6,
an example for the connections is provided.
6.3.5 Combination with a Necklace Map
To assess a clustering’s quality, additional information to the cluster’s spatial orientation should
be provided. These information may include the cluster’s average value of some parameter, its
standard deviation, or its size, etc.
For perfusion imaging, the average perfusion enhancement curve is of major interest from the
radiologist’s point of view. Thus, for each cluster its average curve is provided in a legend
that is based on a necklace map [Speckmann and Verbeek, 2010]. The necklace map was
developed for 2D maps and is similar to cartograms or choropleth maps. However, it arranges
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Figure 6.6: An example of a visually pleasing tube connecting the start point (i.e., an extracted
position for a voxel) and the end point (i.e., the cluster center).
symbols (e.g., circles) around the initial map in a linear ordering. Thus, the symbols can carry
information but no occlusion arises.
The necklace map is perfectly suited for the 3D ClusterView method because additional in-
formation for a group of well-defined objects - the clusters - can be displayed in a 3D scene
instead of a 2D scene. The according symbol for each cluster is a circle that is color-coded
with the corresponding cluster color. All circles are arranged on the necklace ordered by clus-
ter size, starting in the top right. The necklace itself is an ellipse that is obtained by scaling
a circle with the tumor extents. The necklace legend is depicted in Figure 6.7. The size of
the necklace pearls is linearly decreased, and not proportional to the cluster size due to strong
variations of cluster sizes, e.g., a cluster may contain 3 or 500 voxels.
6.3.6 Representation of Clusters
The tubes are rendered with a Phong shading to improve the shape perception. To support
the visualization of the start point, and thus, a good differentiation from the Phong-shaded
connecting tube, Fresnel shading is applied to the start point.
A specific color is assigned to each cluster and its start points. For the color assignment, the
CIELAB color space is employed to establish high perceptual color contrast. The CIELAB
color space was defined by the International Commission on Illumination (CIE)4 and is based
on the Lab color space. Hence, L defines the lightness and a and b the color hue. For
the proposed method, the first cluster is always assigned to orange with the corresponding
CIELAB components L = 67, a = 43, and b = 74. For the n remaining clusters, n colors
are extracted with the following routine. A circle is placed in the CIELAB space. The cir-
cle’s center is set to the origin (a = 0;b = 0). Given the a- and b-value for orange, its ra-
dius r is defined with r2 = a2 + b2. Then, the angle α B arcsin(b/r) is determined. Next,
a new color is extracted by calculating new values for a and b by increasing α with β and
β ∈ {0,1 · 2pin ,2 · 2pin , · · · ,(n− 1) · 2pin }. Thus, a = r · cos(α + β ) and b = r · sin(α + β ) are
extracted and combined with the starting value for L.
For the final representation, the surrounding spheres with the voxels are scaled according to
the tumor extent to highlight the tumor’s biological form. Thus, a tumor with a biological
4International Commission on Illumination; cie.co.at (12/01/2013)
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(a) 3D ClusterView (b) 2D Slice View
(c) Selection of Cluster
Figure 6.7: Example of a breast tumor clustering of tomographic perfusion data. The 3D
cluster visualization (a) and the 2D slice view (b) are integrated in the 3D ClusterView frame-
work and reveal three clusters arranged at three layers. The necklace map (placed around
the 3D visualization) and the slice view allow for a fast selection of clusters. Once the user
selected a cluster, only this cluster is color-coded, and the remaining clusters are visualized
with a Fresnel shading (c). Outliers are highlighted with bright red after selection according
to observations from a user study.
ellipsoid form yields a scaling of the spheres along the main tumor extents, whereas an almost
sphere-like tumor will only cause minimal scaling.
6.3.7 Results
The 3D ClusterView approach adapted to a breast tumor is presented in Figure 6.7. There, an
overview of the 3D scatterplot-like clustering visualization is provided. The user can examine
the spatial extent of the single clusters and their spatial position. The spheres holding the
different neighbor layers are visualized with a Fresnel shading. Gray is assigned to these
spheres. Outliers are presented with white colored spheres. Further, a standard headlight is
applied to the visualization.
The 3D view is accomplished with a necklace map. Thus, the user has a fast overview of all
existing clusters and additional information are mapped. As demanded by the medical experts,
the cluster’s average RE curve is represented in the necklace map. The framework also holds
a conventional slice view. To study a cluster’s spatial orientation in more detail, the user can
pick a cluster by clicking via the necklace map or the 2D view and study its extent in more
detail. Now, Fresnel shading is interactively applied to the non-selected clusters with a gray
color. This emphasizes the selected clusters and supports the individual examination, recall
Figure 6.7.
In Figure 6.8, a brain tumor data set comprising a masked perfusion T ∗2 -weighted MRI data set
is presented. For brain perfusion, the parameter cerebral blood volume (CBV) is analyzed to
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detect hot spots, i.e., regions with elevated CBV values. The brain was decomposed into five
clusters with a k-means algorithm based on the parameter CBV. Hence, no outliers are present.
Instead of presenting the whole contrast agent enhancement curve, the pearls of the necklace
map provide average CBV values and identify the pink cluster as cluster with highest averaged
CBV value.
(b) 2D Slice View
(a) 3D ClusterView of a Brain Tumor
Figure 6.8: Illustration of the clustering result of a brain tumor. The tumor has an elongated
shape and was clustered into five clusters, no outliers exist. The necklace map provides ad-
ditional cluster information, i.e., the cluster’s average parameter value of the cerebral blood
volume (CBV), see (a). The slice view was added for a 2D view of the clusters, see (b).
6.3.8 Evaluation
In the following, a qualitative evaluation of the 3D ClusterView visualization method is pre-
sented. The goal was to assess the capability to express the topology of the clustering result in
the 3D visualization. Hence, the focus relies on the 3D representation of the clusters in combi-
nation with connecting tubes. For comparison, a point-based scatterplot view and a transparent
isosurface were presented to the user, see the example in Figure 6.9. The evaluation was con-
ducted with one medical researcher and physician, and ten researchers who are familiar with
the visualization and evaluation of medical tomographic image data.
In this study, the participants were asked to handle a few minor tasks about
• the topology of the clustering result,
• the presence of outliers, and
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(a) (b) (c)
Figure 6.9: The three 3D views of a clustering result, including a point-based view (a), the
isosurface view (b), and the 3D ClusterView approach (c).
• the impression about the tumor’s boundary and shape.
The topology of the clustering result was covered by the request to identify the largest cluster
and to categorize the clustering result’s topology in pre-defined categories. It was questioned,
if the participants could identify outliers and how many outliers there are with respect to num-
ber and percentage to the whole tumor. The last question concerned the tumor’s boundary
(from round to stellated boundary) and shape (from spherical to ellipsoidal). To make the
answers of different participants comparable, well-defined categories were provided for each
answer.
First, the participants were introduced to the three techniques by presenting a clustering result
of a test data set (recall Fig. 6.9). Next, the subjects solved the tasks for nine examples,
created by applying each visualization technique to three new data sets. The visualizations
were presented such that no data set was consecutively shown, but after each presentation,
another data set with another 3D view was depicted. After answering the questionnaire, the
participants rated the techniques due to their appropriateness to evaluate the clusters’ topology,
the required user interaction, and provided additional feedback.
As a result, all volunteers correctly identified the largest cluster for each example. However,
when it comes to the cluster number, the 3D ClusterView technique achieved better results
than the other two methods, see the diagram in Figure 6.10. This is very relevant, since a
wrong number of clusters implies that some clusters were not detected at all or (very rare)
some single, spatially connected, clusters were interpreted as different clusters. The majority
of the participants rated the 3D ClusterView method to be the most appropriate for evaluating
the clusters’ topology (8 out of 11).
Outliers were present in all examples, and with two exceptions (arising from the 3D Clus-
terView visualization and an isosurface-based view) for two single examples, all participants
detected the outliers for each view. When it comes to tumor shape, the volunteers assign
higher ratings, i.e., more stellated boundaries based on the presented visualization in compar-
ison to the other two conventional views. This is due to the arrangement of the voxels onto
the spheres. Hence, the 3D ClusterView suggests a more stellated boundary, which is a limi-
tation. However, there was no trend with respect to the employed technique present when the
participants should evaluate the tumor size via the number of voxels that were clustered. All
participants had no difficulty with the interaction or with the visualization. But the majority (9
out of 11) needed less interaction with the 3D scene, e.g., camera rotation, comprising the 3D
ClusterView due to the good spatial impression of the connected clusters.
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Figure 6.10: Bar diagrams illustrate the average squared error of the approximated number
of clusters (a) by all users for the three techniques: point-based 3D view, isosurface view and
the 3D ClusterView with connecting tubes. In (b), the number of users is presented that chose
the technique as most appropriate for the evaluation of the clustering’s topology.
However, the study does not allow for a definitive statement. A further evaluation is required
with more participants and data sets. In summary, the participants were able to fulfill the as-
signed tasks with the 3D ClusterView method very well. They rated it as best suited for the
evaluation of a clustering topology. Furthermore, they preferred it due to the visual cluster
connections via tubes and due to the lesser scene interaction in comparison to the other tech-
niques. They asked for a more prominent color-coding of outliers, like bright red, which was
employed in the framework afterwards. It must also be stated that the 3D ClusterView visual-
ization indicates a more stellated boundary due to the spatial representation of the voxels on
the spheres. On the other hand, these representations reduce the amount of occlusion and thus
the amount of required user interaction.
For future work, in case of a huge number of cluster elements, the 3D ClusterView would ben-
efit from a view-dependent transparency representation similar to the work by Günther et al.
[2011]. They reduce the number of displayed lines by smoothly fading them out. Connections
very distant to the camera are opaque, whereas connections far away are rendered transparent.
This is done to improve the visual appearance of the tubes and to concentrate on the focus of
the camera.
6.4 Concluding Remarks of 3D Visualization for Breast
Tumors and Clustering Results
The increasing complexity of medical image data induces an increasing demand for visual an-
alytic solutions [Lundström and Persson, 2011]. Albeit their work identified the diagnosis of
primary and secondary findings in the image data in an efficient way as key issues, the deter-
mination of shape, size, and relative position of different parts of the anatomy were identified
as important component of a radiologist’s image review work. For this aspect, a 3D view has
the great advantage of conveying spatial information when compared to 2D parameter maps.
The visual exploration of breast tumors in 3D (recall Sect. 6.2) provides this spatial information
overview, but the advantages are restricted to this overview. A dedicated analysis is hampered
due to occlusion of inner tumor parts. In contrast to the 2D representations, including the MPR-
based FileCardBrowser View, the tumor’s morphology is difficult to analyse regarding its 3D
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shape. An adaption to multiple linked views (recall Sect. 6.1), like the SimVis framework,
allow for an exploration of the data set, but unless the spatial overview, no further information
can be extracted from the 3D views.
Although conventional analysis is carried out in 2D due to the missing diagnostic information
or occlusions, the 2D visualization of clustering results becomes difficult to interpret. The
information that should be depicted cover the number of clusters, their size, and how they
are spatially aligned. Hence, a 2D view lacks of appropriate visualization for an intuitive
representation. With the 3D ClusterView, the clusters can be adequately represented as a 3D
scene. Hence, the geometric modeling enhances cluster connections. The 3D ClusterView
is completed with a necklace map legend, maintaining that each cluster can be addressed.
Hence, the user can select a cluster of interest for further exploration in the 3D view. While the
appearance of the selected cluster does not change, color and shading of the remaining clusters
change from opaque visibility to Fresnel. The 3D ClusterView was successfully adapted to
brain tumor data and is well suited for any clustered medical tomographic image data. Due
to the increased complexity of medical image data, the biomedical experts will be definitely
confronted with the problem of an effective clustering of their data in the future. In turn, the
extracted clustering results have to be qualitatively and quantitatively evaluated. Hence, for
the qualitative evaluation, the 3D ClusterView yields the most expressive results since it is
specifically tailored to this application area.
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7 Breast Tumor Analysis for Automatic
Classification
In this chapter, the automatic classification of breast tumors in DCE-MRI data is examined
with a strong focus on heterogeneity and lesion enhancement kinetics. These approaches are
strongly motivated by the high sensitivity for the detection of breast cancer in contrast to
the problematic specificity of breast DCE-MRI. The specificity is hampered by overlapping
enhancement kinetics of some benign and malignant lesions [Kuhl et al., 1999] as well as am-
biguous morphologic features [Wedegärtner et al., 2001]. Therefore, the presented approaches
do not only employ features related to the enhancement kinetics, but also measures for the
heterogeneity of the feature values. Therefore, additional criteria to distinguish benign and
malignant lesions can be found. The heterogeneity of breast tumors is strongly associated
with malignancy. This is due to the increased angiogenetic activity of malignant lesions. Es-
pecially for very small breast lesions, the heterogeneity has not been examined in detail. In
larger malignant lesions, central necrosis might occur and cause heterogeneous contrast en-
hancement, which can be visually assessed by the clinician. This does not hold for the small
lesions due to limited spatial resolution of the MRI scan. Furthermore, small malignant lesions
may not develop necrotic areas in an early tumor stage. Nevertheless, they are expected to be
more heterogeneous than benign ones, a hypothesis that will be assessed with the classification
approaches in this chapter.
For the extraction of features regarding the contrast enhancement kinetics, a group of voxels
with similar perfusion characteristics has to be extracted because the contrast enhancement of
the individual voxels is noisy by nature. Hence, a major challenge lays in grouping the vox-
els to homogeneous and spatially contiguous regions. This chapter comprises four different
classification approaches. In Section 7.1, the database containing the breast tumor data sets is
explained. For the sake of comparability, all four classification approaches were applied to this
database. First, the region merging result, embedded in the PerfusionAnalyzer, is employed
for automatic classification in Section 7.2. Second, the grouping of regions is extended and
different density-based clustering approaches are used, see Section 7.3. Hence, the results of
the first approach are integrated such that features with high discriminative power are selected
as well as features that proved to be well suited for an automatic classification approach. In-
spired by the second classification approach, the third classification approach studies how the
formation of regions of similar voxels contributes to distinguishing between benign and ma-
lignant tumors, see Section 7.4. Furthermore, an adaption of spectral clustering is presented
in Section 7.5, since this classification is well suited to create spatially connected regions.
Whereas the first classification approach employs the receiver operating characteristics, the
second, third, and fourth classification approaches extend the classification process by learn-
ing a decision tree model. The decision tree has the strong advantage of being human-readable
and it reveals the most important features, i.e., features that are closer to the root.
118
7.1 The Breast Tumor Database 2009
Integrated in the classification approaches is the detection of the most suspect part of the tumor.
This part is referred to as MSRegion. The identification of the MSRegion does not only play an
important role for the feature extraction, it furthermore substitutes the manual and error-prone
definition of a ROI by the clinical expert.
At the end of this chapter, the conclusions of the classification approaches with focus on the
clinical research on DCE-MRI tumor enhancement kinetics are summarized.
7.1 The Breast Tumor Database 2009
The Breast Tumor Database 2009 comprises breast DCE-MRI data sets with benign and malig-
nant lesions. The DCE-MRI data were clinically indicated, i.e., a suspicious finding was found
with conventional X-ray mammography or the patients suffered from other, breast cancer-
related symptoms. The patients gave their informed consent to the MRI exam and to the fact
that the data might be used for research purposes. The retrospective study was performed ac-
cording to the guidelines of the ethics committee. The breast DCE-MRI data sets were enrolled
from January 2008 to December 2009.
Table 7.1: Histology of the lesions of the Breast Tumor Database 2009.
Histology Number %
Invasive ductal carcinoma 15 22.1
Invasive lobular carcinoma 13 19.1
Fibroadenoma (histology: 4, follow up: 6) 10 14.7
Adenosis 6 8.8
Fibrosis 5 7.3
Ductal carcinoma in situ 4 5.9
Invasive ductal / lobular carcinoma 3 4.4
Papilloma 2 2.9
Undifferentiated carcinoma 2 2.9
Breast tissue 2 2.9
Fibrocystic changes 1 1.5
Hemangioma 1 1.5
Lymph node 1 1.5
Inflammation 1 1.5
Benign (follow up) 2 2.9
7.1.1 Patients and Lesions
The Breast Tumor Database 2009 comprises lesions that were only detected in MRI. Hence,
palpable lesions or lesions detected in X-ray mammography or ultrasound were excluded. The
database consists of 68 breast tumors, arising from 50 patients with a mean age of 55 years
(range: 36 - 73). From these 68 lesions, 31 (45.6%) lesions proved to be benign and 37 (54.4%)
to be malignant. The mean diameter was 8 mm (range: 4 - 18 mm). 60 lesions were confirmed
by histopathology of specimens obtained by core needle biopsy. All biopsies were performed
under MRI guidance with an MR-compatible fully automatic biopsy gun 100 mm, 14G invivo
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Germany. Eight lesions with MR-BI-RADS classification three confirmed to be benign by
follow up after six to nine months. The histology of all lesions is listed in Table 7.1.
7.1.2 MRI Protocol
The breast DCE-MRIs were performed on a 1.0T open MR scanner (Philips Panorama HFO)
with a dedicated breast coil (Philips SenseBreast). The imaging sequence was an axial T1-
weighted 3D gradient echo sequence (TR 11, TE 6, flip angle 25 ◦, voxel size 0.67mm×
0.67mm, matrix 528×528, slice thickness 1.5 - 3 mm without gap). Fat suppression was not
employed. During and immediately after the bolus injection of contrast agent (0.1 mmol/kg
bodyweight), one pre-contrast and four or five post-contrast images were acquired per series
with a temporal resolution of ≈ 80 s. The contrast medium (Magnevist, Schering, Germany)
was administered using an automated pump (Accutron MR MEDTRON 2007) with a flow of
1ml/s. 16 of the 50 patients were premenopausal. In this subpopulation, the MR exam was
performed in the 2nd week of the menstrual cycle.
7.1.3 Image Interpretation and Data Analysis
The breast DCE-MRIs were evaluated by experienced radiologists. First, the data sets were
examined at a commercially available workstation (Philips ViewForum) using subtraction and
parameter images in order to detect lesions unknown from ultrasound and X-ray mammogra-
phy. The radiologists assessed each lesion according to the MR-BI-RADS classification. The
morphologic features (shape and margin) were evaluated and the lesion size was recorded. At
this time, the histology of the lesions was unknown to the radiologists. For the study, lesions
with MR-BI-RADS (recall Table 2.1 at page 18) classification 3 - 5 were included.
7.1.4 Adaption of the 3TP Method
The main advantage of the three-time-point (3TP) method is the quantitative analysis of the
relative enhancement (RE) curves instead of the subject and error-prone qualitative evaluation.
The 3TP classification is adapted to the data sets to provide a quantitative analysis of the curve
shape in the intermediate and late post-contrast phase. In contrast to the study by Degani et al.
[1997], the Breast Tumor Database 2009 exhibits different average total acquisition times of≈
400 s, since another protocol was applied and the scan times depended on different parameters,
e.g., the size of the scanned breast. With this scanning protocol, the early post-contrast phase
lasts until the third point in time t3. In agreement with an experienced radiologist, t ′1 is assigned
to the first point in time, t ′2 to t3 and t
′
3 to the last point in time.
7.1.5 Challenges and Limitations
In this breast tumor database, only lesions with follow up or histology were included. How-
ever, 8 lesions with the BI-RADS classification 3 had a follow up only after 6-9 months. Due to
the retrospective fashion and the limited period of this study, further follow up with MRI or tar-
geted ultrasound was not performed. However, this time frame is not sufficient to downgrade a
120
7.2 Heterogeneity Analysis Based on Region Merging
lesion to BI-RADS 2. According to the BI-RADS lexicon, a time frame of two years or longer
is necessary. Furthermore, motion correction was carried out with the combined rigid and
elastic registration introduced by Rueckert et al. [1999] and integrated in MeVisLab.1 Motion
correction is very important to establish a valid inter-pixel correspondence over time, because
breathing, heartbeat, patient movement, and muscle relaxation can occur. Nevertheless, mo-
tion correction can also lead to artifacts like blurring and loss of small details. Furthermore, in
some cases the motion artifacts cannot be completely removed.
In summary, this database comprises small breast tumors that are only detectable in DCE-
MRI, and cannot be classified with conventional mammography. Thus, they are inherently
difficult to separate, even for a human expert, since all lesions were suspicious enough to
justify biopsy or follow up studies. As a result, typical benign lesions are not part of this
database.
7.2 Heterogeneity Analysis Based on Region Merging
In this section, the first classification approach to distinguish between benign and malignant
breast tumors is presented. It is based on the methods integrated in the PerfusionAnalyzer
and thus employs a classification based on the region merging methods adapted to the Breast
Tumor Database 2009. The ground hypothesis was that - due to neoangiogenesis - malignant
lesions are more heterogeneous than benign lesions, also when the lesion size is so small that
necrosis not yet occurred.
This hypothesis arose, since malignant lesions show rim enhancement or heterogeneous en-
hancement due to necrosis and fibrosis mainly in the tumor center and angiogenetic activity
predominantly at the periphery of the tumor [Buadu et al., 1996]. Benign tumors are pre-
dominantly more homogeneous [Okafuji et al., 2008] and exhibit a lower vessel density than
recurrent invasive breast cancer lesions [Obermair et al., 1994]. Yet, fibroadenomas as well
may display a heterogeneous internal enhancement due to mucinous or myxoid degenera-
tion [Kuhl, 2007]. However, such heterogeneous regions are most often found in larger tumors
that are already known from mammography and ultrasound and histologically confirmed by
ultrasound-guided biopsy. Smaller lesions, depicted only with breast DCE-MRI, show pre-
dominantly a homogeneous internal enhancement, when evaluated visually.
Related studies for the breast cancer MRI classification have been presented in Section 4.2,
and in the conclusion of Chapter 4. The evaluation of heterogeneity has been identified as
important issue (aspect 2 ). This issue has been accompanied by three more aspects which
are integrated in the following way: the kinetic features (aspect 1 ) are employed based on
extracted descriptive perfusion parameters (aspect 4 ) and the analysis is carried out over the
whole lesion ensuring to hold the most malignant tumor part (aspect 3 ).
The classification approach in this section is based on the region merging method described
in Section 5.4, integrated in the PerfusionAnalyzer. The approach aims at the evaluation of
small differences of the perfusion characteristics that are not perceptible in conventional MR
images. Hence, it also intends to define a score, to provide the radiologist with a parameter
combination that automatically determines tumor malignancy.
1Product of Fraunhofer MEVIS, Bremen; www.mevislab.de (12/08/2013)
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To quantify the RE value for each voxel at each point in time, the percentage signal inten-
sity increase was calculated. From the resulting RE curve, the descriptive perfusion parame-
ters washin (the steepness of the ascending curve), washout (the steepness of the descending
curve), peak enhancement (the maximum RE value), Integral (the area under the curve) and
time to peak (the time when peak enhancement occurs), were extracted. These parameters are
substitutes for physiological parameters like tumor perfusion and vessel permeability, recall
Section 2.1.2. Without the parameter Integral, these kinetic features have also been employed
in the related studies in literature, for example by Hauth et al. [2006b] as well as by Williams
et al. [2007].
The voxels were grouped into regions, by applying the region merging method described in
Section 5.4. For the first classification approach, a minimum Pearson’s correlation of 0.99 was
employed and the four-dimensional feature vector −→v4 f was employed. Furthermore, regions
must contain at least three voxels according to the recommendation for the optimal ROI set-
ting [Kuhl, 2007]. Smaller regions were neglected, because they are predominantly influenced
by noise and artefacts.
7.2.1 Feature Selection
For this first classification method, a combined feature set was employed that covers morpho-
logic features, the descriptive perfusion parameters, numbers of regions, and numbers of 3TP
classes. The features are listed in detail in Table 7.2 and 7.3. Hence, Table 7.2 covers the
global tumor attributes regarding tumor size, patient age and morphology as well as margin
type. Table 7.3 covers the kinetic features extracted for all regions. It must be stated that for
this classification approach a multitude of features was employed to detect important features
and to achieve initial results about the discriminating power of the features.
Table 7.2: Features for the first classification approach that include tumor and patient at-
tributes. Margin and boundary classification were based on the MR-BI-RADS protocol.
General Features
1 #Reg Number of regions with at least three voxels.
2 age Age of patient.
3 diameter The lesion’s size, approximated as maximum
slice diameter of the lesion (in mm).
4 quadrant Breast quadrant where the tumor is located.
5 morphology The morphology of the tumor.
6 margin Tumor’s margin.
Since the first classification approach also aims at identification of a score for an automatic
classification, the combination of the descriptive perfusion parameters are included as pc1 and
pc2. Therefore, a principal component analysis (PCA) was carried out over the descriptive per-
fusion parameters of all tumors of the Breast Tumor Database 2009, and the first two principal
components were selected.
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Table 7.3: Region-based and kinetic features for the first classification approach. Hence the
3TP classification is employed to classify RE curves based on their washin with Washin3T P
and based on the curve shape with Washout3T P.
Features for each Region of the Region Merging Result
1 #RegVoxel Number of voxels of the region.
2 Washin3T P Rated washin, a value of 1 is assigned to 3TP curves 1-3; a value
of 2 to 3TP classes 4-6, and a value of 3 otherwise.
3 Washout3T P Rated washout, a value of 1 is assigned to increasing curves, i.e.,
3,6,9; a value of 2 to plateau curves, i.e., 2,5,8; and a value of 3 to
washout curves, i.e., 3TP classes 7,4,1.
4 3TPregion The 3TP class of the region’s average RE curve.
5 pc1 The average value of the region’s voxels for pc1.
6 pc2 The average value of the region’s voxels for pc2.
7 #Present3TP Number of different 3TP classes existing in the region.
8..
16
Exist3T P(1..9) Binary attribute that flags the existence of voxels with 3TP curve
1..9 in the region.
17 Washout The average value for washout.
18 Integral The average value for the parameter integral.
19 PE The average value for the parameter PE.
20 TTP The average value for time to peak.
21 Washin The average value for washin.
22 σWashout The standard deviation value for washout.
23 σ Integral The standard deviation for the parameter integral.
24 σPE The standard deviation for the parameter peak enhancement.
25 σTTP The standard deviation for time to peak.
26 σWashin The standard deviation for washin.
27..
31
REt The region’s average RE value at time step t, t = 2..6
7.2.2 Experimental Settings and Results
The Mann-Whitney U test [Mann and Whitney, 1947] was applied to examine statistically
significant differences between benign and malignant lesions considering significance for p <
0.05. Receiver operating characteristic (ROC) curve analysis and calculation of the area under
the curve (AUC) were performed. The IBM SPSS Statistics software package2 was employed
for statistical analysis.
As a result, malignant lesions showed a significantly higher number of regions #Reg compared
to benign ones (median 17 versus 8, p = 0.005), see the feature description in Table 7.2(1).
Therefore, malignant lesions were more heterogeneous. With a cut-off of ten regions, sen-
sitivity and specificity were 0.8 and 0.58, respectively. The lesion’s diameter of benign and
malignant lesions was similar (mean 7.6 mm and 7.8 mm, respectively), see Table 7.2(3). The
analysis of the 3TP classes revealed significant differences between the groups as well. Ma-
lignant lesions had more present 3TP classes, i.e., a higher value for #Present3T P, compared
to benign lesions (mean 6.2 versus 5.3, p = 0.007), see Table 7.3(7). Hence, the malignant
2Product of IBM, New York, USA; http://www-01.ibm.com/software/analytics/spss/ (12/08/2013)
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lesions also turned out to be more heterogeneous. With a cut-off of five different 3TP classes
existing, sensitivity and specificity were 0.78 and 0.45, respectively.
The perfusion parameters (peak enhancement, wash-in, wash-out, integral, and time to peak)
revealed no significant differences between the groups, listed in Table 7.3(17)-(26). The 3TP
class 7 (Tab. 7.3(14)), i.e., strong early enhancement and following washout, occurred signif-
icantly more often in malignant lesions (18/37) than in benign ones (14/31). The p-Value and
AUC were 0.04 and 0.57, respectively. The sensitivity was determined to be 1.0, but the speci-
ficity was very poor (0.13). In Figure 7.1(a) and (b), the ROC curves for the features #Reg and
#Present3T P are depicted. Figure 7.1(c) demonstrates the box plots of the number of regions
#Reg of benign and malignant lesions. Median, mean, standard deviation, and p-values are
displayed in Table 7.4. AUC values, sensitivity and specificity of selected cut-offs can be seen
in Table 7.5.
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Figure 7.1: Depiction of the ROC curves for the feature #Reg in (a), and #Present3T P in (b).
In (c), the box plots for benign and malignant lesions and #Reg is depicted. (Image adapted
and reprinted from [Preim et al., 2012] c© 2012, Elsevier, with kind permission from Elsevier.)
Table 7.4: Median, mean, standard deviation σ , and p (U-test). The RE value at the third
time point RE(t3), Washin, Washout, Integral, and TTP values are average values for the most
suspect region.
Benign Malignant p
Median Mean σ Median Mean σ
age 61 57.5 10.5 54 53.7 8.3 0.032
diameter 6 7.6 2.9 7 7.8 2.4 0.37
MR-BI-RADS 4 3.7 0.5 4 4.4 0.5 < 0.001
#Reg 8 19.6 29.5 17 25.3 24.3 0.005
#Present3T P 6 5.3 1.4 6 6.2 1.4 0.007
RE3 245.3 330.7 265.5 242.8 251.3 92.4 0.3
Washin 120 152.3 125 117 121.7 48.3 0.6
Washout −8.9 −8.5 25.3 −8.7 −9.4 12.7 0.95
Integral 788.8 974.2 695 805.5 820.3 363.7 0.8
TTP 3.2 3.7 1 3.2 3.5 0.56 0.8
Despite the exclusive evaluation of lesions < 2cm, shape and margin were significantly dif-
ferent. Malignant lesions showed more often an irregular shape 22/37 (59.5 %), but rarely
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Table 7.5: AUC, sensitivity, and specificity for the significant parameters.
AUC Cutoff Sensitivity Specificity
#Reg 0.7 10 0.8 0.58
#Present3T P 0.68 5 0.78 0.45
Exist3T P(7) 0.57 n.a.a 1.0 0.13
a Not applicable.
a round 6/37 (16.2 %), oval 8/37 (21.6 %), or lobulated 1/37 (2.7 %) shape. Benign lesions
were more often characterized by a round shape 17/31 (54.8 %), but rarely by an irregular 6/31
(19.4 %), oval 4/31 (12.9%), or lobulated shape 4/31(12.9 %). The difference was highly sig-
nificant (p < 0.001). The margin showed significant differences as well (p = 0.007). Malignant
lesions showed more often a blurred margin 25/37 (67.6 %) and rarely a well-defined margin
12/37 (32.4 %). Benign lesions displayed more often a well-defined margin 21/31 (67.7 %)
and rarely a blurred margin 10/31(32.3 %). The detailed histology of the lesions can be found
in Table 7.1 at the beginning of this chapter.
Diagnostic criteria in breast DCE-MRI include assessment of morphological features like
shape, margin and heterogeneity (internal architecture) as well as analysis of time-intensity
curves. Heterogeneity is known to be a feature of malignant tumors because larger tumors
develop necrotic areas [Wedegärtner et al., 2001]. Those necrotic areas can be estimated vi-
sually. However, in small lesions without apparent necrosis the visual analysis may not be
sufficient. For that purpose, the region merging-based classification allows for a novel assess-
ment of heterogeneity for this specific data sets, i.e., small enhancing lesions only detectable
in DCE-MRI. Furthermore, it enables the analysis of the whole lesion. In the Breast Tumor
Database 2009, the number of regions as well as the number of 3TP classes showed significant
differences between benign and malignant lesions. Therefore, malignant lesions turned out to
be more heterogeneous than benign ones. The region analysis revealed better results compared
to the analysis of the 3TP classes. The reason could be that the 3TP classification has only nine
classes, whereas the region analysis has much more regions and is thus more sophisticated.
Examples for a benign and a malignant lesion are given in Figures 7.2 and 7.3. The regions
were color-coded and displayed in region images embedded in the PerfusionAnalyzer. Fig-
ure 7.2 shows images of a 63-year-old woman who underwent mastectomy of the right breast.
Breast DCE-MRI revealed another lesion of the left breast. The lesion of 6 mm with oval shape
and sharp margin was classified as MR-BI-RADS 3. 3TP classes 4, 5, 7, and 8 occurred. The
lesion contained 3 regions suggesting homogeneity of a benign lesion. In follow up MRIs,
the lesion did not change and was considered to be a fibroadenoma. Figure 7.3 shows im-
ages of a 45-year old woman with newly diagnosed breast cancer. Breast DCE-MRI revealed
an additional lesion of 6 mm in a distance of 2 cm to the known tumor. The lesion had an
irregular shape and blurred margin and was classified as MR-BI-RADS 4. 3TP classes 4-9 oc-
curred indicating suspect strong enhancement and following wash-out. The lesion contained
41 regions, suggesting suspect heterogeneity. Histology revealed ductal carcinoma in situ, i.e.,
malignancy.
Several studies showed that the heterogeneity can be a helpful parameter, recall Section 4.2.
This first classification approach is important, since the heterogeneity analysis is missing in
current commercially available workstations. The presented first classification approach com-
bines five single descriptive perfusion parameters as well as takes the whole lesion into ac-
count. Hence, the analysis of the heterogeneity provided better results compared to the eval-
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Figure 7.2: Benign lesion, (a) subtraction image, (b) segmented subtraction image, (c) region
image, (d) RE curve view (image adapted and reprinted from [Preim et al., 2012] c© 2012,
Elsevier, with kind permission from Elsevier). The images show a lesion of 6 mm with oval
shape and sharp margin, which was classified as MR-BI-RADS 3. 3TP classes 4, 5, 7, and 8
occurred. The lesion contained 3 regions suggesting homogeneity of a benign lesion. In follow
up MRIs, the lesion did not change and was considered to be a fibroadenoma. (Medical image
data is courtesy of U. Preim, Municipal Hospital Magdeburg, Germany.)
uation of the enhancement kinetics. The results indicate that the evaluation of heterogeneity
is more robust and reliable. Another advantage of the region merging approach is that man-
ual ROI setting can be avoided. Although commercially available software tools can guide
manual ROI setting, they cannot avoid or replace it. Since the regions consist of voxels with
similar perfusion parameters, partial volume averaging due to adjacent necrotic tissue or nor-
mal tissue is prevented. Early strong contrast enhancement and following wash-out were not
capable to predict dignity. Although the 3TP class 7 (early strong contrast enhancement and
following wash-out) revealed significant differences between the groups with a sensitivity of
1.0, the specificity was very poor (0.13). This is in contrast to other studies [Kuhl et al., 1999,
Schnall et al., 2006, Hauth et al., 2008]. Also, the reported sensitivity and specificity rates for
the Göttinger score (recall Sect. 4.2.2) could not be achieved. However, a study of Williams
et al. [2007] also failed to show significant differences between benign and malignant lesions.
The results of this classification approach are influenced by a long acquisition time and poor
temporal resolution of the MRI data. Furthermore, the Breast Tumor Database 2009 mainly
consists of lesions with histology confirmed by biopsy. That means the included lesions were
suspicious enough to justify a biopsy. Thus, typical benign lesions were not included. Another
possible reason is, that with computer aided detection and a 3D analysis voxels with suspect
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Figure 7.3: Malignant lesion, (a) subtraction image, (b) segmented subtraction image, (c) re-
gion image, (d) RE curve view (image adapted and reprinted from [Preim et al., 2012] c©
2012, Elsevier, with kind permission from Elsevier). The images display an additional lesion
of 6 mm in a distance of 2 cm to a known breast cancer. The lesion had an irregular shape and
blurred margin and was classified as MR-BI-RADS 4. 3TP classes 4 - 9 occurred indicating
suspect strong enhancement and following washout. The lesion contained 41 regions, suggest-
ing suspect heterogeneity. Histology revealed ductal carcinoma in situ. (Medical image data
is courtesy of U. Preim, Municipal Hospital Magdeburg, Germany.)
curves are detected without fail. These curves could have been missed with the manual ROI
placement.
7.2.3 Findings of the Region Merging-Based Classification
In conclusion, the 3D quantification of the heterogeneity of small lesions detected in breast
DCE-MRI showed significant differences between benign and malignant lesions. The analysis
of heterogeneity was superior to the analysis of single perfusion parameters and enhancement
curve types. Therefore, despite of an overlap of the number of regions in benign and malignant
lesions, the quantification of the heterogeneity can be a helpful method in differential diagnosis
and should be further evaluated.
Based on the first results, indicating the opportunity of heterogeneity, two more classification
approaches are carried out with a strong focus on heterogeneity based on kinetic features.
Since margin and shape evaluation of tumors suffer from inter- and intra-observer variability
(as reported in [Wedegärtner et al., 2001]), these features are not further investigated. The
study by Sinha et al. [1997] reported better discriminative power for boundary features in
comparison to kinetic features and texture features. However, even with pre-defined choices
via a standard terminology, a considerable variability of morphologic features for breast tumor
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DCE-MRI description was reported by Stoutjesdijk et al. [2005]. This is also expressed by
aspect 5 of Chapter 4. Thus, the following classification approaches yield a more general
data analysis, which is also more independent of the manual evaluation by the clinical expert.
7.3 The Second Classification Approach Integrating
Density-Based Clustering
Despite the promising results of the clinical analysis of the first classification approach, the
classification of breast tumors solely based on DCE-MRI is a challenge in clinical research.
Therefore, the second classification approach, described in this section, focuses on distinguish-
ing between benign and malignant tumors based on kinetic features as well as considering the
tumor’s heterogeneity.
Since the RE curves of the individual voxels are noisy by nature, a major challenge lays in
grouping them to homogeneous and spatially contiguous regions. Thus, the extraction of the
MSRegion is improved. Voxels are grouped via three density-based clustering techniques that
have been adapted to partition a breast tumor into clusters. The MSRegion is chosen to bet the
most suspect cluster or region delivered by the most stable clustering algorithm. The presented
classification approach combines extracted features of the MSRegion as well as the tumor and
yields predictive tumor characteristics that hold for multiple tumors.
At the end of this section, preliminary results are listed that show that the classifier separates
between benign and malignant tumors and returns predictive attributes that are intuitive to the
clinical expert.
7.3.1 Adaption of Density-Based Clustering
In this section, the adaption of density-based clustering techniques is described. The RE plot-
ted over time yields RE curves. Similar to the first classification approach, the descriptive
perfusion parameters washin, washout, peak enhancement, integral, and time to peak are ex-
tracted. Since peak enhancement and integral strongly correlate, peak enhancement is ex-
cluded from the feature space that forms the basis for density based clustering.
The following density-based clustering algorithms were adapted to breast tumor perfusion
MRI:
• the Density-based Spatial Clustering of Applications with Noise (DBSCAN) algorithm
presented by [Ester et al., 1996],
• the Density-Connected Subspace Clustering (SUBCLU) algorithm introduced by [Kail-
ing et al., 2004], and
• the Ordering Points to Identify the Clustering Structure (OPTICS) presented by [Ankerst
et al., 1999].
The algorithms separate objects into clusters based on estimated density distributions and were
described in more detail in Section 3.3.
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These density-based clustering algorithms yield clusters with arbitrary shapes, instead of re-
stricting the cluster shape to convex objects. This is very advantageous for irregular and het-
erogeneous tumor parts. Objects that do not feature similar objects (i.e., objects with similar
parameters) in a given neighborhood are marked as outliers. That is a further advantage, since
outliers may be caused by a missing inter-voxel-correspondence over time due to motion arti-
facts. Based on these two advantages, density-based clustering approaches are well suited for
breast tumor perfusion clustering.
Each voxel of a tumor is interpreted as a data object and the descriptive perfusion parameters
are employed as attributes. Each of the three algorithms requires two parameters: the mini-
mum number of points to build a cluster MinPoints and the maximum radius ε defining the
neighborhood of a point. Since no automatic generation of MinPoints was available, MinPoints
is empirically set to 4, 6, and 8. The calculation of ε depends on the clustering algorithm. All
clustering algorithms were implemented in MATLAB.3
Adaption of DBSCAN. For the DBSCAN algorithm and each MinPoints value ∈ {4,6,8},
ε was automatically determined as suggested in [Daszykowski et al., 2001]. Hence, an ar-
tificial data set is generated based on the original data. The artificial data set exhibits the
same dimensionality in the feature space, but a uniform distribution (within the original data’s
range). Then, the k-distance is extracted for each of the artificial objects. The k-distance
is the distance from an object to its k nearest neighbors. When setting k = MinPoints, then
each artificial object’s k-distance is sorted, an ε is assigned to the 95% quantile of all sorted
k-distances.
Adaption of SUBCLU. For SUBCLU, ε was extracted from the k-distances graph that maps
the k-distance of an object to its k next neighbors [Ester et al., 1996]. Thus, objects that form
clusters, exhibit smaller values for k-distance than outliers. In the k-distances graphs, the
k-distances are sorted, i.e., the object with the smallest k-distance is mapped first. The best-
suited ε can be found where the k-distance graph has an increasing slope, see in Figure 7.4.
Thus for each MinPoints value, a k-distance graph was created (with k = MinPoints) for all four
perfusion parameter sets. The ε value is automatically determined by choosing the point with
the largest distance perpendicular to a line g connecting the first and the last point of the graph
(see Fig. 7.4). This approach was well suited for the employed database. However, for a more
general approximation for ε , the L-method by Salvador and Chan [2004] can be employed. It
detects the knee in a graph and achieved similar results for the Breast Tumor Database 2009.
After extracting four values for each descriptive perfusion parameter, ε was assigned to the
mean. Since the SUBCLU algorithm analyzes subspaces of the data, the ε values were es-
timated based on the one-dimensional perfusion parameter sets. The ε approximation based
on the k-distances graph was empirically tested, and yielded better results for the SUBCLU
algorithm than the ε approximation employed for the adapted DBSCAN.
Adaption of OPTICS. For OPTICS, ε was empirically set to 0.5 and 0.75 for the first
classification approach. For a more expanded analysis, the OPTICS parameter choice was
refined, which will be explained in more detail in Section 7.4.1.
3Product of the MathWorks, Natick, USA; www.mathworks.de/products/matlab/ (12/08/2013)
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Figure 7.4: Determination of ε: for an example data set (a small breast tumor with ≈ 220
voxels) the k-distances graph for a MinPoints value equal to 4 was extracted (image adapted
and reprinted from [Glaßer et al., 2013b] c© 2013, Springer-Verlag, with kind permission from
Springer Science and Business Media). The graph maps the distance of an object to its k next
neighbors (with k = MinPoints). A well suited ε can be detected at a position with increased
slope, i.e., the point with a maximum distance perpendicular to g. Objects with a k-distance
≤ ε will be assigned to clusters, otherwise they are classified as noise.
7.3.2 Extraction of the MSRegion
The actual classification approach strongly focuses on the most suspect tumor part, i.e., the
MSRegion. The MSRegion is extracted via density-based clustering over the descriptive per-
fusion parameters, taking also the 3TP classification in account, see Figure 7.5.
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Figure 7.5: Schematic overview of the second classification approach. First, each tumor’s
MSRegion is extracted from the density-based clustering results. Second, a classifier is learned
to predict malignancy.
With MinPoints ∈ {4,6,8}, and the parameter choices described in the previous Section 7.3.1,
twelve clustering results per data set are obtained: three configurations for DBSCAN and
SUBCLU and six configurations for OPTICS. Connected component analysis is applied to the
clustering results such that a cluster that contains spatially not connected groups is split into
these groups yielding only spatially connected voxels per region.
To select the MSRegion, the clustering with the least outliers is chosen. Next, all regions that
contain less than three voxels are rejected. From the remaining regions, the largest region
with an average RE curve of 3TP class 7 is declared as MSRegion. If no such region exists,
a search is carried out for the biggest region with average RE curve 3TP class 9, 8, 4, 6, 5, 1,
3, 2 in that order. Although this is a user-defined ranking, this empirical ranking worked well
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for all tested data sets and is furthermore based on definitions of the most malignant tumor
enhancement kinetics: a present washout in combination with a strong washin.
7.3.3 Feature Selection Including Purity, Jaccard Coefficient and F1
score
For the classification step of the second classification approach, a number of features is ex-
tracted. The selection of features is based on the results of the first classification approach.
Thus, features describing the boundary of the tumor are excluded and the focus is set on ki-
netic and heterogeneity-based features. Similar to the first classification approach, patient’s
age and lesion size is kept. In contrast to the first approach, the tumor size is automatically
extracted as 3D volume in mm3.
Hence, data enrichment is carried out by including attributes of the tumor and its MSRegion.
To strengthen the influence of the tumor’s heterogeneity
• the purity P,
• the Jaccard coefficient J, and
• the F1 score
are employed as heterogeneity measurements. The approximation of P, J, and F1 are explained
in the following. As a result, all employed features are listed in Table 7.6.
To extract the heterogeneity measurements, the clustering result is compared with the 3TP
classes yielding a supervised evaluation method. The three criteria will be described in more
detail in the following. Hence, the term class is employed for a group of voxels that belong to
the same 3TP class, i.e., which exhibit RE curves with the same 3TP class. The term region is
employed for a group of spatially connected voxels that were derived from the density-based
clustering result. The measurements P, F1, and J are employed as external validation indices,
since their values are based on the extra knowledge about the data, i.e., the 3TP classes.
The Jaccard coefficient J. The value for the Jaccard coefficient (J) can be determined by:
J =
f11
f01+ f10+ f11
, (7.1)
where f01 denotes the number of pairs of voxels of different classes but the same region, f10
denotes the number of pairs of voxels of the same class but different regions, and f11 denotes
the number of pairs of voxels of the same class and the same region. The value of J lies in the
interval [0,1]. Higher values indicating a better result, i.e., a higher match of 3TP classes and
clustering result.
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Table 7.6: Features for the second classification approach.
Features of MSRegion
1 TumorSize size (in mm3).
2 #RegVoxel Number of voxels of the MSRegion.
3 RelRegSize The percentaged MSRegion size (with respect to the tumor size).
4..
6
P, J, F1 The value for P, J, and F1 based on the 3TP class division and the
clustering result.
7..
9
Poutlier, Joutlier,
F1outlier
The value for P, J, and F1 based on the 3TP class division and the
group of all outliers of the chosen clustering.
10..
14
REt The MSRegion average RE value at time step t, t = 2..6
15 Integral The average value for the parameter integral.
16 Washin The average value for washin.
17 Washout The average value for washout.
18 TTP The average value for time to peak.
19 3TPregion The 3TP class of the MSRegion’s average RE curve.
20..
28
#Voxels3TP(1..9) Number of MSRegion voxels that have a 3TP curve 1..9.
29 #Present3TP Number of different 3TP classes existing in the MSRegion.
30 Majority3TP 3TP class with the most voxels in the region.
31..
33
PMSRegion,
JMSRegion,
F1MSRegion
The value P, J, and F1 based on the 3TP class division and the
MSRegion.
34 #R3TP(7) The number of regions with an average RE curve classified as 3TP
class 7.
35 age Age of patient.
The F1 score. The value for the F1 score (also called F - measure) is based on the values
precision and recall:
F1 =
2 · precision · recall
precision+ recall
, and (7.2)
precision =
f11
f11+ f10
, with (7.3)
recall =
f11
f11+ f01
. (7.4)
Likewise to the domain of J, the values of F1 lie in the interval [0,1] and values equal to 1 are
the best possible result.
The Purity P. The purity P approximates the amount of pairs of voxels of a region that belong
to the same class. Hence, pi j denotes the probability that a voxel of region i exhibits the 3TP
class j:
pi j =
mi j
mi
, (7.5)
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where mi is the number of voxels in region i and mi j is the number of voxels in region i that
have the 3TP class j. Next, the purity pi for region i is extracted by choosing the highest value
of pi j, i.e., over all 3TP classes j and employed to extract P:
pi = max
j
pi j, and (7.6)
P =
K
∑
i=1
mi
m
pi, (7.7)
where m is the number of voxels of all regions, i.e., the whole tumor. A P value equal to
1 means that for each cluster of a clustering result, all voxels exhibit the same 3TP class.
Features covering the values for P, F1, and J are employed for the further classification step.
As it can be interfered from Table 7.6, the value for P, J, and F1 are extracted based on the
comparison between:
• the whole clustering result and the 3TP classification of the tumor, see Table 7.6(4) - (6),
• the group of outliers and the 3TP classification of the voxels belonging to this group, see
Table 7.6(7) - (9),
• the MSRegion and the 3TP classes of the MSRegion’s voxels, see Table 7.6(31) - (33).
7.3.4 Experimental Settings and Results
In contrast to the first classification approach, where ROC and AUC analysis was employed
(recall Sect. 7.2), for the following classification approaches a decision tree is created. The
decision tree is a supervised learning method, i.e., a model that is employed for classification.
Each tumor of the Breast Tumor Database 2009 forms an item, the extracted features are the
attribute values and the class label is extracted by the report. Then, the decision tree model is
constructed from the study by dividing the database into training and test set. The decision tree
classifier has the strong advantage of being human-readable. Furthermore, it reveals the most
important features, i.e., features that are closer to the root. Thus, it allows for identification of
features with high discriminative power for clinical practice. Decision trees are very similar to
diagnostic algorithms medical physicists and in particular radiologists are familiar with since
they are frequent parts of medical publications and guidelines. The decision tree is usually
visualized as node-link diagram and each internal node represents a test on a feature (e.g., a
feature of Tab. 7.6). The test results are represented via the links between the nodes. Finally,
each leaf node contains a class label.
For the presented approach, the J4.8 classification algorithm was employed to learn a decision
tree classifier. The J4.8 algorithm is based on the C4. 5 decision tree classification [Quinlan,
1993] and integrated in the Waikato Environment for Knowledge Analysis (Weka) library -
a Java software library that encompasses algorithms for data analysis and predictive model-
ing [Holmes et al., 1994]. It performs 10-fold or 5-fold cross validation and requires at least
two instances (two tumors) for each tree leaf. Cross validation means that for a k-fold cross
validation the database is splitted into k equally-sized partitions [Tan et al., 2006]. Then, k
runs are carried out. During each run, one of the partitions is employed for testing, and the
remaining ones are used for training. The total error of the k-fold cross validation is extracted
by summing up the error for each run.
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As a result, the second classifier was obtained, see Figure 7.6. Hence, the decision tree is
presented as node-link diagram. A test (or a range of values) is assigned to each internal node
where the links represent the test value. The leaf nodes contains the class labels, i.e., benign
and malignant.
The C4. 5 decision tree classifier [Quinlan, 1993] employs 18 of the original ca. 40 features.
The evaluation criterion is the number of Correctly Classified Instances (#CCI). The best de-
cision tree employs eight features only, namely the features (5), (8), (12), (17), (25), (28), (30),
and (35) of Table 7.6. It yields a #CCI of 46 of the 68 (67.65%) lesions. 22 (32,35%) instances
were classified incorrectly. The true positive (TP) and false positive (FP) rate are:
• for benign tumors: TP = 0.548 and FP = 0.216, and
• for malignant tumors: TP = 0.784 and FP = 0.452.
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Figure 7.6: Learned decision tree: the attributes at the upper part of the tree, i.e., close to the
root, are the most important ones since they influence the classification of more objects than
attributes at the lower part.
Features closer to the root of the tree are more important than those at lower levels, because the
former help in splitting a larger set of tumors. Very important is the fact that the most important
attributes are the heterogeneity of the tumor, represented by JTumor and JOutlier, and the age of
the patient. The most prominent 3TP class, the number of voxels in the 3TP class 9 (#(3T P9))
and 6 (#(3T P6)), the contrast agent washin (RE(t3)), and washout are also important.
7.3.5 Findings of the Density-Based Classification
In the presented classification approach, a novel combination of within-tumor clustering and
tumor classification to predict tumor malignancy was carried out yielding preliminary results
on the Breast Tumor Database 2009 with 68 breast tumors. These first results indicate that the
identification of the most suspect region or tumor part with clustering and the exploitation of
this region’s features in classification are promising steps in tumor separation. The focus of
the second classification approach was the kinetic features of the tumor.
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The low sensitivity of the results must be attributed to the specific tumor type, for which
it is difficult to distinguish between benignity and malignancy. The next step examines how
features of clusters derived from different clustering algorithms affect the discriminative power
of a classifier.
7.4 The Third Classification Approach Including
Ensembles
Since the intermediate results indicate a relationship between tumor heterogeneity in terms of
contrast enhancement kinetics and malignancy, this work is extended by learning classifiers
on different sets of derived features. This means, it is analyzed how the formation of regions
of similar voxels contributes to distinguishing between benign and malignant tumors. Hence,
the focus is set on features of an MSRegion found through clustering, rather than the features
of all clusters, i.e., the whole lesion. This classification approach aims at answering the re-
search question: Is it feasible to automatically assess tumor malignancy by identifying and
characterizing the tumor’s most suspect (i.e., malignant) region?
As expected, such an approach would be sensitive to the (clustering) algorithm that forms the
regions. Therefore, not only the density-based clustering algorithms were employed, but also
different MSRegions were extracted. Thus, it is possible to study how the formation of regions
of similar voxels contributes to distinguishing between benign and malignant tumors. The
MSRegions’ features are employed to train different classifiers and combine them into ensem-
bles. The different kind of classifiers exploit different combinations of features for learning.
As a result, features are determined that contribute to the classification and should therefore
be considered in clinical practice. To make the results comparable, the same database, i.e., the
Breast Tumor Database 2009 is employed (recall Sect. 7.1). In Figure 7.7, the three phases of
the extended classification approach are illustrated.
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Figure 7.7: Schematic overview of the presented approach (image adapted and reprinted from
Glaßer et al. [2013a] c© IEEE 2013 with kind permission from IEEE). In phase I, several clus-
tering runs are carried out (I.a) to form regions (I.b), of whom the MSRegions were selected
(I.c). Second, for each MSRegion features were extracted for data enrichment (II). In phase
III, learners over the set of all tumors and their MSRegions are trained.
In phase I, several clustering runs employing density-based clustering algorithms with different
parameter settings are performed. For each run, voxels that exhibit similar perfusion character-
istics are grouped into clusters (I.a). Then, clusters with spatially non-connected parts are split
into spatially connected regions (I.b). Finally, the MSRegion per clustering type is selected
(I.c). This step will be described in Section 7.4.1.
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In phase II, a set of features that reflect the homogeneity of the region is extracted. Informally,
a region is homogeneous if all its voxels exhibit the same washin / washout behavior. Hence, a
region consisting only of 3TP class 8 voxels is more homogeneous than one with voxels from
3TP classes 7 and 8. The extraction of this feature set will be described in Section 7.4.2.
In phase III, classifiers are trained on subsets of the features extracted from the data in phase
II. Since phase I delivers one MSRegion per clustering run on the same tumor, the classifiers
are combined and each of them considers the MSRegion of a different clustering run and
predicts tumor malignancy (the label). A combination of such classifiers is an ensemble, which
collectively decides on the label of a tumor by majority voting; each ensemble member has
one vote. The classifier specification will be provided in Section 7.4.3.
7.4.1 Extended Extraction of MSRegions
For the subsequently applied tumor classification, a set of MSRegions is extracted and the clas-
sification features are derived from this set later on. The adaption of density-based clustering
is almost identical to the previous approach. The segmentation of the voxels belonging to the
breast tumor was carried out with the PerfusionAnalyzer. Next, the four descriptive perfusion
parameters washin, washout, time to peak, and integral were extracted. As it was reported
in Section 7.3.1, values for peak enhancement and integral were correlating. For autoscaling,
z-scoring was applied, which was described in Section 3.4.2. The DBSCAN algorithm and the
SUBCLU algorithm were adapted as described in Section 7.3.1. However, for OPTICS, more
parameter choices were employed. Hence, ε was experimentally determined by successively
applying 20 potential ε values (in the range from 0.05 to 2) to the clustering algorithm. If a
OPTICS run for one of the 20 values showed the best result compared to the 19 other ones, the
score of this ε value was incremented. To assess the quality of a run, the sums of weighted val-
ues for Jaccard coefficient, F1 score and Purity were computed based on the actual clustering
and the 3TP division. Then, the two best ε values were picked.
Again, with MinPoints ∈ {4,6,8}, twelve configuration for clustering algorithms are obtained:
three configurations for DBSCAN and SUBCLU and six configurations for OPTICS. Also,
clusters that cover spatially not connected voxels (w.r.t. an 18 neighborhood) are split into
different groups of spatially connected voxels.
Next, for each clustering algorithm type (i.e., DBSCAN, SUBCLU, and OPTICS), the best
clustering result is selected by choosing the clustering result with the least outliers. Thus, the
three best clustering runs ADB, ASC, and AOP are obtained. From the results of ADB, ASC, and
AOP, all regions that contain less than three voxels are rejected. From the remaining regions,
the largest region with an average RE curve of 3TP class 7 is chosen. If no such region exists,
a search for the 3TP class 9, 8, 4, 6, 5, 1, 3, and 2 in that order, is performed. Although this
is a user-defined ranking, this empirical ranking is based on definitions of the most malignant
tumor enhancement kinetics: a present washout in combination with a strong washin. Thus,
for each tumor and each clustering type (i.e., for ADB, ASC, and AOP) the three most suspect
regions MSRegionDB, MSRegionSC, and MSRegionOP are extracted.
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7.4.2 Extended Feature Selection
The complete feature space describing a patient’s tumor is based on the actual MSRegion and
the tumor attributes. Hence, the following sets of features are obtained:
• the features concerning the MSRegion’s size for each of the clusterings ADB, ASC, and
AOP (listed in Tab. 7.7),
• the features concerning homogeneity of these clusterings (listed in Tab. 7.8), and
• the features on washin and washout behavior based on the MSRegion and the corre-
sponding clustering (listed in Tab. 7.10) as well as
• features associated with the whole tumor (listed in Tab. 7.9).
Table 7.7: Features of the MSRegion of a clustering; these features reflect the region size.
General features of MSRegion
1 #RegVoxel Number of voxels of the MSRegion for a given clustering.
2 RelRegSize The percentaged region size (with respect to the tumor size).
Table 7.8: Homogeneity features over the regions of a clustering.
Features on Homogeneity and 3TP Class
1 P Purity value based on the comparison of the 3TP class division and
a given clustering.
2 J Jaccard coefficient based on the 3TP class division and a given
clustering.
3 F1 F1-score value based on the 3TP class division and a given cluster-
ing.
4 #R3TP(7) The number of regions with an average RE curve classified as 3TP
class 7.
Table 7.9: Listing of global tumor features.
Global Tumor Features
1 #Voxel Number of tumor voxels.
2 age Age of patient.
7.4.3 Extended Classifier and Ensemble Specification
Based on the presented feature set, three base classifiers L1 - L3 for the three most suspect
regions MSRegionDB, MSRegionSC, and MSRegionOP are defined. Next, the intersection of
these three regions is extracted yielding the MSRegion∩. The MSRegion∩ is the starting point
for the fourth base classifier L4. Furthermore, L1-L4 are combined into two more classifiers:
L5 and L6. The detailed description of L1-L6 is listed in Table 7.11. Each of these classifiers
learns a decision tree.
The analysis is extended to combinations of classifiers into the ensembles C1(a)−C1(d) de-
scribed in the upper part of Table 7.12. Finally, two baseline classifiers C2 and C3 are learned
that assign the label according to some intuitive but simplistic rule (see lower part of Tab. 7.12).
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Table 7.10: Selection of washin and washout features for the MSRegion.
Washin and Washout Features for the MSRegion
1 REt3 The RE at the third time step.
2 Integral The average value for the parameter integral.
3 Washin The average value for washin.
4 Washout The average value for washout.
5 TTP The average value for time to peak.
6 3TPregion The 3TP class of the region’s average RE curve.
7..
15
#Voxels3TP(1..9) Number of region voxels that have an 3TP curve 1..9.
16 #Present3TP Number of different 3TP classes existing in the region.
17 Majority3TP 3TP class with the most voxels in the region.
Table 7.11: Table of learners L1 - L6.
Decision Tree Classifiers
L1 All features of the MSRegionDB of Table 7.7-7.10 are applied.
L2 All features of the MSRegionSC of Table 7.7-7.10 are applied.
L3 All features of the MSRegionOP of Table 7.7-7.10 are applied.
L4 All features of the MSRegion∩ (Tab. 7.10), all tumor attributes (Tab. 7.9) and
region size attributes (Tab. 7.7) are applied.
L5 Two features from each of the four MSRegions of L1 - L4 are applied: the
region’s size (Tab. 7.7(2)) and average 3TP class (Tab. 7.10(6)).
L6 Extension of L5. For each of the four MSRegions (of L1− L4) the relative
region size (Tab. 7.7(2)) and average 3TP curve (Tab. 7.10(6)) is used. For the
clustering with the least outliers from ADB, ASC, and AOP, the homogeneity
measures (Tab. 7.8)(1)-(3) are extracted. Also, the tumor attributes are used
(Tab. 7.9).
7.4.4 Experimental Settings and Results
The learners and classifiers were applied to the data sets to study the influence of the different
clusterings and features. Again, the evaluation criterion is the number of correctly classified
instances #CCI. Hence, the specificity and sensitivity are considered as less important, because
the Breast Tumor Database 2009 lacks of typical benign tumors. Thus, the sensitivity and
specificity measures would be misleading, as it was also indicated by the previous classification
result (see Sect. 7.3.5).
Hence, the same experimental setup was created, applying again the Weka library and the
included J4.8 decision tree classification algorithm (recall Sect. 7.3.4). To create a classifier
covering a strong variety of features, three runs were carried out.
In the first run, the classification algorithm was applied to all complete attribute sets. For the
second run, feature subsets of L1-L6 were mined to optimize the achieved #CCI value. For
feature subset search, two approaches were adapted, yielding run 2(a) and run 2(b), based on
methods already available in Weka:
a) The information gain of each attribute in all respective feature sets is evaluated. An
attribute is excluded if its information gain is zero.
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Table 7.12: Table of classifiers C1 (C1(a)−C1(d)), C2, and C3 based on L1 - L6 from Tab. 7.11.
Ensemble Classifiers C1(a)−C1(d)
The classifiers C1(a) - C1(d) carry out a majority voting based on their inputs. If
50% of each classifier’s inputs predict malignancy, then the classifier labels the
tumor as malignant.
The following inputs (based on Tab. 7.11) are employed:
C1(a) C1(a) was created from L1−L6.
C1(b) C1(b) was created from L1−L5.
C1(c) C1(c) was created from L1−L4 and L6.
C1(d) C1(d) was created from L1−L4.
Rule-based Classifiers C2 and C3
C2 Labels the tumor based on the MSRegion∩. If its average curve type equals
3TP class 1, 4, or 7 the tumor is labeled as malignant. Otherwise it is labeled
as benign.
C3 If the number of voxels with an RE curve classified as 3TP class 1, 4, or 7
is greater or equal to 3 then the tumor is labeled as malignant. Otherwise it
is labeled as benign.
b) The wrapper approach, described in [Kohavi and John, 1997], is used to neglect irrele-
vant attributes. It delivers an attribute subset with the highest possible accuracy.
Since age and #Voxel show a high significance to almost every constructed decision tree, the
third run investigates the impact of these two global tumor attributes on the classification re-
sults. Therefore, the full attribute set is applied initially. Next, the classification is conducted
such that the features age, #Voxel, or both were excluded. It becomes apparent that their influ-
ence on #CCI is very high. The restriction to attributes of the MSRegion only (run 3) results
in a drastic decrease of maximum and average #CCI.
In the following, the results for each run are described. For the first run, L2 yields the best
decision tree and achieves 53 of 68 (≈ 78%) #CCI. Hence, the attributes Majority3T P, age,
and #Voxel are employed.
The second run covers the runs 2(a) and 2(b). For the run 2(a), the maximum #CCI is 50
(≈ 74%), achieved by L2, C1(b), and C1(d). L2 is based on the MSRegionSC. The decision
tree of L2 contains the attributes JSC, F1SC, 3TPregion, Majority3TP, and age. For the run 2(b),
L2 also yields the best result with #CCI= 56 (≈ 82%). This is the overall maximum of all runs
as well. The corresponding decision tree (see Fig. 7.8(a)) consists of the attributes Majority3TP,
age, and #Voxel. Both runs 2(a) and 2(b) yield an increased number of average #CCI.
The best tree solely based on MSRegion features (run 3) was produced by L4 and yields 45
(≈ 66%) #CCI, see Figure 7.8(b). The two baseline classifiers C2 and C3 achieved 33 (≈ 49%)
#CCI and 38 (≈ 56%) #CCI, respectively. Thus, simple rules of thumb are not adequate to
predict malignancy of lesions on this difficult data set.
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Figure 7.8: The presented decision tree in (a) achieved the best #CCI value. The decision tree
in (b) is the best among the classifiers that did not consider the features age and #Voxel.
7.4.5 Findings of the Extended Classification Analysis
In this section, the third classification approach, which is an extension of the second ap-
proach, has been presented. Thus, density-based clustering algorithms with slightly different
parametrizations have been employed and the same database, i.e., the Breast Tumor Database
2009, was used for training of different classifiers. Hence, the focus relied on the cluster-
ing, i.e., how the formation of similar regions of similar voxels contributes to distinguishing
between benign and malignant tumors. As a result, it has been shown that for the final classifi-
cation step only a few features have to be employed. Another finding is the influence of patient
age and tumor size. Both attributes strongly correlate with tumor malignancy and thus prove
the challenges of automatic DCE-MRI breast tumor classification solely based on perfusion
data. However, the presented analysis identified features that correspond to tumor heterogene-
ity (i.e., Jaccard coefficient and Purity) and are also suited to predict malignancy.
In conclusion, the adapted specific density-based clustering is much more important for clas-
sification instead of the extraction of complex ensembles. The analysis yields a feature set that
is best suited to automatically determine tumor malignancy. This feature set has a much higher
discriminative power than simple rules of thumb, i.e., the two baseline classifiers C2 and C3.
Finally, the features of the MSRegion alone cannot distinguish between benign and malignant
tumors, yet the properties of this region are indicative for tumor malignancy for the data set
of the Breast Tumor Database 2009. The presented classification approach is still limited by
the number of tested tumor data sets and the techniques as well as the feature sets should be
applied to a larger study. Furthermore, the tumors of this database are hard to classify even for
a human expert (recall also the limitations described in Sect. 7.1.5).
7.5 The Fourth Classification Approach in the Spectral
Domain
As it was demonstrated by the previous classification approaches, the clustering result of breast
tumors strongly depends on the chosen clustering algorithm and its parameter settings. The
goal of the adapted spectral clustering approach is an improved spatial connectivity of the re-
maining regions. In theory, the most homogeneous clusters may be formed by voxels that are
not spatially connected. This case may occur with the presented density-based approaches in
Section 7.3 and Section 7.4. In practice, the clinician demands spatially connected voxels to
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form a ROI for further diagnosis like core needle biopsy. With the presented fourth classifica-
tion approach in the spectral domain, the clustering result is improved in a qualitative way by
sorting only spatially connected voxels into clusters.
7.5.1 Adaption of k-Means Clustering in the Spectral Space
Like the previous classification approaches, the clustering is applied to the normalized (via
z-scoring) perfusion parameters peak enhancement, time to peak, washin, and washout. Based
on the descriptive perfusion parameters per voxel, a spectral clustering is applied.
Spectral clustering carries out a dimension reduction, i.e., the objects are transformed into
the spectral domain, recall Section 3.4.3. In this new representation, clusters can be easier
separated (regarding the high-dimensional space) by applying simple clustering techniques
like k-means.
For the presented approach, the Ng-Jordan-Weiss Algorithm is employed to directly partition
the data into k groups. The similarity graph is constructed based on the descriptive perfusion
parameters. Each node of the graph represents a voxel of the corresponding breast tumor.
Hence, the tumor data are represented in a regular orthogonal 3D grid and each node is con-
nected to its adjacent nodes within a 26-neighborhood. This is a crucial part during clustering
process since the 26-neighborhood maintains clusters with spatially connected voxels. As
proposed by Von Luxburg [2007], the Gaussian similarity function is employed:
s(xi,x j) = exp
(
−dist(xi,x j)
2σ2
)
to represent the local neighborhood relationships. The distance dist(xi,x j) between two voxels
xi and x j is measured by using the cosine similarity of their corresponding perfusion parameter
values [Tan et al., 2006]:
dist(xi,x j) = cos(xi,x j) =
xi · x j
‖xi‖‖x j‖ . (7.8)
This distance function yields best clustering results w.r.t. the internal cluster indices that will
be presented in the following. The scaling parameter σ describes how rapidly the affinity
decreases with the distance between xi and x j. Instead of manually selecting σ , the approach
by Zelnik-Manor and Perona [2004] is employed to calculate a local scaling parameter for
each data point. Hence, the number neigh of neighbors that should be considered to compute
this scale has to be determined. For the presented approach, neigh is empirically determined,
i.e., different values for neigh are used. Afterwards the neigh which yields the best clustering
result is selected. To assess the clustering result’s quality, three internal cluster validation
measurements are extracted [Rendón et al., 2011]:
• the Davies-Bouldin index,
• the Dunn index, and
• the Calinski-Harabasz index.
In contrast to external validation indices, internal cluster validation evaluate the clustering
result with respect to the information intrinsic to the data alone.
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The Davies-Bouldin Index. The Davies-Bouldin index DB is a measure for the average
similarity between each cluster and its most similar cluster. It is approximated as [Davies and
Bouldin, 1979]:
DB =
1
N
N
∑
i=1
Ri, (7.9)
where Ri is the similarity between each cluster and its most similar cluster ci, i.e.:
Ri = max j=1..N,i, j{Ri j},
Ri j =
si+ s j
d(vi,v j)
, and
si =
1
mi
mi
∑
k=1
d(xk,vi),
where si denotes the scatter within cluster ci, mi refers to the number of voxels in cluster i, vi
refers to the centroid of cluster i, N to the number of clusters, and x to a data element, i.e., a
voxel. The smaller the value of DB is, the better is the clustering result, i.e., the clusters are
well separated.
The Dunn Index. The Dunn index is a measure for the smallest cluster distance in relation
to the largest intra-cluster distance in a clustering result. Several variations of this index have
been proposed. Hence, the Dunn index is computed by [Dunn, 1973]:
Dunn =
mini=1..N
{
min j=1..N,i, j d(ci,c j)
}
maxk=1..N diam(ck)
,with (7.10)
d(ci,c j) = min
x∈ci,y∈c j
{dist(x,y)}, and
diam(ci) = max
x,y∈ci
{dist(x,y)}.
Here, ci and c j refer to the clusters i and j. Larger values of the Dunn index indicate a better,
i.e., compact and well-separated, clustering result.
The Calinski-Harabasz index. The Calinski-Harabasz CH index [Calin´ski and Harabasz,
1974] is calculated by:
CH =
SSB
SSW
·M−N
N−1 , (7.11)
where SSB and SSW refer to the sum of squared distances between the clusters and the sum of
squared distances within a cluster, respectively. They are calculated by:
SSW =
N
∑
i=1
Mi
∑
j=1
d(x j,vi)2
SSB =
N
∑
i=1
(Mi ·d(vi,v)2).
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Here, M is the number of all voxels, Mi is the number of voxels in cluster ci, vi is the centroid
of cluster ci, v is the centroid of the whole data set. Larger values of the Calinski-Harabasz
index indicate a better clustering result (larger values for SSB and smaller values for SSW yield
increased inter- but reduced intra-cluster variances).
For the empirical determination of neigh, it is varied in the range of [3 . . .11]. Best results
w.r.t. the three internal cluster validation indices are obtained for neigh = 3, see Figure 7.9.
Next, an automatic approximation of the number of clusters k is carried out. Several methods
to automatically determine k have been proposed, e.g., a look for the eigengap. Unfortunately,
the tumor data sets of the Breast Tumor Database 2009 are noisy due to their small size and
this criterion becomes less effective. Therefore, the three internal cluster validation indices
are employed again. For each data set, the spectral clustering is computed several times with
different number of clusters k (k ∈ {3..9}) and the optimal k is selected according to the valida-
tion indices via majority voting. If no majority exists, the Davies-Bouldin index is considered,
as suggested by Rendón et al. [2011].
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Figure 7.9: Result of the average Davies-Bouldin (DB), Dunn, and Calinskie Harabasz (CH)
index for a varying number of neighbors (n∈ {3,5,7,9,11}) and a fixed cluster number. For
n=3, all indices show good results (a minimal DB, a maximal Dunn, and a maximal CH index).
In summary, the distance function dist(xi,x j) detects similar descriptive perfusion parameter
values and the 26-neighborhood yields the spatial connectivity of voxels in a cluster. With the
internal cluster validation indices, automatic parameter choices are extracted for neigh, i.e., a
local scaling parameter and the cluster number k.
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7.5.2 Feature Selection
Based on the spectral clustering result, features are extracted to learn a classifier. Hence, the
feature selection is closely adapted to the previous feature selection of the second and third
classification approach. Likewise, one cluster is chosen as most suspect region MSRegion.
Therefore, the 3TP class ranking is employed for the obtained clusters. The largest cluster
with an average RE curve of 3TP class 7 is chosen. If no such cluster exists, a search for
the 3TP class 9, 8, 4, 6, 5, 1, 3, and 2 in that order, is performed, recall the description in
Section 7.4.1.
From the MSRegion the following features for each tumor are extracted (see also Tab 7.13):
• biological features, i.e., age and tumor size in mm3,
• features of the MSRegion and its average RE curve, i.e., washin, washout, integral, time
to peak, and 3TP class as well as the percentage region size (when compared to the
whole tumor), and
• the number of clusters, the separability (i.e., the inter-cluster variance) and the homo-
geneity (i.e., the averaged intra-cluster variance) of the clustering result (see [Zhao et al.,
2009] for more information), and
• the similarity measures Purity P, Jaccard index J, and F1 score based on the comparison
of the clustering result and the 3TP method classification of all tumor voxels.
Table 7.13: Features for the fourth classification approach.
Features of MSRegion
1 size size (in mm3).
2 age Age of patient.
3 RelRegSize The percentaged MSRegion size (with respect to the tumor size).
4..
6
P, J, F1 The value for P, J, and F1 based on the 3TP class division and the
clustering result.
7..
11
REt The MSRegion average RE value at time step t, t = 2..6
12 Integral The average value for the parameter integral.
13 Washin The average value for washin.
14 Washout The average value for washout.
15 TTP The average value for time to peak.
16 Majority3TP 3TP class with the most voxels in the region.
17 #cluster The number of clusters.
18 Separability The inter-cluster variance.
19 Homogeneity The intra-cluster variance (average of all clusters).
7.5.3 Experimental Settings and Results
The adapted spectral clustering approach was employed for all tumor data sets of the Breast
Tumor Database 2009. For the classification based on the spectral clustering approaches, the
same experimental setup was employed, i.e., the Weka library and the included J4.8 decision
tree classification algorithm (recall Sect. 7.3.4). Again, the evaluation criterion is the number
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of correctly classified instances #CCI. Also, the specificity and sensitivity are considered as
less important, because the data set lacks of typical benign tumors and these measures would
be misleading, as it was also indicated by the previous classification result (see Sect. 7.3.5).
In Figure 7.10, the learned classification model with the best results, i.e., highest #CCI is
depicted.
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Figure 7.10: Learned decision tree: the attributes at the upper part of the tree are the most
important ones (image adapted and reprinted from [Glaßer et al., 2014b] c© 2014, Springer-
Verlag, with kind permission from Springer Science and Business Media).
The best decision tree correctly classifies 56 of 68 tumors, i.e., 82.24%. Inherent to decision
trees, the most important features are at top levels, i.e., closer to the root, since they split a
larger set of tumors. Hence, the feature patient age was employed as most important fea-
ture. However, all other attributes characterize the tumor’s heterogeneity and kinetic contrast
enhancement behavior.
7.5.4 Findings of the Fourth Clustering Approach
The contribution of the fourth classification approach is the adaption of spectral clustering
to breast DCE-MRI tumors. To be more precise, k-means was carried out in the spectral do-
main of the descriptive perfusion parameter space extracted from breast tumor voxels and their
RE curves. For the employed algorithms, automatic parameter choices were provided for the
input parameters. The learned classifier achieves classification results that can be ordered be-
tween the second and the third classification approach. However, it has the great advantage
that spatially connected homogeneous regions are obtained. In Figure 7.11, an example of the
clustering result is presented. This is in contrast to the approaches described in Sections 7.3
and 7.4 where a connected component analysis is necessary to guarantee spatial connectiv-
ity. When compared to the first classification approach described in Section 7.2, the similarity
function of the spectral clustering is better suited, since the constructed similarity graph com-
pares each voxel. The region merging averages the parameter values over all voxels that are
contained in one region which may induce errors due to this averaging.
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Cluster c1
Cluster c2
Cluster c3
Cluster c4
Spectral Clustering Result
Figure 7.11: Five slices showing the clustering result for a small breast tumor (image adapted
and reprinted from [Glaßer et al., 2014b] c© 2014, Springer-Verlag, with kind permission from
Springer Science and Business Media).
7.6 Summary of Heterogeneity Analysis
In this chapter, an important contribution for the clinical research focus on DCE-MRI tumor
enhancement kinetics based on four different classifications approaches has been presented.
All classification approaches have been carried out on the Breast Tumor Database 2009 to
achieve comparable results. This database is special since the comprising data sets are small
breast tumors that could only be detected in DCE-MRI and are even hard to separate for a
human expert. Based on the requirements of ROIs, i.e., groups of spatially connected voxels
with similar perfusion characteristics, the methods in this chapter analyze how such ROIs can
be employed for automatic classification.
The first classification approach is a general classification approach combining kinetic and
morphological features and was conducted within the clinical environment. Based on ROC
analysis, the first classification approach yields a better discriminative power for heterogeneity
related features than the analysis of single perfusion parameters and enhancement curve types.
These finding inspired the second and third classification approaches. The region concept was
refined due to these first results and the focus was set on detecting the most suspect region
MSRegion of a tumor as well as heterogeneity analysis adapted to enhancement kinetics. To
make a transition to a machine learning problem, and to reduce the influence of subjective
criteria, tumor margin and shape evaluation was removed from the feature set. The second
classification approach combines the concept of formation of regions with the extraction of
heterogeneity with respect to enhancement kinetics. An adaption of density-based clusterings
was introduced to account for outliers, to speed up the segmentation process, and to extend the
previous region merging method. Furthermore, a decision tree model is learned for the classi-
fication. Thus, the employed feature set is human readable and the most important features for
the classification become visible. Although only 46 of 68 tumors could be correctly classified
by the learned decision tree of the second classification approach, the most important features
for distinguishing between benign and malignant tumors were again related to the heterogene-
ity of the tumor enhancement kinetics beyond the patient’s age. The new aspect of the third
classification approach is the focus on the features of the MSRegions found through clustering,
rather than the features of all cluster, i.e., the whole lesion. As a result, the clustering, i.e., the
grouping of voxels into regions is more important for classification instead of the extraction
of complex ensembles. Most important, the method yields a feature set that is best suited to
automatically determine tumor malignancy (with 56 of 68 correctly classified tumors) based
on the heterogeneity of tumor enhancement kinetics and patient’s age as well as tumor size.
The contribution of the fourth classification approach is the adaption of spectral clustering to
breast DCE-MRI tumors. Thus, spatially connected homogeneous regions are obtained.
In summary, the spectral clustering approach may be best suited for the clinician to identify
a ROI for further diagnosis like core needle biopsy. For an automatic classification approach,
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the third classification approach yields a higher discriminating power for the Breast Tumor
Database 2009. Hence, outliers can be identified, but a connected component analysis may
be necessary to guarantee spatial connectivity. Although the region merging approach does
provide a division into spatially connected regions as well, its similarity function is inferior
compared to the other approaches. The region merging averages the parameter values over all
voxels that are contained in one region which may induce errors due to this averaging.
The presented approaches evaluate all the whole lesions (in terms of global features) as well as
the tumor’s MSRegion. Furthermore, they are superior to simple rules of thumb, for example
the C2 and C3 classifiers test during the third classification approach in Section 7.4.3. Beyond
the semi-automatic extraction of the lesion, all classification approaches are fully automatic,
i.e., no user input is necessary like pre-definition of number of clusters etc. Therefore, the
presented method could be adapted to breast tumor data sets independent of specific scanning
protocols or parameters.
When evaluating the achieved classification results, it must also be stated that the classification
was only covering DCE-MRI data for the clinical research focus. In clinical practice, rather
the combination of different image modalities (e.g., X-ray and MRI) with patient-specific at-
tributes (e.g., genetic risk factors) is indispensable for a complete diagnosis. It was not possible
to create a score for automatic tumor classification solely based on perfusion MRI, but the best
suited kinetic features to distinguish between benign and malignant tumors have been identi-
fied.
In conclusion, a combination of the reported features and the region formation could be easily
integrated within the clinical workflow and can support the radiologist when finding a tumor’s
most malignant part and to rate the tumor’s malignancy. The detection of the MSRegion
has great importance for further diagnosis like core needle biopsy. As limitations for the
presented classification approaches, the adapted 3TP classification and the strong influence
of patient’s age and tumor size have to be mentioned. However, an extensive clinical study
is needed to assess, whether the adapted 3TP method classification is reliable with current
DCE-MRI scanning protocols and to make sure that no critical exceptions exist. In future,
the investigation how the clinical expert could direct the clustering (e.g., set the clustering’s
parameters) bears great potential for a semi-automatic classification approach. The presented
classification approaches strongly depend on the important breast cancer classification aspects
1 , 2 , 3 and 4 , recall Chapter 4. Without the morphologic features (aspect 5 ), a more
standardized classification approach is provided.
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8 Visual Analysis of Brain Tumor Data
In clinical research on diagnosis and evaluation of brain tumors, longitudinal perfusion MRI
studies are acquired for tumor grading as well as to monitor and assess treatment response
and patient prognosis. Within this chapter, it is demonstrated how visual analysis techniques
can be adapted to multidimensional data sets from such studies. The developed framework
supports the computer-aided diagnosis of low grade gliomas (LGGs) and high grade gliomas
(HGGs). It includes two innovations. First, a pipeline is introduced that yields comparative,
co-registered quantitative perfusion parameter maps over all time steps of the longitudinal
study. Second, based on these time-dependent parameter maps, visual analysis methods were
developed and adapted to reveal valuable insight into tumor progression, especially regarding
the clinical research area of LGG transformation into HGGs. The framework underwent an
informal evaluation based on four longitudinal brain studies, which demonstrates the suitabil-
ity of the presented visual analysis methods and comprises new possibilities for the clinical
researcher to characterize the development of LGGs. The framework was created with the
MeVisLab platform1, supported by OpenGL and VTK.2
Related studies for the evaluation of LGGs and HGGs have been presented in Section 4.3,
and in the conclusion of Chapter 4. Hence, the important aspects 6 and 7 have been identi-
fied which will be taken into account in the next sections. Furthermore, an approximation of
heterogeneity will be presented, as demanded by aspect 9 .
8.1 Clinical Motivation
MRI is used for evaluating brain tumors due to its high soft-tissue contrast. In addition to
morphologic aspects represented by conventional MRI, the dynamic susceptibility contrast
(DSC) perfusion imaging enables the characterization of dynamic aspects, recall Chapter 2.
In particular, the evaluation is based on the cerebral microvasculature that is represented by
the quantitative perfusion parameter relative cerebral blood volume (rCBV), see Figure 8.1.
DSC-MRI, in combination with conventional MRI, is a good presurgical indicator for glioma
grade and may identify the most malignant parts of a tumor for guiding stereotactic biopsy
as well as to monitor and assess treatment response and patient prognosis. Gliomas – tumors
with a glial cell origin – are the most common primary brain tumors. They histopathologically
vary from LGGs to HGGs.
Grading of gliomas and thus the differentiation between LGGs and HGGs plays an impor-
tant role for treatment planning and patient outcome [Covarrubias et al., 2004]. Furthermore,
LGGs may transform into HGGs at some point in time and an early detection of such a trans-
formation is of significant clinical importance. If a surgical removal or radiation treatment
1Product of Fraunhofer MEVIS, Bremen; www.mevislab.de (12/08/2013)
2The Visualization Toolkit, New York, USA; http://www.vtk.org/ (12/08/2013)
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is not possible, e.g., due to the tumor’s location or patient’s request, patients with LGGs are
commonly subject to a life-long MRI monitoring. Here, the clinical research focus lies on
the detection of LGG transformation in longitudinal brain data acquired over several years.
Furthermore, the evaluation of rCBV is a clinical research focus as well. It is an important
indicator for a patient’s survival and gliomas with high rCBV values have a significantly faster
progression time [Law et al., 2008]. Since HGGs have in general foci of higher rCBV values
and rCBV correlates with the tumor grade, rCBV is also employed for differentiation between
LGGs and HGGs [Law et al., 2003, Emblem et al., 2008, Law et al., 2008].
As it was stated in Section 4.3, longitudinal rCBV evaluation is a challenge since rCBV maps
of different acquisitions have to be compared. This is a complex and exploratory analysis task
due to the absence of standardized intensity values and the high variability of MRI scanners and
patient data. Thus, longitudinal studies are in general assessed with software intended for the
diagnosis of a patient at one point in time. In contrast, the framework presented in this chapter
comprises dedicated support for longitudinal LGG studies. It provides the normalization of
the image data and a visual comparison of the data from different points in time.
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Figure 8.1: MRI slices with a tumor (see arrow). For a single voxel (see arrowhead) of the
DSC-MRI data, the time-intensity curve is extracted and converted into the concentration-time
curve (see diagrams). From the concentration-time curve, the parameter CBV is extracted,
yielding a CBV map (low values are mapped to blue, high values to red). Note the varying
data size, orientation, and image resolution. (Data is courtesy of Atle Bjørnerud, Depart-
ment of Medical Physics, Rikshospitalet-Radiumhospitalet Medical Centre and Department of
Physics, University of Oslo, Norway.)
In Section 4.3, a detailed description about the ROI-based evaluation of rCBV values was
provided. Hence, different recommendations about the optimal size and placement of the ROI
were reported. Furthermore, no gold standard for a cut-off value between LGGs and HGGs
based on a ROI’s average rCBV value is available.
Finally, the strong focus on tumor heterogeneity discussed in the previous chapter influences
the demand for assessment of brain tumor heterogeneity. Hence, first results indicated that
tumorous areas with increased heterogeneity might reflect the most suspicious tumor part, see
the examples in Figure 8.2. This illustration was created with the SimVis framework presented
by Doleisch et al. [2003]. Note that after excluding voxels with high-correlating rCBV and
rCBF, only voxels with increased integral parameter values are remaining.
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5
(a) (b)
(c) (d)
Figure 8.2: Exploration of rCBV and rCBF via SimVis. Two different brains are depicted and
the brain tumor is visualized with color-coding (mapping integral from red to green values).
The scatterplots on the left show all brain voxels’ rCBV and rCBF values in yellow. Values
of tumor voxels are visualized in red revealing a stronger correlation for tumor voxels. After
transforming the scatterplot along the correlation line, a brush (see pink boxes) is defined such
that voxels with strong correlating rCBV and rCBF are excluded, see (b) and (d). Hence, the
LGG exhibits a smaller part at the right boundary with high integral values. This is a possible
indication for high neoangiogenetic activity at the tumor boundary. The HGG at the bottom
exhibits a larger area of voxels without rCBV and rCBF correlation. This might indicate a
higher neoangiogenetic activity. (Data is courtesy of Atle Bjørnerud, Department of Medical
Physics, Rikshospitalet-Radiumhospitalet Medical Centre and Department of Physics, Univer-
sity of Oslo, Norway.)
8.2 Application Scenario and Image Data
This section introduces the application scenario in more detail. Therefore, clinical research
questions regarding LGGs and their development are presented. Furthermore, the longitudinal
brain perfusion studies are described.
8.2.1 Clinical Research Questions
The comparison of rCBV maps is the most important question of the clinical experts. As
a prerequisite, preprocessing has to be carried out to incorporate rCBV maps from different
perfusion scans. Since LGG transformation relates to increased tumor heterogeneity, the eval-
uation of the tumor’s heterogeneity based on quantitative perfusion parameters is demanded
as well. Tumor transformation is also related to tumor growth, which should be visualized.
In summary, there are four clinical research question and a last question regarding the visual
analysis framework:
1. How can a comparative rCBV evaluation be achieved for a longitudinal brain perfusion
study?
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2. When does the LGG transformation start based on the evaluation of rCBV maps?
3. How is the tumor’s heterogeneity characterized in terms of local rCBV and rCBF corre-
lation?
4. How does the tumor grow and develop during the longitudinal study?
5. How can visual exploration and analysis of longitudinal studies be carried out?
8.2.2 Image Data
The case study consists of a selection of four patients fulfilling two special conditions. First,
each patient had a confirmed diagnosis of an inoperable grade II glioma, i.e., an LGG, and was
thus monitored over several years. Second, during this time period, a transformation into an
HGG took place. The brain MRI data of these four patients was evaluated resulting in four
longitudinal studies L1 – L4. For each study, up to five MRI protocols including perfusion
T ∗2 -weighted DSC-MRI sequences, T1 pre- and post-contrast scans, T2 scans, and Fluid Atten-
uated Inversion Recovery (FLAIR) MRI were acquired. Typical sequence parameters for the
T ∗2 DSC-MRI perfusion studies are gradient-echo echo planar imaging (GRE-EPI) with a tem-
poral resolution TR of 1.4− 1.72 s, echo time TE 30− 52 ms, image matrix 128× 128, slice
thickness 6.5 mm, in-plane resolution 1.8 mm ×1.8 mm, number of slices 12−19, number of
acquisitions 50−75, and a total acquisition time ranging from 73 s to 119 s.
For each study, the point in time of the LGG transformation was estimated by an experienced
radiologist. The estimation is based on all MRI protocols – instead of the single perfusion
scan – of all time steps for each study.
The Study L1. L1 was acquired over almost three years at four time steps t1− t4 for monitoring
of an LGG. The transformation into an HGG started between t1 and t2.
The Study L2. The patient of study L2 underwent surgical intervention and the remaining
LGG was monitored for four years. MRI data was acquired at five time steps and the LGG
transformation started between t3 and t4.
The Study L3. L3 contains an oligodendroglioma, a glioma type exhibiting foci of high CBV
values irrespective of the tumor grade [Lev et al., 2004]. MRI scans have been acquired at four
time steps during two and a half years. The transformation started between t3 and t4.
The Study L4. Image data for L4 has been acquired at five time steps t1-t5 to supervise an LGG
over a time period of three and a half years. The transformation into an HGG started after t3.
8.3 Visual Analysis of Longitudinal Brain Tumors
The framework for computer-aided diagnosis of longitudinal brain tumor studies includes two
innovations: a preprocessing pipeline for the MRI perfusion scans and the framework contain-
ing the adapted visual analysis techniques.
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8.3.1 Preprocessing Pipeline
The preprocessing pipeline facilitates the comparison of the different perfusion data sets (with
possible different image parameters) of a longitudinal brain perfusion study. It comprises five
steps, which are described in the following.
Co-Registration of Perfusion Data Sets
Motion artifacts in brain perfusion imaging typically result from patient movement. With
the skull as static reference object, rigid registration algorithms allow for co-registration of
brain perfusion data. First, each T ∗2 -weighted DSC-MRI perfusion scan was motion corrected
with the software package nordicICE.3 Second, each study’s perfusion DSC-MRI data set was
co-registered to the study’s DSC-MRI data set acquired last in time with RView4, employing
a rigid registration algorithm [Studholme et al., 1999]. Thus, a concurrent analysis of all
perfusion scans of a longitudinal study is supported.
Extraction of CBV and CBF maps
To assess CBV and cerebral blood flow (CBF), the distribution of the contrast agent is
analyzed. The contrast enhancement results in time-intensity curves for each voxel (see
Fig. 8.1). Hence, the software package nordicICE is employed to transform these curves
into concentration-time curves, applying the regularized singular value decomposition for de-
convolution [Rosen et al., 1990]. The arterial input function was extracted from the arteria
cerebri media [Østergaard et al., 1996b]. Contrast agent leakage correction was carried out
due to possible contrast agent extravasation in regions of blood-brain barrier (BBB) disrup-
tion [Boxerman et al., 2006], caused by the tumor. CBV is approximated as the area under the
concentration-time curve and defined as the total volume of blood traversing a given region of
the brain. It is measured in ml of blood per 100 g of brain tissue. CBF is defined as the volume
of blood traversing a given region of brain per unit time. It is measured in ml of blood per 100
g of brain tissue per minute. Although in ischemic stroke diagnosis, CBF is thoroughly ana-
lyzed, the role of this parameter in brain tumor diagnosis has not been as extensively studied
as CBV [Covarrubias et al., 2004].
However, since tumor heterogeneity indicates tumor malignancy, the framework includes het-
erogeneity evaluation in terms of correlation between CBV and CBF. While a small decrease
in CBF is expected as a consequence of normal aging in a longitudinal study, the transfor-
mation from LGG to HGG is expected to involve significant stronger changes. However, a
gold standard for CBV and CBF evaluation seems hard to establish due to different imaging
modalities, age, and gender [Bjørnerud and Emblem, 2010].
Normalization of CBV and CBF maps
For comparison of CBV and CBF values from DSC-MRI scans, normalization has to be carried
out. In the framework, the general approach is employed where CBV and CBF maps are
3Product of NordicNeuroLab, Bergen, Norway; www.nordicneurolab.com (12/08/2013)
4By C. Studholme, Seattle, USA; rview.colin-studholme.net (12/08/2013)
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normalized with the averaged white matter’s values of the contralateral side [Wetzel et al.,
2002], yielding relative CBV (rCBV) and relative CBF (rCBF) values. Visual inspection and
ROI placement are realized with MeVisLab.
Exclusion of Vessels and Adapted Smoothing
Next, vessels were excluded from the rCBV and rCBF maps since brain vessels exhibit higher
values than the surrounding tissue. They can be identified and removed based on the earlier and
stronger contrast enhancement in the T ∗2 -weighted DSC-MRI data. A vessel mask is extracted
with nordicICE based on the cluster analysis of the estimated perfusion-related parameters to
separate vessels (both arteries and veins) from other tissue. For each rCBV and rCBF map the
corresponding vessel mask is applied. Afterwards, a 3×3 modified average filter is applied to
smooth the data as well as to reduce holes caused by the vessel mask. This filter empirically
accounts best for rCBV changes due to noise or subtle artifacts. The modified filter only
averages over non-vessel voxels in the 3×3 neighborhood of the current filter kernel. Hence,
outliers, i.e., isolated voxels with rCBV values higher than a certain threshold, are removed.
The 0.995 quantile of a data set’s rCBV value is employed as cut-off value for outliers.
Extraction of Tumor Masks
In a last step, a tumor mask for each of the perfusion data sets was created. Hence, the T2
and FLAIR images were co-registered to the perfusion data sets acquired at the same point
in time of the studies with RView. Next, binary tumor masks based on hyperintense areas in
T2 and FLAIR data for each study’s time step were extracted and applied to the rCBV maps.
Tumor mask creation was manually carried out. Afterwards, it was validated by an experienced
radiologist.
8.3.2 A Framework for Visual Analysis of Longitudinal Brain Tumors
Based on the preprocessed longitudinal scans, a framework was developed for the longitudinal
evaluation of brain perfusion data. The framework contains color-coded 2D and 3D visualiza-
tions, a local heterogeneity map, and a parallel coordinates plot view. The related work for
these concepts was provided in Section 4.1.
Direct 2D and 3D Visualizations
The 2D and 3D visualizations directly map each voxel’s rCBV value to color. For direct rCBV
extraction, a standard 2D slice view of the brain tumor with voxelwise rCBV is presented. All
tumor slices of a study’s scans are provided. A modified rainbow color scale from blue to red
is applied, see Figure 8.3. The color scale is based on the scale suggested by Wetzel et al.
[2002]. Red highlights critical rCBV values (values > 5), and suspicious rCBV values greater
than 1 are mapped to cyan. Although rainbow color scales do in general lack an intuitive visual
interpretation of the data’s order, they support visual clustering. Hence, regions with mostly
red colors (and thus high rCBV values) or blue regions can be observed. Based on the rCBV
maps a selection of voxels, – the rCBV threshold selection – can be defined. This selection
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consists of all voxels with an rCBV value greater than a user-defined threshold and can be
combined with all other views.
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Figure 8.3: 2D rCBV maps of all slices (horizontally aligned) of study L1 for all four time
steps (vertically aligned). At t1 and t4, the tumor is covered by four and six slices, respectively.
Note the hot spot with high rCBV values (arrow). The encircled regions exhibit lower rCBV
values.
The 3D overview provides a direct volume rendering applying the same color scale (see
Fig. 8.3) for highlighting tumor voxels. A linear opacity transfer function assigns α-values of
0.2 to low rCBV values ≤ 1 and α-values of 1 to rCBV values ≥ 5. The brain is displayed as
isosurface context object and was extracted from the perfusion data set with thresholding. The
tumor is presented as focus object. The visibility of the focus object from all viewing points
is maintained with a simple cut-out technique, see Figure 8.4. Hence, the tumor’s enclosing
sphere is slightly enlarged and employed to cut the isosurface of the brain. The 3D overview
visualizes the tumor’s progression as well as its spatial localization in the brain. However, only
limited information about a tumor’s malignancy can be provided since no exact quantification
of rCBV hot spots is possible. The 3D overview reveals the spatial variability of rCBV hot
spots. They may occur at slightly different positions across all scans of a longitudinal study
due to tumor growth (see Fig. 8.4).
L 3D Overview1
t1 t2 t3
Figure 8.4: 3D view of tumor growth of L1 at t1, t2, and t3. The brain is depicted as context
object and the tumor is emphasized with a cut-out technique.
Visual Analysis of Local Tumor Heterogeneity
In clinical research, tumor growth and malignancy are associated with increased tumor het-
erogeneity due to necrosis mainly in the tumor center. Also, some neoangiogenetic tumor
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parts are expected to exhibit increased heterogeneity. For an assessment of local heterogene-
ity, approximated as correlation of rCBV and rCBF, the local correlation coefficient (LCC)
measure [Cachier and Pennec, 2000] is extracted. An important property of LCC is the inde-
pendence of scaling of the data value range. Thus, the LCC maps are independent of rCBV
and rCBF normalization factors, which had been used to normalize CBV and CBF maps. The
LCC values are extracted from the preprocessed rCBV and rCBF parameter maps yielding a
color-coded 2D LCC parameter map, see Figure 8.5. LCC values of 1 indicate an increasing
linear relationship. Values equal to 0 illustrate a missing linear dependency. A heat color map
from dark red to bright orange is applied to map increasing values of LCC.
t2
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L LCC Parameter Map1
Figure 8.5: LCC parameter maps of L1. Heterogeneous areas are mapped to dark red. The
encircled regions at time steps t3 and t4 exhibit low rCBV values, see Figure 8.3.
The rCBV Profile Parallel Coordinates Plot
A parallel coordinates plot allows for the exploration of multivariate data where each axis
presents a data dimension. Recall Sect. 4.1.2 for related work regarding parallel coordinates
plots. The parallel coordinates plot is adapted as follows: For each voxel, the rCBV values
over time (i.e., the scans at different time steps of a study) are extracted yielding rCBV curves.
In Figure 8.6, the rCBV profile view of L1 is presented (the same color scale is applied, recall
Fig. 8.3). According to discussions with the clinical experts, the rCBV changes, i.e., the
voxel’s rCBV differences between two subsequent time steps were of great interest resulting
in the rCBV change profile view, see Figure 8.6. Hence, shadows support depth perception.
The rainbow color scale’s hue changes support the differentiation between rCBV values. The
data’s order can be easily inferred from the curves’ height. In addition, height lines support
direct quantitative rCBV or rCBV change extraction and curve differentiation is supported by
contour lines and Fresnel shading.
To obtain groups of similar curves, different strategies to sort the curves were empirically
tested. Hence, the best result (i.e., the lowest amount of occlusions of curves in the back-
ground and the easiest detection of trends) was achieved with a sorting based on the squared
differences of each rCBV change curve’s integral. The order is applied to both rCBV profile
views. Tumors with larger extents and thus a larger amount of voxels yield a higher number
of rCBV change curves, which may lead to visual clutter. To reduce the curve number, the
user can apply the rCBV threshold selection and only curves that have at least one rCBV value
greater than this threshold are included. In addition, the rCBV profile views allow for the
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Figure 8.6: The rCBV profile view (left) with all voxels’ rCBV curves. The rCBV values are
color-coded (a) and height lines support direct measurement (b). Differentiation of curves is
supported by dark contour lines (c), with Fresnel shading attached to (d). The rCBV change
profile view presents the rCBV parameter curves’ differences (right). Thus, all differences are
mapped to zero for t1.
rCBV curve index selection. Hence, all voxels with a corresponding curve index inside the
selected range of curve indices are combined. The curve indices are sorted depending on the
rCBV profile view. Although the rCBV profile views allow for simultaneous display of all
voxels’ rCBV changes, the spatial connectivity of the voxels is lost, as the voxels’ order purely
depends on the rCBV curves and not on their spatial position.
8.3.3 Combination of Visual Analysis Techniques
The presented techniques can be combined via the rCBV threshold selection and the rCBV
curve index selection. Then, a tumor voxel is only mapped to color or represented as curve
when it is part of all chosen selections. Furthermore, the 2D views can be combined with
lenses to allow for simultaneous evaluation of rCBV and LCC values.
8.4 Informal Evaluation with Clinical Research Questions
In this section, the studies L1−L4 were discussed with two physicians regarding the clinical
research questions (recall Sect. 8.2.1).
How Can a Comparative rCBV Evaluation Be Achieved?
With the presented pipeline, a concurrent evaluation of each study’s perfusion scans can be
achieved. User interaction is only necessary during ROI placement in the contralateral healthy
brain tissue. The pipeline can be applied to all brain DSC-MRI data sets independent of MRI
scanner or specific scanning protocol parameters. Also, distortion of a ROI’s rCBV values due
to vessel voxels is prevented.
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When Does the LGG Transformation Start Based on the Evaluation of rCBV Maps?
In general, rCBV maps are evaluated with the hot spot method. If the hot spot’s average rCBV
value is greater than a certain threshold, e.g., > 1.5 [Covarrubias et al., 2004], the tumor is
expected to be an HGG. The transformation of the LGG of L1 started between t1 and t2 since
a hot spot occurs at t2 with an average rCBV value > 1.5. The patient of L2 was monitored
after surgical intervention. In Figure 8.7(a), the development of the recurrent LGG can be
observed. First, there is a lesion dominated by radiation necrosis and low rCBV values. Next,
the rCBV view at t4 reveals some rCBV hot spots, whereas at t5 increased extents of hot
spots with higher rCBV are visible. The reported rCBV differences of oligodendrogliomas in
comparison to other brain gliomas is reflected by L3 since foci with high rCBV values do occur
at all time steps (see Fig. 8.8(a)). Study L4 comprises an LGG and between t3 and t4 more hot
spots with increased rCBV values occur, see Figuer 8.9(a). However, in clinical research, it
is not always clear at which extent and number of hot spots and which threshold of rCBV, a
glioma is graded as HGG [Law et al., 2003, Covarrubias et al., 2004, Emblem et al., 2008].
Furthermore, the normalization of rCBV with a possibly too low or too high normalization
factor (extracted on the contralateral brain side) could strongly hamper this analysis and ROI
placement suffers from inter-observer variability [Wetzel et al., 2002]. These limitations also
hold for the 2D parameter maps.
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Figure 8.7: The rCBV map (a) with corresponding LCC map (b) and 3D overview (d) of L2.
To improve readability, the first and the last 2 tumor slices are not presented. The combination
of (a) and (b) with a lens for a selected slice (marked with *) is depicted in (c), revealing a hot
spot with increased local heterogeneity at the tumor’s boundary. An rCBV threshold selection
(rCBV threshold = 1.5) is applied, mapping lower rCBV values to gray. In (d), increased
rCBV values and larger hot spots (see arrows) are revealed.
159
8 Visual Analysis of Brain Tumor Data
0
1
2
3
4
>5
rCBV
(d) L 3D Overview3(c) L Combination via Lens3
(a) L rCBV Parameter Map3 (b) L LCC Parameter Map3
t2 t3 t4
* *
t2
t3
t4
t1
LCC
Figure 8.8: Presentation of the rCBV map (a) with corresponding LCC map (b) and 3D
overview (d) of L3. To improve readability, the first and the last 2 tumor slices are not pre-
sented. In c), the combination of (a) and (b) via a lens for a selected slice (marked with *)
is depicted, revealing a hot spot with increased local heterogeneity in the tumor’s center. An
rCBV threshold selection (rCBV threshold = 1.5) is applied, mapping lower rCBV values to
gray. In (a) and (d), increased rCBV values and larger hot spots (marked with arrows) are
revealed.
How is the Tumor’s Heterogeneity Characterized in Terms of Local rCBV and rCBF
Correlation?
To support stereotactic biopsy, the most malignant tumor parts have to be determined. These
parts are characterized by areas with increased angiogenesis and therefore with highest rCBV
values. Furthermore, the clinical research partners presumed increased heterogeneity and thus
uncorrelated rCBV and rCBF values for these parts. The LCC maps of L1 are presented in
Figure 8.5 and of L2-L4 in Figures 8.7(a), 8.8(a), and 8.9(a). Hence, also the combination of
LCC maps and rCBV maps with lenses (see Fig. 8.7(c) and 8.8(c)) is demonstrated. Two facts
can be observed. First, with increased tumor growth, heterogeneous areas in the tumor center
become visible, which may be caused by necrotic areas. Second, at the tumor’s boundary, areas
with uncorrelated rCBV and rCBF values exist. During tumor growth, necrotic areas in the
tumor center show up with typical low rCBV values, see the encircled regions in Figures 8.3
and 8.5. Necrotic tumor parts typically exhibit low rCBV values. For stereotactic biopsy, these
parts should be explicitly spared. In contrast, areas with high rCBV and high heterogeneity in
terms of LCC should be aimed at. These areas can be defined by applying an rCBV selection
first. Next, a ROI is set in the remaining rCBV map (see Fig. 8.7(c)). Another finding of the
LCC maps is the lack of relationship between LGG transformation and the amount of LCC
approximated heterogeneity.
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Figure 8.9: Presentation of the rCBV map (a) with corresponding LCC map (b) and 3D
overview (d) of L4. In c), the rCBV curve index selection is applied to the slices marked
with *. Only the voxels, which were selected in the rCBV profile view in Figure 8.10(c). In (d),
increased rCBV values are marked with arrows.
How Does the Tumor Grow and Develop?
For a qualitative overview of tumor growth, the 3D view is provided (see Fig. 8.4, 8.7(d),
8.8(d), and 8.9(d)). Although the medical expert has fast access to the spatial extent of the
tumor, no quantitative evaluation is possible. Quantitative information is provided in the 2D
parameter maps and the rCBV profile views. Furthermore, the rCBV profile views provide a
fast overview of significantly changing rCBV values and thus a possible LGG transformation.
This relationship is illustrated in Figure 8.10. Hence, the rCBV values and the rCBV changes
of L4 suddenly increase after t3 matching the estimated transformation point in time. Due to
the large tumor extent of L3, a reduction of the number of curves is necessary, see Figure 8.11.
Still, no rapid rCBV value increase can be observed due to the oligodendroglioma type.
How Can Visual Exploration and Analysis of Longitudinal Studies Be Carried Out?
A possible user scenario is carried out in the following way. First, the preprocessing pipeline
provides co-registered rCBV parameter maps. Now, the clinical researcher starts with the
spatial 3D cut-out view for a first overview. Next, the data sets are analyzed in the rCBV profile
curve view and the 2D rCBV maps. Hence, the transformation time step can be estimated by
examining the rCBV curves, the rCBV change curves, or scalar values of rCBV. The analysis
involves combinations of the rCBV threshold selection and the rCBV curve index selection
(see Fig. 8.7(c), 8.8(c), 8.9(c), and 8.10(c)) to determine the most malignant tumor part for
tumor grading or stereotactic biopsy. Hence, the region marked with an arrow in Figure 8.9(c)
exhibits only moderate rCBV, but these voxels belong to the selected curve indices. Thus, this
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Figure 8.10: The rCBV profile view (a) and the rCBV change profile view (b) of L4 reveal
increased rCBV values and changes, marked with arrows, after t3 – matching the estimated
transformation starting time. In (c), an rCBV curve index selection is carried out by applying
the selection plane (see arrows). From all rCBV curves, the n (n=300) curves, ordered by their
integral, are selected. The selection for L4 yields the example in Figure 8.9(c).
tumor part may be one of the most malignant parts since these voxels correspond to rCBV
curves with the highest curve indices, i.e., the highest integrals.
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Figure 8.11: Depiction of the rCBV profile view in (a). In (b), the rCBV threshold selection is
applied and thus, the number of curves is reduced. In (c), the rCBV change view for selected
curves is provided.
In summary, for all tumors but the oligodendroglioma of L3, the transformation time step
(which initially was estimated also based on structural MRI sequences) could be approximated
with the application employing only the perfusion data sets (recall Sect. 8.2.2).
8.5 Conclusion
In this chapter, an application for the evaluation of longitudinal brain perfusion studies focus-
ing on the development of LGGs within the context of clinical research was presented, recall
also the two brain tumor aspects in the conclusion of Chapter 4. A preprocessing pipeline
enables the simultaneous evaluation of tumor localization, tumor size, and rCBV values of
all perfusion scans. The visual analysis techniques include linked 2D parameter maps, a 3D
overview, and the new 3D rCBV profile view that represents all rCBV values of all voxels at
all time steps. Once the user examined the LGGs temporal development and the point in time
of a starting LGG transformation, the analysis can be restricted to foci with high rCBV values
and local tumor heterogeneity. Combination of the different views as well as selecting a set
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of voxels, which may represent the most malignant tumor part is carried out with lenses in the
2D views, the rCBV threshold selection, and the rCBV curve index selection. The resulting
voxel set can be used for ROI placement for tumor grading or stereotactic biopsy.
Without the presented application, a clinician would have to mentally integrate scans of the
same study acquired at earlier time steps to evaluate the LGG progression. In addition, the
application prevents vessel voxels to be integrated in ROIs and thus avoids distortions of rCBV
averaging. The clinical partners did especially like the rCBV change profile view depicting
each voxel’s rCBV changes due to their ability to visualize the temporal development. Hence,
the tumor changes are analyzed for a retrospective evaluation. However, with the heterogeneity
analysis based on the LCC, additional information is provided to guide a stereotactic biopsy.
The framework is a prototype application for clinical research and may be adapted to longitu-
dinal studies of breast and prostate tumors where perfusion data is acquired for diagnosis and
treatment monitoring. Due to the growing number of longitudinal medical image data and the
general need of comparison of sequenced image data (e.g., cohort study data), an increasing
demand for visual exploration and analysis of this kind of medical data is expected.
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The diagnosis of cancer includes the detection of signs and symptoms, screening tests, and
medical imaging. Especially the medical imaging has gained increased importance due to
substantial improvements regarding the image quality. These data sets become larger and
more complex. To improve and support the radiologist’s work, advanced methods including
visual analytic solutions are required. Hence, perfusion imaging plays an important role for
the evaluation of breast cancer due to its high sensitivity as well as for monitoring low grade
gliomas in brain tumor imaging. This thesis contributes to an improved diagnosis of low grade
gliomas and breast tumor perfusion MRI data sets. The contributions, motivated by the nine
aspects 1 - 9 in Chapter 4 can be summarized as follows:
1. Visual Analysis and Exploration of Breast Tumor DCE-MRI Data.
2. Visual Analysis and Exploration of Longitudinal Brain Tumor DSC-MRI Data.
3. Region-based Division and Analysis of the Whole Lesion.
4. Characterization of Tumor Heterogeneity via Kinetic Features.
5. Suitability of Heterogeneity Features for the Automatic Classification of Breast Tumors.
9.1 Summary
In this section, the contributions will be explained in more detail.
1. Visual Analysis and Exploration of Breast Tumor DCE-MRI Data.
The PerfusionAnalyzer is a software prototype covering multiple linked views with the in-
tegrated 2D visual exploration techniques for the evaluation of breast tumor perfusion data.
Beyond standard views, e.g., color-coded 2D parameter maps of relative enhancement (RE)
values or subtraction views, also novel visualization techniques were integrated. The lesion
detection and delineation was implemented with a volume growing method. The voxel-wise
glyph-based visualization allows for a fast overview of data sets and allows for a finer classifi-
cation of RE values than the three-time-point (3TP) method. The voxel-wise glyph assignment
avoids interpolation and distortion due to average RE curves. The region merging segmenta-
tion on the other hand reduces the influence of outliers. With the integrated region merging
method, employing a descriptive perfusion parameter-based feature vector, a semi-automatic
subdivision of a suspicious tumor into different regions is established. The most suspect region
can be employed as region of interest (ROI). Since a region contains similarly perfused vox-
els, the distortion of the average RE curve of the ROI as well as the inter-observer variability
concerning the ROI’s placement is reduced.
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Beyond the kinetic evaluation, a new multiplanar reformation (MPR) view was designed and
integrated to account for the tumor’s morphology. The FileCardBrowser View is adapted to
each tumor, i.e., it creates a new MPR plane that is adapted to the tumor’s extent. The presented
examples illustrated the main advantages of this method: the improved boundary evaluation
as well as the identification of spatially connected and similarly perfused regions. While the
first one allows for a better evaluation of the tumor’s morphology, the second one is important
for further treatment planning. Therefore, the kinetic evaluation can be combined with this
additional technique.
A further extension is the combination of T1- and T2-weighted breast MRI scans. The joint
inspection of both sequences is important for differential diagnosis when evaluating breast
cancer. In particular, it allows to distinguish between benign cyst-type and malignant lesions.
In clinical practice, both images are regarded independently and immediate correlation is pre-
vented by patient motion and tissue deformations. With the integrated lens view, the radiologist
can visually combine the MRI sequences for a faster diagnosis without the effort of mentally
integrating both images.
2. Visual Analysis and Exploration of Longitudinal Brain Tumor DSC-MRI Data.
The presented application for the evaluation of longitudinal brain DSC-MRI perfusion studies
focuses on the development of LGGs within the context of clinical research. A preprocessing
pipeline enables the simultaneous evaluation of tumor localization, size, and rCBV values of
all perfusion scans. The visual analysis techniques include linked 2D parameter maps, a 3D
overview, and the new 3D rCBV profile view that represents all rCBV values of all voxels at
all time steps. Once the user examined the LGGs temporal development and the point in time
of a starting LGG transformation, the analysis can be restricted to foci with high rCBV values
and local tumor heterogeneity. The combination of the different views as well as the selection
of a set of voxels which may represent the most malignant tumor part is carried out with lenses
in the 2D views, the rCBV threshold selection, and the rCBV curve index selection.
3. Region-Based Division and Analysis of the Whole Lesion.
The presented frameworks and approaches have the important advantage that the whole lesion
is taken into account. In contrast, existing approaches are mostly limited to certain samples,
slices, or parts of the data set. The presented classification approaches for breast tumor data
took the whole lesion into account (in terms of global features) as well as the tumor’s most
suspect region (MSRegion). The region-based division of the data and the automatic identi-
fication of the MSRegion avoid inter- and intra-observer variability. Hence, the error-prone
and time-consuming manual ROI placement is obsolete. The MSRegion can be employed for
further diagnosis like core needle biopsy.
Likewise, the framework for exploration of longitudinal brain tumors allows for a selection of
a voxel set with high rCBV values. This set can be used for ROI placement for tumor grading
or stereotactic biopsy. Without the framework, a clinician would have to mentally integrate
scans of the same study acquired at earlier time steps to evaluate the LGG progression.
With the 3D ClusterView, a well-suited visualization of the region-based tumor division has
been presented. Hence, the geometric modeling enhances cluster connections. Conventional
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3D views are often hampered due to occlusion of inner tumor parts. Moreover, no further
information can be extracted. Therefore, the 3D ClusterView is completed with a necklace
map legend and each cluster can be easily selected. The 3D ClusterView was successfully
adapted to brain tumor data and is well suited for any clustered medical tomographic image
data. Due to the increased complexity of medical image data, the biomedical expert will
be definitely confronted with the problem of an effective clustering of her or his data in the
future. For the qualitative evaluation of the clustering result, the 3D ClusterView should be the
visualization of choice.
4. Characterization of Tumor Heterogeneity via Kinetic Features.
The presented techniques within the two different application areas of breast and brain tumor
diagnosis have a strong focus on the heterogeneity of the kinetic contrast enhancement.
The clustering results for breast tumor data sets were compared with external cluster validation
indices. A variety of features with focus on kinetic contrast enhancement were extracted and
their usefulness was demonstrated with further classification approaches.
For the longitudinal brain perfusion scan, the heterogeneity was assessed in a qualitative way
by analyzing the correlation of the quantitative perfusion parameters CBV and CBF via the lin-
ear correlation coefficient measure (LCC) [Cachier and Pennec, 2000]. The clinical expert can
explore the CBV as well as the LCC parameter maps with lenses. However, with the hetero-
geneity analysis based on the LCC, additional information is provided to guide a stereotactic
biopsy.
5. Suitability of Heterogeneity Features for the Automatic Classification of Breast
Tumors.
For the small breast tumors, a quantitative heterogeneity analysis was carried out including
four complex automatic classification approaches. All classification approaches have been
carried out on the Breast Tumor Database 2009 to achieve comparable results. This database
is special since it contains small breast tumors that could only be detected in DCE-MRI and
are even hard to separate for a human expert. Based on the requirements of ROIs, i.e., groups
of spatially connected voxels with similar perfusion characteristics, the methods in Chapter 7
analyze how such ROIs can be employed for automatic classification.
The first classification approach is a general approach combining kinetic and morphological
features and was conducted within the clinical environment. The first classification approach
yields a better discriminative power for heterogeneity related features than the analysis of sin-
gle perfusion parameters and enhancement curve types. These findings inspired the following
classification approaches. The focus was set on detecting the MSRegion of a tumor as well as
on improved heterogeneity analysis based on the enhancement kinetics.
The second classification approach adapts the density-based clustering. A decision tree classi-
fier is learned to ensure that the model is human readable and the most important features for
the classification become visible. Although only 46 of 68 tumors could be correctly classified
by the learned classifier, the most important features for distinguishing between benign and
malignant tumors were related to the heterogeneity of the tumor enhancement kinetics and the
patient’s age.
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The new aspect of the third classification approach is the concentration on the features of the
MSRegion found through clustering, rather than the features of all clusters, i.e., the whole
lesion. As a result, the clustering, i.e., the grouping of voxels into regions is more important
for classification instead of the extraction of complex ensembles. Most important, the method
yields a feature set that is best suited to automatically determine tumor malignancy (with 56 of
68 correctly classified tumors) based on the heterogeneity of tumor enhancement kinetics and
patient’s age as well as tumor size.
The contribution of the fourth classification approach is the adaption of spectral clustering
to breast DCE-MRI tumors. Thus, spatially connected homogeneous regions are obtained.
Although the classification result could not be improved, this approach is well suited for iden-
tification of appropriate tumor parts for core needle biopsy.
The presented classification approaches are superior to simple rules of thumb. Apart from
the semi-automatic extraction of the lesion, all classification approaches are fully automatic,
i.e., no user input is necessary like the pre-definition of number of clusters etc. Therefore, the
classifiers are well suited and universally compatible for breast tumor data sets independent
of specific scanning protocols or parameters. In conclusion, a combination of the reported
features and the region formation can be easily integrated within the clinical work flow and
support the radiologist when finding a tumor’s most malignant part and to rate the tumor’s
malignancy.
In summary, a very special property of the thesis at hand (originating with a strong focus
on visualization and visual analysis), is the adaption to a broad range of patients, covering
a breast tumor database with 68 lesions as well as a rare set of 4 longitudinal brain tumor
perfusion studies that all consist of low grade gliomas that transform into high grade gliomas.
Thus, the proposed methods could be tested with real application data. The second remarkable
attribute is the concrete clinical research focus on automatic classification of breast cancer. The
developed visualizations and techniques were employed as input for a classification approach,
which was step by step refined and yields results that are comparable or even better to related
studies in literature.
9.2 Drawbacks and Limitations
The presented techniques were closely adapted to the DCE-MRI and DSC-MRI data sets.
Although these concrete clinical scenarios bear great potential for application-oriented soft-
ware development, they are also accompanied by some drawbacks and limitations. These are
grouped into
• data-based constraints,
• application-based constraints, and
• medical constraints.
9.2.1 Data-Based Constraints
Data-based constraints comprise the moderate temporal resolution for breast DCE-MRI and
the moderate spatial resolution for brain DSC-MRI, respectively. Futhermore, MRI is prone to
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various artifacts, e.g, inhomogeneities of the magnetic field. More important, motion artifacts
hamper the evaluation of the contrast enhancement per voxel. Improved imaging modali-
ties will reduce these obstacles. Also, dedicated motion correction approaches could further
improve the inter-pixel correspondence. The promising approach by Schäfer et al. [2011]
includes pharmacokinetic modelling for an improved motion correction of breast DCE-MRI
data. However, as it is stated by Behrens et al. [2007], an appropriate fitting would require a
higher temporal resolution. On the other hand, high spatial resolution is necessary for identi-
fication of small lesions.
9.2.2 Application-Based Constraints
The presented approaches are based upon the evaluation of a clustering result and thorough
analysis of perfusion parameter values, i.e., the relative cerebral blood volume. Hence, a gold
standard for clustering is missing. Furthermore, ”the validation of clustering structures is the
most difficult and frustrating part of cluster analysis [Jain and Dubes, 1988]“. A sophisticated
study with medical experts that manually subdivide a tumor in MRI data with respect to histo-
pathologic differences within a clinical environment would be a great gain for this application
area. Likewise to the lack of a clustering ground truth, the adapted 3TP classification should
be raised to question. An extensive clinical study is needed to asses whether the adapted 3TP
method classification is reliable with current DCE-MRI scanning protocols. Other concepts
for an external cluster validation are needed to confirm the appropriateness of the presented
clustering methods. Also, no gold standard for rCBV cut-off values exists. However, with
increasing MRI studies of brain tumors and more standardized evaluation criteria, such cut-off
values might be formed in the future.
9.2.3 Medical Constraints
The main drawback of the proposed case studies is the missing of typical benign tumors or
healthy patients. Although the longitudinal studies of the brain give insight to a transformation
from low grade to high grade tumor, the low grade tumors were acquired at an advanced stage,
i.e., no scan of the same patient without any tumor burden was available. Likewise, the Breast
Tumor Database 2009 contains benign lesions. However, the benign lesions were suspicious
enough to justify biopsy or follow-up evaluation. In future, a systematic evaluation should be
combined with a cohort study like the SHIP study [Völzke et al., 2011], comprising MRI scans
of the body. Then, the adaption of computer-aided detection and diagnosis can be carried out
on a whole new level.
It is expected that the limited standardized evaluation of tumor morphology will be improved in
the next years. Hence, morphology-based features will be gain more importance for automatic
tumor classification approaches.
Another drawback is the supplemental character of perfusion imaging. This thesis strongly
focuses on this imaging modality. However, in clinical practice, rather the combination of dif-
ferent image modalities (e.g. X-ray and MRI) with patient-specific attributes (e.g. genetic risk
factors) is indispensable for a complete diagnosis. Finally, an important restriction of the pre-
sented methods for breast tumor evaluation is the focus on kinetic contrast agent enhancement
features. As presented by Jansen et al. [2008] for breast tumors in DCE-MRI, these features are
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inappropriate for non-mass like enhancing lesions. Future work could include a preselection.
Dependent on the tumor’s properties, different feature sets (e.g. a feature set describing the
tumor’s morphology and another feature set with focus on kinetic features) could be employed
for further analysis. Hence, the study by Montemurro et al. [2007] reports poor classification
results for the Göttinger score [Fischer et al., 1999] of intermediate-low suspicious DCE-MRI
lesions, which further strengthens the need for lesion adapted feature sets.
9.3 Future Potential
For future work, the extension of the presented methods for breast and brain tumor MRI is
dicussed first. Afterwards, the transferability to other medical application areas is described.
For the improved evaluation of breast tumor perfusion data, an automatic extraction of mor-
phology features should be developed. Based on the Göttinger score [Fischer et al., 1999],
automatic computer-based classification algorithms should extract the values for the lesion
margin and the lesion shape (based on the DCE-MRI sequence) and combine it with the pre-
sented classification approaches of this thesis. Furthermore, Malich et al. [2005] extended
the Göttinger score with features from the T2-weighted breast MRI data. Also, Behrens et al.
[2007] suggested a combination of T2-based features for improved classification results. With
the co-registration of T2-weighted breast MRI as proposed by Böhler [2011], a software frame-
work could automatically extract these features. Thus, our approach described in [Boehler
et al., 2011] can be integrated in the classification step. Then, automatically derived T2-based
features will be included in the feature set. The next step for brain tumor evaluation is an
adaption of the classification methods that were developed for the breast tumor data sets. Al-
though the evaluation of brain tumor DCS-MRI strongly focuses on rCBV analysis, a feature
set (like rCBV mean, rCBV median etc.) can be built up by employing the rCBV histogram as
proposed by Friedman et al. [2012].
For future work, the presented methods can be transferred to other medical application areas
involving MR perfusion data. An example is prostate cancer evaluation. Hence, T2-weighted
MR images are acquired to locate the cancer. Franiel et al. [2011] presented a comprehensive
overview dealing with the importance of DCE-MRI for prostate cancer due to the additional
DCE-MRI-derived features. DCE-MRI is increasingly employed for extraction of pharma-
cokinetic parameters and for assessment of the tumor’s aggressiveness. Prostate cancer also
exhibits neoangiogenesis, increased heterogeneity, and vessel permeability with increased ma-
lignancy [Franiel et al., 2011]. Therefore, this research area is well-suited for the adaption of
the presented classification approaches. In a first step, the feature sets proposed in this the-
sis can be extended with the pharmacokinetic parameters. Next, clustering can be employed.
Hence, the same concepts for heterogeneity assessment can be applied. Prostate cancer and
abnormal but non-cancerous conditions like fibrosis, prostatitis or hemorrhage exhibit simi-
lar signal intensities in T2-weighted MRI. Thus, in a second step, a classifier (by extending
the presented classifiers in this thesis) can be trained to discriminate between prostate cancer
and these pathologies. Another promising application area is renal perfusion data [Zöllner
et al., 2009]. Here, k-means clustering is employed for the subdivision into different kidney
compartments (i.e., cortex, medulla, and pelvis). This analysis could be extended with the
presented heterogeneity-based methods of this thesis. Therefore, the k-means clustering can
be compared to a density-based clustering result. Next, features (e.g., the Jaccard coefficient)
describing the heterogeneity of perfusion can be extracted.
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In general, the visual analysis and exploration adapted to specific medical applications has
great potential. The increasing amount and size of medical data sets demands for computer-
aided support. For the group of cancer-related diseases, incidence rates increase due to im-
proved cancer screening and medical image acquisitions. Visual analysis techniques for breast
and brain tumors play an important role for the detection of cancer as well as its most suspect
tumor part and may replace the error-prone manual ROI definition. Furthermore, with increas-
ing number of longitudinal studies, visual analysis techniques are appropriate to evaluate a
tumor’s temporal development. On the other side, clinical applications for automatic tumor
classification are usually rated based on the comparison with the diagnosis result of medical
doctors. Published studies in literature do not contain a solution for the perfect tumor classifi-
cation based on perfusion MRI. This is also reflected by the results of this thesis: the character
of perfusion MRI remains supplemental to the prevailing imaging methods in clinical practice.
However, the presented frameworks could successfully improve the current state-of-the-art
evaluation.
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3TP Three-Time-Point
AIF Arterial Input Function
BBB Blood-Brain Barrier
CBF Cerebral Blood Flow
CBV Cerebral Blood Volume
CTC Concentration-time curve
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TIC Time-intensity Curve
TTP Time to Peak
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